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ABSTRACT 
 
Newcastle disease virus (NDV) belongs to the Paramyxoviridae, a family of enveloped RNA 
viruses that includes many important human and animal pathogens.  Although many aspects 
of the paramyxovirus life cycle are known in detail, our understanding of the mechanisms 
regulating paramyxovirus assembly and release are poorly understood.  For many enveloped 
RNA viruses, it has recently become apparent that both viral and host cellular determinants 
coordinate the proper and efficient assembly of infectious progeny virions.  
 Utilizing NDV as a model system to explore viral and cellular determinants of 
paramyxovirus assembly, we have shown that host cell membrane lipid raft domains serve as 
platforms of NDV assembly and release.  This conclusion was supported by several key 
experimental results, including the exclusive incorporation of host cell membrane raft-
associated molecules into virions, the association of structural components of the NDV 
particle with membrane lipid raft domains in infected cells and the strong correlation 
between the kinetics of viral protein dissociation from membrane lipid raft domains and 
incorporation into virions.  Moreover, perturbation of infected cell membrane raft domains 
during virus assembly resulted in the disordered assembly of abnormal virions with reduced 
infectivity.  These results further established membrane raft domains as sites of virus 
assembly and showed the integrity of these domains to be critical for the proper assembly of 
infectious virions. 
 Although specific viral protein-protein interactions are thought to occur during 
paramyxovirus assembly, our understanding of how these interactions are coordinated is 
incomplete.  While exploring the mechanisms underlying the disordered assembly of non-
 vi
infectious virions in membrane raft-perturbed cells, we determined that the integrity of 
membrane raft domains was critical in the formation and virion incorporation of a complex 
consisting of the NDV attachment (HN) and fusion (F) proteins.  The reduced virus-to-cell 
membrane fusion capacity of particles released from membrane raft-perturbed cells was 
attributed to an absence of the HN – F glycoprotein-containing complex within the virion 
envelope.  This result also correlated with a reduction of these glycoprotein complexes in 
membrane lipid raft fractions of membrane raft-perturbed cells.  Specifically, it was 
determined that the formation of newly synthesized HN and F polypeptides into the 
glycoprotein complex destined for virion incorporation was dependent on membrane lipid 
raft integrity.  
 Finally, a novel virion complex between the ribonucleoprotein (RNP) structure and 
the HN attachment protein was identified and characterized.  Unlike the glycoprotein 
complex, the detection of the RNP – HN protein-containing complex was not affected by 
membrane raft perturbation during virus assembly in the cell.  The biological importance of 
this novel complex for the proper assembly of an infectious progeny virion is currently under 
investigation.  
 The results presented in this thesis outline the role of host cell membrane lipid raft 
domains in the assembly and release processes of a model paramyxovirus.  Furthermore, the 
present work extends our understanding of how these particular host cell domains 
mechanistically facilitate the ordered assembly and release of an enveloped RNA virus.  
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CHAPTER I 
INTRODUCTION 
 
A.  General statement of topic 
Enveloped RNA viruses, consisting of families Filoviridae, Rhabdoviridae, 
Orthomyxoviridae, Paramyxoviridae and Retroviridae, include many clinically relevant 
human and animal pathogens.  Although several aspects of the viral life cycle of these 
pathogens are unique from virus family to virus family, many utilize the same molecular 
mechanisms to usurp host cell components in order to achieve entry, replication and egress of 
their genetic material.  Utilizing the avian Paramyxoviridae member Newcastle disease virus 
(NDV) as a model system, the aim of this thesis was to define the role of host cellular 
membrane lipid raft domains in the assembly and release of enveloped RNA viruses.  The 
results presented here establish that the integrity of membrane lipid raft domains is critical 
for the ordered assembly of infectious and functional NDV particles.  This work also begins 
to outline the molecular mechanisms by which these specific host cell membrane domains 
facilitate the proper viral protein-protein interactions necessary for the ordered assembly of 
infectious progeny virions.  The results presented here have implications for the design and 
construction of vaccines in addition to the development of novel anti-viral therapeutics 
targeting the assembly and release of enveloped RNA viruses. 
 
B. Newcastle disease virus – clinical and biological aspects  
Newcastle disease virus (NDV) is the only member of genus Avulavirus within the family 
Paramyxoviridae, which contains many other ubiquitous pathogenic human and animal 
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viruses, including mumps, human parainfluenza, human respiratory syncytial, measles, 
canine distemper, Hendra and Nipah viruses.  Depending on the virus strain and host species 
infected, Newcastle disease virus causes mild to severe disease in un-vaccinated birds; 
clinical manifestations vary from sub-clinical respiratory tract infections to multi-organ 
failure/death (181).  Due to the severe pathogenesis associated with highly virulent strains 
and the potential economic impact on the United States’ (US) poultry industry, many virulent 
strains of Newcastle disease virus have been deemed agents of agro-bioterrorism and 
classified as select agents under the Patriot Act of 2001 (181). 
 Newcastle disease virus particles are pleiomorphic in shape and typically range from 
150 to 300 nm in diameter.  The virion possesses a single lipid bilayer (the virion envelope) 
which is acquired from the plasma membrane of infected cells during budding, i.e. pinching 
off, of the virus particle.  Subsequently, the virion envelope imparts NDV particles with a 
specific buoyant density of 1.18 – 1.20 g/cm3 (82). 
 The non-segmented RNA genome of NDV is of negative polarity and is 
approximately 15, 000 nucleotides in length encoding seven genes, one of which (V gene) 
results from a RNA editing event (Fig. 1.1).  The genes of NDV are positioned 3’ – NP – P/V 
– M – F – HN – L – 5’ and each gene is separated by varying (but typically short) stretches of 
nucleotides which are not transcribed.  The NDV gene products can be designated either as 
membrane components (HN, F and M proteins) or core components (NP, P and L proteins) 
of the virus particle (Fig. 1.2).  Embedded in the virion envelope of NDV are two viral 
transmembrane glycoproteins, the hemagglutinin-neuraminidase (HN) protein and the fusion 
(F) protein.  The matrix (M) protein is peripherally associated with the inner leaflet of the  
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Legend to Figure 1.1:  Linear diagram of Newcastle disease virus genome.   
Approximate gene lengths and subsequent polypeptide masses are indicated below and 
above, respectively, for each viral gene.  Underlined numbers indicate the nucleotide lengths 
of untranslated regions between viral genes (referred to as intergenic regions), the 3’ leader 
(le) and 5’ trailer (tr) sequences.  The NDV V protein is the result of RNA editing of the 
NDV P open reading frame in which the viral polymerase complex co-transcriptionally 
inserts one G residue into the P mRNA at a specific position.  The resulting V protein shares 
a common N-terminal region with the P protein but differs in its C-terminal region from the P 
protein (82).  NP, nucleocapsid protein; P, phosphoprotein; V, V protein; M, matrix protein; 
HN, hemagglutinin-neuraminidase protein; F, fusion protein; L, large protein; kDa, 
kilodalton; nt, nucleotide.  Adapted from Lamb and Kolakofsky (82). 
 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend to Figure 1.2:  Schematic of Newcastle disease virus particle.   
HN, hemagglutinin-neuraminidase protein; F, fusion protein; P, phosphoprotein; L, large 
protein; NP, nucleocapsid protein; M, matrix protein. 
 5
virion envelope.  Within the NDV particle are the core components consisting of the genomic 
viral RNA (vRNA) completely encapsidated by approximately 2600 subunits of the 
nucleocapsid protein (NP).  Together the phosphoprotein (P) and large (L) protein make up 
the viral polymerase complex, which associates with the NP-bound vRNA to form the 
ribonucleoprotein (RNP) structure (82).  
 
C.  Paramyxoviridae life cycle 
The first step of the paramyxovirus life cycle is attachment of the virus particle to a host 
cellular receptor (Fig. 1.3).  As the viral attachment protein, the HN protein of the Newcastle 
disease virus particle mediates binding to sialic acid on the surfaces of host cells (82).  The 
binding of HN protein leads to an activation of the viral F protein to induce fusion of the 
virion envelope to that of the host cell plasma membrane at neutral pH.  This membrane 
fusion event allows the release of the RNP structure into the cytosol of the host cell (Fig. 
1.3).  Following uncoating of the genomic vRNA, primary transcription of the viral genes 
takes place by the virion-associated viral polymerase complex.  Due to the stuttering and 
falling off of the viral polymerase complex across intergenic regions, a gradient of 
monocistronic transcripts accumulate in the order NP > P > M > F > HN > L.  Upon 
sufficient translation of NP, the negative-sense vRNA is transcribed by the viral polymerase 
complex into a positive-sense complementary full-length RNA intermediate, called the anti-
genome (Fig. 1.3).  The anti-genome is then used as a template for the generation of the 
negative-sense, genomic vRNA destined for incorporation into progeny virions (82).  The 
newly synthesized genomic vRNA is then used for secondary transcription of the viral genes 
by the viral polymerase complex, thereby providing the major source of viral mRNAs (82). 
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Legend to Figure 1.3:  Schematic of paramyxovirus life cycle.   
1. Attachment of virus particle to host cellular receptor, 2. fusion of virion envelope with host 
cell plasma membrane results in release of viral genome, 3. primary transcription and 
subsequent translation of viral genome, 4. replication of negative-sense (–) viral RNA 
through a positive-sense (+), anti-genome RNA intermediate, 5. secondary transcription, 6. 
accumulation and assembly of viral structural components, and 7. release of progeny virions. 
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 The viral transcripts encoding the viral HN and F glycoproteins are translated at the 
rough endoplasmic reticulum (RER).  The individual polypeptides then transit from the RER 
through the Golgi membranes and to the plasma membrane (82).  The remaining viral 
structural proteins, NP, P, M and L proteins, are synthesized on free ribosomes in the cytosol.  
It is thought that assembly and release of progeny virions occurs at the host cell plasma 
membrane upon sufficient accumulation and localization of all viral structural components 
(Fig. 1.3) (82).   
 
D. Molecular mechanisms of paramyxovirus assembly and release 
In comparison to other aspects of the paramyxovirus life cycle, relatively little is known 
about the assembly and release of progeny virions.  Until recently, it was assumed that the 
viral structural proteins arbitrarily assembled and virions randomly budded from the surfaces 
of infected cells.  However, studies in many enveloped RNA virus systems have revealed that 
specific viral protein-protein interactions take place in infected cells during virus particle 
assembly (183).  It has also been documented in many systems that several host cell 
components aid in the assembly and release of enveloped RNA virus particles (134, 157).   
 Initial studies consisted of using temperature-sensitive virus mutants to examine viral 
determinants of virion assembly and release.  Recently, the development of virus-like particle 
(VLP) systems has aided in our understanding of the requirements for enveloped RNA virus 
particle assembly and release.  Upon expression of viral structural proteins from transient 
transfection of cDNA or through expression via transduction with recombinant baculovirus 
or recombinant vaccinia virus, virus-like particles, which are structurally very similar to 
authentic virus (70) but lack the corresponding genetic material necessary for virus 
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replication, can be isolated from cell culture supernatants.  Similarly, the establishment of 
reverse genetics systems to generate recombinant viruses from plasmid DNA for many 
enveloped RNA viruses has significantly contributed to elucidating the molecular 
mechanisms of virus assembly and release. 
 Studies using these systems have shown that several key events must first take place 
before assembly of an infectious progeny paramyxovirus particle commences: 1. efficient 
transport of the viral transmembrane glycoproteins through the secretory pathway to the cell 
surface, 2. efficient transport/localization of the viral soluble components (M protein and 
viral RNP structures) near the cell surface, 3. specific organization/interaction among the 
viral structural components for the set-up of the viral assembly site, and 4. any interactions 
between viral structural proteins with host cell machinery necessary for efficient virion 
egress (157). 
 
Role of the paramyxovirus glycoproteins in virus assembly 
Paramyxoviruses encode and package into virions two transmembrane glycoproteins required 
for virus entry: an attachment protein (HN, H or G) and a fusion (F) protein.  Initial studies 
using a temperature-sensitive mutant of Sendai virus (SeV) where virally-encoded HN 
protein was degraded prior to reaching the cell surface revealed that virions lacking HN 
protein were released (99, 135, 136, 179, 184).  Later studies using a Sendai VLP system 
confirmed that HN protein was dispensable for virion assembly and release (89, 182).  
Furthermore, the Sendai virus F protein was found to intrinsically bud into F protein-bearing 
particles when expressed alone; Sendai HN protein did not demonstrate this capability (182).  
Experiments analyzing the assembly/release of another paramyxovirus, simian virus 5 (SV5), 
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concluded that the roles of SV5 glycoproteins were redundant during virus assembly; SV5 
VLP budding efficiency was not affected upon sole expression of either HN or F 
glycoprotein in comparison to expression of both glycoproteins (158).    
 Although the paramyxovirus glycoproteins might have redundant functions during 
assembly and budding, the cytoplasmic tails (CT) of each have been shown to be critical for 
efficient virus assembly and release when expressed in the absence of the other glycoprotein.  
Several different studies using the Sendai VLP and recombinant Sendai virus systems have 
identified a small region of the F protein CT as being important for efficient Sendai particle 
release (41, 182).  Also, truncation of the Sendai HN protein CT resulted in poor particle 
budding (41).  Similar results were obtained in the SV5 VLP system where inefficient 
particle release was observed when single HN or F glycoproteins possessing truncated CT 
domains were solely expressed (156).  These Sendai and SV5 virus studies further suggested 
that both HN and F glycoproteins have important, but redundant, roles in virus assembly; 
however, the function of each glycoprotein in assembly requires the presence of the 
glycoprotein CT domain. 
 
Role of the paramyxovirus M protein during virus assembly 
In many enveloped RNA virus systems, the matrix-like proteins (e.g. filovirus VP40, 
rhabdovirus M, orthomyxovirus M1, paramyxovirus M and retrovirus Gag proteins) are 
peripherally associated with membranes in both infected cells and in virions (157).  Due to 
their intimate contact with the inner leaflet of the virion envelope, it is believed that matrix-
like proteins serve to link glycoprotein tails to the RNP structure.  Moreover, it has been 
shown in several enveloped RNA virus systems that these matrix-like proteins are central 
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organizers of virus assembly and typically are needed to drive the release of both authentic 
virus and virus-like particles (157).   
 Regarding the Paramyxoviridae, Sendai viruses encoding temperature sensitive 
mutations in the M gene, which resulted in unstable M protein levels, were defective in 
Sendai virus release; expression in trans of wild-type M protein or substantial over-
expression of the mutant M protein rescued normal levels of virus release (75, 195).  These 
results suggested that an appropriate level of M protein expression was necessary for virus 
particle release to commence.  Furthermore, studies of a natural variant of measles virus, 
isolated from patients suffering from a persistent measles virus infection called subacute 
sclerosing panencephalitis (SSPE), revealed that the SSPE-derived measles viral genome 
possessed extensive mutations in the M gene that affected the production of virus particles 
from infected cells (24, 25, 190).  Similarly, the poor release of virions from cells persistently 
infected with Sendai virus correlated with mutations in the M gene resulting in unstable M 
protein levels (148).  Moreover, Sendai recombinant viruses generated to lack the M gene 
resulted in poor virus release (67).  
 The establishment of VLP systems has further defined a central role for the 
paramyxovirus M protein in virus assembly and release.  Similar to results obtained after the 
sole expression of matrix-like proteins from other enveloped RNA viruses, like filovirus 
VP40 (68), rhabdovirus M (69), orthomyxovirus M1 (120) and retrovirus Gag (113), the 
paramyxovirus M proteins were shown to release as M protein-containing enveloped 
particles upon expression of human parainfluenza virus type 1 (hPIV1) (29), Sendai virus 
(182) and Newcastle disease virus (130). 
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 However, the self-budding capacity of paramyxovirus M proteins varies from 
individual virus to individual virus.  Unlike the hPIV1, Sendai and Newcastle disease virus 
encoded M proteins, the SV5 M protein required co-expression of NP and either the HN or F 
glycoprotein for release of SV5 VLPs (158).  Subsequent studies suggested that expression of 
other viral components enhanced the release of VLPs driven by the paramyxovirus M 
proteins, like Sendai virus P protein (182).   
 Similar to the matrix-like proteins of other enveloped RNA viruses (e.g. filovirus 
VP40, rhabdovirus M and retrovirus Gag proteins), the self-budding capability of 
paramyxovirus M proteins was attributed to the presence of a short amino acid motif called a 
late domain(s); so named to indicate its function late in the viral life cycle (13, 157, 183).  As 
a form of molecular mimicry, viral late domains are thought to bind to and usurp the host cell 
machinery used for host cell vesicle formation/budding for the purposes of virus particle 
budding (42).  Although several different late domains have been found throughout 
paramyxovirus M proteins, the exact role of these protein motifs in virus assembly/release is 
undefined and controversial.   
 
Viral protein-protein interactions during paramyxovirus assembly 
Given the importance of the paramyxovirus glycoproteins and matrix protein for efficient 
virus assembly and release, paramyxovirus assembly-related research has focused on the 
details of the viral protein-protein interactions necessary for the actual assembly process and 
the exact cellular localization of the virus assembly/budding site. 
 Regarding paramyxovirus protein-protein interactions during the assembly process, 
the M protein is thought to be a key organizer due to its location near the viral 
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transmembrane glycoprotein tails and its proximity to RNP structures in the cytosol.  The 
paramyxovirus M proteins are thought to self-associate to form large crystalline arrays 
underlying the plasma membrane, which have been observed by electron microscopy in 
infected cells (7, 58).  However, data on the protein-protein interactions of paramyxovirus M 
proteins with viral glycoproteins varies from study to study.  In respiratory syncytial virus 
(RSV), the G attachment protein was found to specifically bind to the M protein (46); 
similarly, in NDV VLPs the HN attachment protein was found to interact with M protein 
(130).  However, in addition to binding the HN or G attachment protein, some reports also 
suggest an interaction between paramyxovirus M proteins specifically with the F protein (3, 
154, 156, 158).      
 Incorporation of the viral RNA genome, which is encapsidated by NP to form the 
RNP structure, is of utmost importance during progeny virus assembly to ensure egress of the 
genetic material.  In the absence of experimental data supporting a direct interaction between 
the viral glycoproteins and components of the RNP structure, several reports have implicated 
the paramyxovirus M protein in binding to NP (82).  The overall acidity of paramyxovirus 
nucleocapsid proteins is thought to not only facilitate the encapsidation of viral RNA but also 
play a role in binding to the paramyxovirus M protein, which is quite basic (82). The NP and 
M protein interaction perhaps serves as a mechanism to tether the RNP complex to the 
attachment and fusion glycoproteins during virus assembly.  This hypothesis is substantiated 
by the reduced co-localization of viral RNP structures with viral glycoproteins in cells 
infected with a recombinant measles virus lacking the M gene (23).     
 However, given the absence of a definitive interaction between the M protein and 
either of the glycoproteins in several paramyxovirus systems, the molecular mechanism(s) 
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that ensure the RNP structure is efficiently incorporated into assembling virus particles is 
unknown.   
 Therefore, data outlining the interactions between the different viral proteins needed 
to assemble and release an authentic paramyxovirus particle are not complete.  Although the 
results obtained thus far start to address some of the questions regarding the molecular 
mechanisms underlying paramyxovirus assembly and release, many factors specific to the 
different experimental systems employed complicate the results.  For example, many VLP 
studies have failed to address the role of minor structural proteins, like paramyxovirus L 
protein, P protein and the P gene-derived protein(s), during the assembly/release process.  
Furthermore, in the context of an infected cell, the expression of these minor structural 
proteins has dramatic consequences on cellular events, such as antagonism of the 
intracellular IFN-α/β response, host cell RNA transcription and host cell protein synthesis 
(82).  The roles of these minor virion components in paramyxovirus assembly and release 
have yet to be fully defined. 
 Many other issues also cloud several paramyxovirus assembly/release studies.  
Because the Paramyxoviridae family includes viruses infecting a broad range of host species 
with specific pathologies, one must consider utilizing an appropriate cell type from an 
appropriate species when studying a particular paramyxovirus in vitro.  Like many viral 
pathogens, paramyxoviruses, as species specific viruses, have evolved to be most efficient at 
each stage of their life cycle while infecting the appropriate host cell type in vivo.  Therefore, 
drawing conclusions from assembly studies in which, for example, a mouse paramyxovirus is 
being studied in a human cell line, can be problematic.  
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 In addition to the issues raised thus far, several key and relatively general questions 
regarding viral protein-protein interactions during paramyxovirus assembly still remain:  
1. Is it the case that individual glycoproteins or complexes composed of both 
glycoproteins exist in infected cells as substrates for virus assembly? 
2. Is there a definitive, physical interaction between the viral glycoproteins and other 
virion components, such as the M protein or RNP structures? 
3. How is the RNP structure containing the viral genomic RNA efficiently 
incorporated into assembling particles?  
4. Are there host cell determinants that dictate (or have been utilized by the virus to 
facilitate) the viral protein-protein interactions that occur in infected cells?  
 
Viral protein-lipid interactions during paramyxovirus assembly 
Being an enveloped virus and encoding two transmembrane glycoproteins essential for 
sustaining their replicative life cycle, paramyxoviruses critically rely on interactions with 
host cellular membranes during virus assembly and release.  Following biosynthesis and 
transit through the secretory pathway, the attachment and fusion glycoproteins are embedded 
into the surface plasma membrane of infected cells.  The M proteins of Sendai (178), measles 
(146) and Newcastle disease (37) viruses have all been shown to display an intrinsic affinity 
for membrane bilayers.  Furthermore, the reconstituted NDV M protein demonstrated the 
ability to associate and self-bud into synthetic liposomes (162).  Intriguingly, the addition of 
cholesterol to these synthetic liposomes significantly increased the budding activity of the 
NDV matrix protein (162). 
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 It is speculated that the targeting of the glycoproteins to the plasma membrane, via 
their hydrophobic transmembrane domains, and the innate membrane affinity displayed by 
the paramyxovirus M proteins (along with associated RNP structures) serve to concentrate all 
the components necessary for virion production to the virus assembly site at the cell surface.  
In the context of an infected cell, spatially considering the abundant distribution of each 
glycoprotein on the cell surface along with the intracellular localization of multiple virion 
components like the M protein and RNP structures, several key questions remain:  
1. How is the virus assembly/release site chosen from among the copious volume of 
lipid bilayer that is the cellular plasma membrane?  
2. Which viral protein(s) ultimately determines the localization of the virus 
assembly/release site? 
3. How is it that all the necessary viral proteins are exclusively (and efficiently) 
incorporated into budding virus particles while host cell proteins are largely 
excluded from virus assembly/release sites? 
 Several clues to the answers of these types of questions are found among several 
experimental observations gathered over the years.  Although the assembly of many 
enveloped RNA viruses occurs at the host cell surface, the composition of the virion 
envelopes differed quite significantly from the composition of the host cell plasma membrane 
from which the virus was released (4, 108, 131, 138, 139, 143, 171).  These observations 
suggested to researchers that enveloped viruses may bud specifically from a set of cell 
surface membrane microdomains with unique lipid compositions (131).   
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E. Host membrane lipid raft domains in enveloped RNA virus assembly and release 
Biological properties of membrane lipid raft domains 
The plasma membrane of mammalian cells has been characterized as possessing lateral 
microdomains, termed membrane lipid raft domains (19, 167).  Membrane lipid raft domains 
are primarily composed of a subset of lipids – sphingolipids (35), which possess highly 
saturated fatty acid tails.  The arrangement of the sphingolipid hydrocarbon tails allows for 
the tight packing of cholesterol molecules between their interstitial space, thereby creating a 
local membrane environment referred to as liquid-ordered (lo) (35).  Liquid-ordered 
membranes display drastically different biophysical properties in comparison to fluid phase 
membranes, which typically are mixtures of lipids possessing unsaturated fatty acid tails.  
The unique properties of liquid-ordered membrane allows for the inclusion of specific 
molecules, while excluding others.  For example, specific proteins, such as raft-organizing, 
acylated, and glycosylphosphatidylinositol (GPI)-anchored proteins partition into membrane 
lipid raft domains, resulting in their concentration into small patches within the plasma 
membrane (Fig. 1.4). 
 Although current technology limits the ability to characterize fully these biological 
microdomains, several biochemical and molecular techniques have helped to shed light on 
their existence and function.  Isolation of detergent-resistant membranes (DRMs), which are 
largely thought to experimentally reflect membrane raft domain composition in vivo (167), 
can be achieved upon extraction of cells in cold non-ionic detergents (e.g. Triton X-100 and 
Brij-98) followed by equilibrium flotation centrifugation of DRMs to their specific buoyant 
densities.  Several pharmacological agents have proven useful in the study of membrane lipid  
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Legend to Figure 1.4:  Schematic diagram of membrane lipid raft domains and raft-
associated host cell molecules at the cell surface.   
Exoplasmic and cytoplasmic refer to the two leaflets of the plasma membrane bilayer.  GPI, 
glycosylphosphatidylinositol.       
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raft domains, taking advantage of the cholesterol requirement for their formation.  The 
antibiotics nystatin and amphotericin serve to sequester cholesterol from membranes, while 
methyl-β-cyclodextrin (mβCD) depletes cholesterol from membranes (155, 167, 192). 
 Cholesterol-rich membrane lipid raft domains have been implicated in a variety of 
important cellular processes, including membrane and protein trafficking events, signal 
transduction, endocytosis, cell-cell attachment and immunological synapse formation (19, 
165, 167).  Recently, membrane lipid raft domains have been shown to participate in both 
viral entry and exit (97).  As a means of concentrating specific molecules to increase the 
specificity and efficiency of molecular events occurring at membrane surfaces, the intrinsic 
ability of these specialized membrane domains to include/exclude specific molecules is an 
ideal cellular feature for an assembling enveloped virion to hijack. 
 
Role of membrane lipid raft domains in enveloped RNA virus assembly and release 
Initial experimental observations suggested that membrane lipid raft domains are sites of 
enveloped RNA virus assembly and release.  Evidence for this conclusion included the 
presence of specific membrane lipid raft-associated molecules/markers in purified virions; 
for example, raft-associated ganglioside GM1, GPI-anchored Thy-1 and CD59 proteins and 
caveolin-1 have all been variably detected in human immunodeficiency virus type 1 (HIV-1), 
influenza virus and several paramyxoviruses (20, 122, 132, 149).  Mechanistically, host cell 
membrane lipid raft domains appear to facilitate the assembly/release of enveloped RNA 
viruses in several non-mutually exclusive ways (126).  First, these specialized membrane 
domains may provide a means of efficiently targeting viral transmembrane glycoproteins to 
virus assembly sites.  Many viral glycoproteins of enveloped RNA viruses fractionate with 
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detergent-resistant membranes, the cellular membrane fraction that biochemically reflects 
membrane lipid raft domains (167).  The Env glycoproteins of Retroviridae members HIV-1 
(122) and murine leukemia virus (91) have been detected in DRMs.  Both influenza HA 
(169) and NA (9) glycoproteins were found associated with DRMs.  Among the 
paramyxovirus glycoproteins, the Sendai virus F and HN proteins (152), measles virus F 
protein (187), the respiratory syncytial virus (RSV) F protein (59), RSV SH protein (147) and 
NDV F protein (33) were associated with DRMs.   
 Similarly, membrane lipid raft domains may provide an efficient way to localize other 
viral structural components to viral glycoprotein-enriched virus assembly sites.  The 
peripheral membrane-associated matrix-like proteins of different types of enveloped RNA 
viruses, which typically drive the release of virus and virus-like-particles (157), have also 
been found associated, directly or indirectly, with DRMs.  The HIV-1 Gag protein 
intrinsically associates with DRMs (122).  However, the influenza M1 protein only targets to 
DRMs when co-expressed with HA and NA glycoproteins (2).  Similarly, Sendai virus M 
protein stably associates with DRMs only when F or HN proteins are present (3) while RSV 
M protein requires expression of the F protein for DRM association (59).  In contrast, the 
measles virus M protein displays an innate affinity for DRMs in the absence of other viral 
proteins (187).    
 Additional evidence supporting a role for membrane lipid raft domains in enveloped 
RNA virus assembly came from studies examining the effects of membrane lipid raft 
disruption on virus release.  Pickl et al. (132) reported a significant reduction in Moloney 
murine leukemia virus particle production as well as particle infectivity upon treatment of 
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virus-producing cells with the cholesterol-extracting drug methyl-β-cyclodextrin (167); 
similar results were obtained with HIV-1 release studies (125, 127).   
 Together with the observations documenting the accumulation of key viral structural 
proteins in membrane lipid raft domains, these results suggest that membrane lipid raft 
domains participate in some unknown manner in the assembly and release of enveloped RNA 
viruses.  It has been speculated that these specific host cell microdomains, by concentrating 
viral structural proteins, may facilitate the viral protein-protein interactions necessary for the 
proper assembly of infectious progeny virions.   
 
F. Contents of dissertation 
Utilizing Newcastle disease virus as a model system, the important role of host cellular 
membrane lipid raft domains in the assembly and release of enveloped RNA viruses is 
explained in this thesis.  The molecular mechanisms by which these domains facilitate the 
proper viral protein-protein interactions necessary for the ordered assembly and release of an 
infectious Newcastle disease virus particle are also presented.  Evidence supporting the 
conclusions that membrane lipid raft domains serve as sites of NDV assembly and function 
as platforms for the formation of protein-protein interactions necessary to generate an 
infectious progeny virion is incorporated into this thesis from two peer-reviewed published 
manuscripts, the abstracts of which are shown below for Chapters II and III.  Also presented 
are unpublished results exploring the role of cholesterol in the formation and maintenance of 
HN – F glycoprotein-containing complexes in cells (Chapter IV).  In addition, recently 
acquired results documenting the identification and characterization of a novel membrane 
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lipid raft-independent complex between the HN protein and nucleocapsid protein in NDV 
particles is presented (Chapter V).   
 
Chapter II: Integrity of membrane lipid rafts is necessary for the ordered assembly and 
release of infectious Newcastle disease virus particles (published in Journal of Virology 
Vol. 80, No. 21) 
Membrane lipid raft domains are thought to be sites of assembly for many enveloped viruses. 
The roles of both classical lipid rafts and lipid rafts associated with the membrane 
cytoskeleton in the assembly of Newcastle disease virus (NDV) were investigated. The lipid 
raft-associated proteins caveolin-1, flotillin-2, and actin were incorporated into virions, while 
the non-lipid raft-associated transferrin receptor was excluded. Kinetic analyses of the 
distribution of viral proteins in lipid rafts, as defined by detergent-resistant membranes 
(DRMs), in non-lipid raft membranes, and in virions showed an accumulation of HN, F, and 
NP viral proteins in lipid rafts early after synthesis. Subsequently, these proteins exited the 
DRMs and were recovered quantitatively in purified virions, while levels of these proteins in 
detergent-soluble cell fractions remained relatively constant. Cholesterol depletion of 
infected cells drastically altered the association of viral proteins with DRMs and resulted in 
an enhanced release of virus particles with reduced infectivity. Decreased infectivity was not 
due to effects on subsequent virus entry, since the extraction of cholesterol from intact virus 
did not significantly reduce infectivity. Particles released from cholesterol-depleted cells had 
very heterogeneous densities and altered ratios of NP and glycoproteins, demonstrating 
structural abnormalities which potentially contributed to their lowered infectivity. Taken 
together, these results indicate that lipid rafts, including cytoskeleton-associated lipid rafts, 
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are sites of NDV assembly and that these domains are important for ordered assembly and 
release of infectious Newcastle disease virus particles. 
 
Chapter III: Incorporation of functional HN – F glycoprotein-containing complexes into 
Newcastle disease virus is dependent on cholesterol and membrane lipid raft integrity 
(published in Journal of Virology Vol. 81. No. 19) 
Newcastle disease virus (NDV) assembles in plasma membrane domains with properties of 
membrane lipid rafts and disruption of these domains by cholesterol extraction with methyl-
β-cyclodextrin (mβCD) resulted in the release of virions with irregular protein composition, 
abnormal particle density, and reduced infectivity (J. Virol. 80:10652-10662, 2006).  In the 
present study, these results were confirmed using Niemann-Pick syndrome type C (NPC) 
cells, which are deficient in normal membrane rafts due to mutations affecting cholesterol 
transport.  Furthermore, cholesterol extraction of infected cells resulted in the release of 
virions that attached to target cells at normal levels, but were defective in virus-cell 
membrane fusion.  The reduced fusion capacity of particles released from cholesterol-
extracted cells correlated with significant loss of HN – F glycoprotein-containing complexes 
detected in the virion envelopes of these particles and with detection of cell-associated HN – 
F protein-containing complexes in extracts of cholesterol extracted cells.  Extraction of 
cholesterol from purified virions had no effect on virus-cell attachment, virus-cell fusion, 
particle infectivity or the levels of glycoprotein-containing complexes.  Taken together, these 
results suggest that cholesterol and membrane rafts are required for the formation or 
maintenance of HN – F glycoprotein-containing complexes in cells but not the stability of 
pre-formed glycoprotein complexes once assembled into virions. 
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Chapter IV: The role of cholesterol and membrane lipid raft domains in the formation 
and maintenance of the Newcastle disease virus HN – F glycoprotein-containing 
complex   
The presence of the HN – F glycoprotein-containing complex in infected cells is critical to 
the assembly of a virus-to-cell membrane fusion-competent and infectious Newcastle disease 
virus (NDV) particle.  Cellular cholesterol depletion and membrane lipid raft perturbation 
significantly reduced the availability and incorporation of HN – F glycoprotein-containing 
complexes into virions, thereby rendering released particles relatively non-infectious.  To 
extend these studies, we characterized the cholesterol- and membrane raft-dependent phase 
of the glycoprotein complex’s existence in infected cells, specifically analyzing whether the 
maintenance of pre-formed glycoprotein complexes and/or the formation of new HN – F 
glycoprotein-containing complexes is cholesterol-sensitive.  Utilizing the release of 
infectious virions as an experimental readout, the levels of infectious virus released during 
and shortly after cholesterol extraction of infected cells suggested that those pre-formed 
glycoprotein complexes at virus assembly sites were unaffected by cholesterol depletion.  
However, at times when the individual HN and F proteins were synthesized and available for 
virion incorporation in cells already depleted of cholesterol, the infectivity of released virions 
was significantly reduced.  This result suggested that the formation of the HN – F 
glycoprotein-containing complex was aberrant when cellular cholesterol levels were low and 
the integrity of membrane raft domains compromised.  The formation and direct detection of 
the glycoprotein complex was decreased in the Niemann-Pick syndrome type C cellular 
background, in which membrane lipid raft domain formation and function are intrinsically 
abnormal.  Together these results imply that the cholesterol-enriched membrane lipid raft 
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domains of cells facilitate the formation of newly synthesized HN and F polypeptides into the 
HN – F glycoprotein-containing complexes necessary for the assembly of an infectious 
virion.  Furthermore, following the formation of the glycoprotein complex, cholesterol and 
the integrity of membrane lipid raft domains becomes less important for the maintenance of 
the complex. 
 
Chapter V: Dissection of Newcastle disease virion architecture: identification of a novel 
complex of RNP-associated NP and HN protein (manuscript in preparation) 
The molecular mechanisms regulating the assembly and release of paramyxovirus particles 
are poorly understood.  Since virion associated protein complexes likely reflect the 
complexes required for virus assembly in infected cells, virion associated protein complexes 
in Newcastle disease virus particles were characterized by sucrose gradient sedimentation, 
virion fractionation, and co-immunoprecipitation.  Sedimentation of virion proteins into a 
linear sucrose gradient suggested the existence of several viral protein-protein complexes, 
including the previously characterized HN – F glycoprotein-containing complex (J. P. 
Laliberte, L. W. McGinnes, and T.G. Morrison, J. Virol. 81:10636-10648, 2007).  However, 
distinct individual populations of HN and F glycoproteins were also found, suggesting at 
least two populations of HN and F protein in virions.  Furthermore, sucrose gradient 
sedimentation as well as virion fractionation into membrane and core components suggested 
a novel RNP – HN protein complex with a ratio of NP to HN protein of 30 to 1.  The 
presence of this complex was confirmed by specific immunoprecipitation of the majority of 
NP and P protein with anti-HN protein antibody, and reciprocally, the specific precipitation 
of HN protein with anti-P protein antibody.  In contrast, the virion M protein was not 
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detected in a complex with the RNP-associated NP and HN protein.  Indeed, virion M protein 
was not detectably associated with either HN or F glycoprotein and was only minimally 
detected in a complex with NP. 
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CHAPTER II 
Integrity of membrane lipid rafts is necessary for the ordered assembly and release of 
infectious Newcastle disease virus particles 
 
A. Introduction 
Paramyxoviruses, such as Newcastle disease virus (NDV), are enveloped negative-sense 
RNA viruses.  NDV virions contain four main structural proteins: nucleocapsid protein (NP), 
matrix (M), fusion (F) and hemagglutinin-neuraminidase (HN) proteins, as well as the 
polymerase complex of phosphoprotein (P) and large (L) protein (82).  Although many 
details of the paramyxovirus life cycle are well-known, virion assembly and release are less 
well characterized.  Specific viral protein-protein interactions are likely required for 
assembly but are incompletely characterized (183).  Cellular proteins are necessary for the 
release of many enveloped viruses, including paramyxoviruses (134, 157), but their roles 
remain to be fully clarified.  Membrane lipid raft domains are also thought to be important in 
virion assembly and release of several types of enveloped viruses (126), however, the role of 
these domains in paramyxovirus assembly and release is not well understood. 
 Membrane lipid raft domains have been implicated in the assembly and release of a 
wide variety of viruses, including human immunodeficiency (HIV), Ebola and Marburg 
viruses, influenza and measles viruses [reviewed in (126)].  Membrane lipid rafts are defined 
as cholesterol- and sphingolipid-rich microdomains in the exoplasmic leaflet of the cellular 
plasma membrane (167).  The tight packing of cholesterol molecules among the saturated 
fatty acid tails of sphingolipids creates a local membrane organization, referred to as “liquid-
ordered,” which possesses properties different from that of the surrounding bulk plasma 
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membrane (167).  Specific proteins, such as raft-organizing, acylated and 
glycosylphosphatidyl-inositol (GPI)-anchored proteins, partition into these domains, 
resulting in their concentration into patches within the plasma membrane.  Membrane lipid 
rafts function in membrane trafficking events and cell-cell attachment and serve as signal 
transduction platforms in many cell types (167). 
 Membrane lipid rafts are also thought to be sites of virus assembly and release, based 
primarily on two lines of reasoning.  First, lipid raft-associated molecules are found in 
purified virions.  For example, ganglioside GM1, GPI-anchored Thy-1 and CD59 proteins, 
and caveolin-1 have all been variably detected in HIV, influenza virus and several 
paramyxoviruses (20, 122, 132, 149).  Second, viral proteins fractionate with detergent-
resistant membranes (DRMs), a cell fraction that biochemically reflects lipid rafts (167).  The 
Env glycoproteins of HIV-1 (122) and murine leukemia virus (91) have been detected in 
DRMs.  Both influenza HA (169) and NA (9) glycoproteins were found associated with 
DRMs.  Among the paramyxovirus glycoproteins, the Sendai F and HN proteins (152), 
measles virus F protein (187), the respiratory syncytial virus (RSV) F protein (59), RSV SH 
protein (147) and NDV F protein (33) are associated with DRMs.   
 The peripheral membrane-associated matrix-like proteins of different types of 
enveloped viruses drive the release of virus and virus-like-particles (157).  These proteins 
also associate, directly or indirectly, with DRMs.  The HIV Gag protein intrinsically 
associates with DRMs (122).  However, the influenza M1 protein only targets to DRMs when 
co-expressed with HA and NA glycoproteins (2).  Similarly, Sendai M protein stably 
associates with DRMs only when F or HN proteins are present (3) while RSV M protein 
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requires expression with the F protein for DRM association (59).  In contrast, the measles M 
protein displays an innate affinity for DRMs in the absence of other viral proteins (187). 
 To explore the functional significance of paramyxovirus protein association with 
membrane lipid rafts, the role of these domains in the assembly and release of Newcastle 
disease virus was characterized.  As reported in other systems, NDV particles contained lipid 
raft-associated proteins but not a non-raft protein and NDV proteins were found in DRMs.  
To extend these results, first, NDV proteins were shown to be associated with a newly 
defined class of DRMs, those that are attached to the cortical membrane cytoskeleton (121).  
Second, a kinetic analysis of the NDV proteins’ association and dissociation with DRMs and 
incorporation into virions suggested a direct relationship between DRM dissociation and 
virion release.  Third, the perturbation of membrane lipid rafts by cholesterol depletion 
significantly stimulated the release of structurally abnormal and non-infectious virus 
particles.  Taken together, these results suggest that the integrity and organization of 
cholesterol-rich membrane lipid rafts are critical for the ordered assembly and release of 
infectious Newcastle disease virus particles. 
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B.  Materials and Methods 
Cells, virus and reagents 
East Lansing Line (ELL-0) avian fibroblasts from American Type Culture Collection were 
maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with penicillin-
streptomycin and 10% fetal calf serum (FCS).  NDV, strain AV, stocks were prepared by 
growth in eggs by standard protocols (105) under BSL-3 conditions.  Methyl-β-cyclodextrin 
(Sigma-Aldrich) was re-suspended in DMEM.  Lovastatin (Sigma-Aldrich) was prepared in 
H2O and activated as described previously (40).  Triton X-100 was purchased from Pierce 
Biotechnology. 
Antibodies 
Anti-caveolin-1 was obtained from Santa Cruz Biotechnology; anti-flotillin-2 from BD 
Transduction Labs; anti-transferrin receptor from Zymed Laboratories; anti-actin from 
Sigma-Aldrich.  Anti-NDV (106), anti-M (38), HN protein-specific anti-A (103), F protein-
specific anti-HR1 (102), anti-HR2 (33), anti-Ftail (188), anti-F2-96 (103) and anti-Fu1a (118) 
have been described previously. 
Infections and radioactive labeling  
ELL-0 cells seeded at approximately 6 x 105 cells per 35-mm plate were grown overnight and 
then infected with NDV at a multiplicity of infection (MOI) of 10 in 0.25 ml of medium 
under BSL-3 conditions.  After 45 min one ml of medium was added and monolayers 
incubated for 5-8 hours.  For radioactive labeling, cells were radiolabeled at 6 h post 
infection for 20 min (kinetic experiments) or 1 h (mβCD experiments) at 37oC in DMEM 
supplemented with 100 μCi of [35S] methionine and cysteine per ml (New England Nuclear).  
At the end of the labeling period, cells were incubated with chase media (DMEM 
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supplemented with 0.1 mM cold methionine with or without 10% FCS).  At the end of each 
non-radioactive chase time-point, culture supernatants were collected for virion purification 
on gradients and cells harvested for isolation of DRMs as described below.   
Virus purification 
Culture supernatants were clarified by centrifugation at 5,000 RPM for 5 min and then 
particles in the supernatant were subjected to sedimentation through 20% sucrose (w/vol) to a 
20-65% sucrose interface (24,000 RPM for 10-12 h at 4°C using a Beckman SW50.1 rotor).  
For virion flotation, purified virus taken from 20-65% sucrose interface fractions was 
adjusted to ~60% sucrose (w/vol) and overlaid on top of ~80% (1.24 g/cm3) sucrose.  The 
sucrose layer containing virus was then overlaid with 1 ml 50%, 1 ml 38% and 0.5 ml 10% 
sucrose in a SW50.1 tube.  Samples were subjected to centrifugation at 100,000 x g for 18 h 
at 4oC.  Fractions were collected from the bottom of the gradient (each fraction was 0.5 ml, 
except the first fraction which had a volume of 1 ml).  For virion sedimentation, purified 
virus taken from 20-65% sucrose interface fractions was adjusted to ~10% sucrose (w/vol) 
and overlaid on top of a 20-65% continuous sucrose gradient.  Samples were subjected to 
centrifugation at 100,000 x g for 18 h at 4oC.  Fractions (0.5 ml in volume) were collected 
from the bottom of the gradient.  All fractions were made 1% with respect to Triton X-100 
and 0.5% with respect to sodium deoxycholate.  Viral proteins were immuno-precipitated and 
resolved by SDS-PAGE as described below.  The densities of all sucrose fractions were 
measured using a refractometer and are indicated as g/cc. 
Preparation of protein-containing samples for SDS-PAGE and Western analysis 
For cell extracts, ELL-0 cell monolayers were washed in PBS and lysed in TNE buffer (25 
mM Tris-HCl pH 7.4, 150 mM NaCl2 and 5 mM EDTA) containing 1% Triton X-100, 0.5% 
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sodium deoxycholate and 2.5 mg/ml of N-ethylmaleimide (NEM).  For gradient fractions, 
viral proteins were immuno-precipitated using a cocktail of antibodies (α-NDV, α-M, α-A, 
α-Fu1a, α-F2-96, α-HR1, α-HR2 and α-Ftail antibodies).  Antibody complexes were 
precipitated with pansorbin cells (Calbiochem) and washed three times in PBS containing 
0.4% sodium dodecyl sulfate (SDS).  All protein-containing samples were diluted in 2X 
sample buffer (125 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol) with or without 0.7 M ß-
mercaptoethanol and boiled for 2-5 min prior to loading on 8% polyacrylamide gels.  
Following electrophoresis, gels were transferred to Immobilon-P (Millipore Corporation) 
membranes for Western blot analysis.  The membranes were blocked 2-4 h at 4°C in PBS 
containing 0.5% Tween-20 and 10% nonfat milk, washed with PBS-Tween-20 and incubated 
for 1 h at room temperature with primary antibody in PBS-Tween-20.  Membranes were then 
washed, incubated for 1 h at room temperature with secondary antibody (goat anti-rabbit 
immunoglobulin coupled to horseradish peroxidase [Amersham Biosciences]) in PBS-
Tween-20 and then washed in PBS-Tween-20 prior to detection with the ECL Western 
Blotting Detection Reagent System (Amersham Biosciences).  Polyacrylamide gels 
containing radiolabeled proteins were fixed in acetic acid, treated with 2,5-diphenyloxazole 
(Sigma-Aldrich), dried for 1.5 – 2 h and placed on X-ray film at -80oC.  Signals in 
autoradiographs were quantified using a Fluor-S phosphoimager (Bio-Rad). 
Isolation of detergent-resistant membranes 
Cell monolayers were washed once in ice-cold PBS and cells lysed in ice-cold TNE 
containing 1% Triton X-100 and 2.5 mg/ml NEM.  Lysates were incubated on ice at 4oC for 
30 min and then subjected to centrifugation for 15 sec at 5,000 RPM.  The supernatants were 
kept on ice for an additional 30 min, mixed with ice-cold sucrose to produce a final sucrose 
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density of ~60% (w/vol), placed on top of 0.25 ml ~80% (1.24 g/cm3) sucrose in a SW50.1 
tube and overlaid with 1 ml 45%, 0.5 ml 43%, 0.5 ml 38%, 0.5 ml 32%, 0.5 ml 28%, 0.5 ml 
18% and 0.5 ml 5% sucrose all dissolved in TNE.  Samples were subjected to centrifugation 
at 100,000 x g for 18 h at 4oC.  Fractions were collected from the bottom of the gradient 
(each fraction was 0.25 ml except the second fraction which had a volume of 1 ml).  Proteins 
in each fraction were resolved by 8% SDS-PAGE and detected by Western analysis with the 
appropriate primary and secondary antibodies.  An uninfected cell plate with comparable cell 
numbers was used for the detection of host cell proteins.  After centrifugation, the densities 
of all sucrose fractions were measured using a refractometer and are indicated as g/cc.  
Determination of cholesterol levels 
Cholesterol levels in ELL-0 cell monolayers and virion envelopes were determined using the 
Amplex Red Cholesterol Assay Kit (Molecular Probes) and was performed according to the 
manufacturer’s protocol. 
Extraction of cholesterol  
ELL-0 cells seeded on 35-mm plates were infected and radiolabeled for 1 h as described 
above.  At the end of the labeling period, monolayers were incubated with chase media 
(DMEM supplemented with 0.1 mM cold methionine only) for 1 h.  Cells were then either 
left untreated or treated with increasing concentrations of methyl-β-cyclodextrin and 4 μg/ml 
lovastatin for 1 h in DMEM supplemented with 0.1 mM cold methionine only at 37oC.  A 
final 4 h non-radioactive chase was performed in the absence of mβCD but in the presence of 
lovastatin.  Culture supernatants were then collected for virion purification and cells 
harvested for isolation of DRMs.  Uninfected and unlabelled cells were treated with mβCD 
in an identical protocol.    
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Actin and surface GM1 staining and visualization  
ELL-0 cells were grown to confluency on glass coverslips in 35-mm plates.  Cells were then 
left untreated or treated with 4 μg/ml lovastatin alone, 5 mM mβCD and 4 μg/ml lovastatin 
or 10 mM mβCD and 4 μg/ml lovastatin for 1 h followed by a 1 h recovery in DMEM only.  
Cells were then washed twice with ice-cold IF buffer (PBS containing 1% bovine serum 
albumin, 0.02% sodium azide and 5 mM CaCl2), fixed with 2% paraformaldehyde for 10 min 
on ice and blocked with IF buffer overnight at 4oC.  Cells processed for actin visualization 
were permeabilized with IF buffer containing 0.05% Triton X-100 for 20 min on ice at 4oC 
prior to the overnight block in IF buffer.  Cells were then incubated for 1 h at 4°C in IF 
buffer containing Alexa Fluor 488-conjugated cholera toxin subunit B (Molecular Probes) or 
Alexa Fluor 568-conjugated phalloidin (Molecular Probes), washed three times with ice-cold 
IF buffer and incubated for 20 min on ice with IF buffer containing Hoechst nuclei stain 
(Molecular Probes).  Cells were washed twice with ice-cold IF buffer and mounted on slides 
using Vectashield Mounting Medium (Vector Laboratories) for fluorescence microscopy.  
Fluorescence images were acquired using a Nikon fluorescence microscope and Openlab 
software. 
Viral plaque assay 
Purified virus, taken from 20-65% sucrose interface or density gradient flotation fractions, 
was serially diluted in Ca++-rich media and allowed to adsorb to confluent monolayers of 
ELL-0 cells for 45 min.  Agar diluted to 1% in DMEM and supplemented with nonessential 
amino acids, vitamins, penicillin-streptomycin, sodium bicarbonate, and 10% FCS was then 
placed over monolayers.  After 48 hours of incubation, plaques were counted.  To normalize 
infectivity to the levels of NP found in virus particles, the calculated PFU/ml value was 
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divided by the Fluor-S value obtained for NP found in released virions for the corresponding 
sample. 
Negative-staining of particles for transmission electron microscopy 
Virions were purified to 20-65% sucrose interfaces as described above.  Particles contained 
in interface fractions were then pelleted (40,000 RPM for 10-12 h at 4°C; Beckman SW50.1 
rotor) and re-suspended in TNE containing 2.5% glutaraldehyde.  The fixed samples were 
then spread on freshly prepared carbon-stabilized Formvar Support films (either copper or 
gold grids).  After 30 sec the grids were washed twice in TNE buffer.  The grids were 
negatively stained with 1% uranyl acetate in water. 
Extraction of cholesterol from NDV particles 
Egg-grown, purified virions were mixed with Ca++-rich DMEM or with increasing 
concentrations of mβCD in Ca++-rich DMEM and incubated for 1 h at 37oC.  One percent of 
the treated virus was serially diluted in Ca++-rich DMEM and used for viral plaque assays as 
described above.  The remainder of virus was purified away from mβCD:cholesterol 
complexes by sedimentation through 20% sucrose.  Virion-associated cholesterol from 
pelleted virions was released by treatment of virus with 1% Triton X-100 and 0.5% sodium 
deoxycholate and measured using the Amplex Red Cholesterol Assay Kit. 
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C.  Results 
Incorporation of cellular lipid raft- and non-lipid raft-associated proteins into NDV 
particles  
To determine if membrane lipid rafts serve as preferential platforms for the assembly and 
release of NDV, proteins in purified virions were probed by Western analysis for the 
presence of both lipid raft-associated and non-lipid raft membrane proteins.  The lipid raft-
associated proteins caveolin-1 (111) and flotillin-2 (150) were detected in avian ELL-0 cells 
and also detected in virus particles (Fig. 2.1A).  However, the non-raft associated plasma 
membrane transferrin receptor, CD71 (53), was not found in virions although it was detected 
in avian cells (Fig. 2.1A).  These results are consistent with membrane lipid rafts as sites of 
NDV assembly and release. 
Association of NDV viral proteins with detergent-resistant membranes  
If virus assembly occurs in membrane lipid rafts, then viral proteins should be associated 
with these domains in infected cells.  Since detergent-resistant-membranes (DRMs) are 
thought to experimentally reflect lipid rafts, the association of viral proteins with these 
membranes from infected cells was characterized after cell lysis with cold Triton X-100.  For 
this analysis, a class of DRMs only recently recognized was included.  Luna and colleagues 
(121) have characterized a class of DRMs with heavier buoyant densities (1.20 – 1.1.4 g/cm3) 
than classical DRMs, which have densities from 1.13 – 1.08 g/cm3.  The heavy density 
detergent-resistant-membranes were termed DRM-H while classical DRMs were termed 
DRM-L.  The increased density of DRM-H is due to association with underlying membrane 
cytoskeleton as illustrated by the presence of actin in the corresponding gradient fractions 
(Fig. 2.1B) (121).  DRM-H also contains flotillin-2 while DRM-L  
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Legend to Figure 2.1:  Preferential assembly and release of NDV from lipid raft 
domains.   
Panel A:  Proteins in gradient purified, egg-grown NDV (virus) and in avian ELL-0 cell 
extracts (E) were resolved by SDS-PAGE and detected by Western analysis with antibodies 
directed against the indicated proteins.   
Panel B:  DRMs in extracts of uninfected avian ELL-0 cells were isolated by flotation in 
sucrose gradients as described in Materials and Methods.  Proteins present in DRM gradient 
fractions were probed by Western analysis for the indicated proteins.   
Panel C: DRMs in extracts of NDV-infected avian ELL-0 cells were isolated by flotation in 
sucrose gradients and proteins present in the gradient fractions were probed with antibodies 
specific for NDV proteins: anti-NDV (NP), anti-A (HN) or anti-HR2 (F0+ F1-F2).  Each lane 
contains 12% of the corresponding gradient fraction except fraction 2 which contains 3% of 
the total.  Densities of each gradient fraction are indicated as g/cc.  E, total cellular extract; 
Sol, detergent-soluble gradient fractions; DRM-H, heavy density DRM gradient fractions; 
DRM-L, light density DRM gradient fractions; NP, nucleocapsid protein; HN, 
hemagglutinin-neuraminidase protein; F0, uncleaved fusion protein; F1-F2, disulfide linked, 
cleaved fusion protein. 
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possesses preferentially caveolin-1 (Fig. 2.1B) (121).  Non-raft membrane material was 
effectively solubilized as the non-raft transferrin receptor protein remained in the bottom of 
the gradient and did not float up into the gradient with either class of DRMs (Fig. 2.1B).   
 HN protein, F protein and NP protein could be detected in both DRM-H and DRM-L 
(37%, 84% and 33% of total HN, F and NP protein, respectively) (Fig. 2.1C).    The majority 
of DRM-associated NP protein and most of HN protein was found in DRM-H.  The detection 
of significant amounts of the major structural NDV proteins in detergent-resistant 
membranes further suggested that membrane lipid rafts may serve as sites of virus assembly 
and release.      
Kinetics of viral protein DRM dissociation and virion incorporation  
If membrane lipid rafts serve as platforms for virus assembly, then viral proteins should 
transit through lipid rafts prior to assembly into virions.  Thus, the kinetics of DRM 
dissociation and virion incorporation of HN, F, NP and M proteins were analyzed, utilizing a 
[35S] pulse-chase labeling protocol.  At each non-radioactive chase time-point, culture 
supernatants were collected for virion purification while cell monolayers were harvested for 
DRM isolation in sucrose gradients.  Representative autoradiographs of the sucrose gradient 
distribution of radiolabeled proteins for three different chase time-points are shown in Figure 
2.2A.  Radiolabeled proteins recovered in virions at different chase time-points are shown in 
Figure 2.2B.  After short chases, the HN and F glycoproteins fractionated primarily with 
DRM-L, while the majority of DRM-associated NP and M proteins were found in DRM-H.  
Levels of all viral proteins in both classes of DRMs  
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Legend to Figure 2.2:  Kinetics of pulse-labeled viral protein dissociation with DRMs 
and virion incorporation.  Monolayers of NDV-infected avian ELL-0 cells were pulse-
labeled with [35-S] methionine/cysteine and then subjected to non-radioactive chases of 0 to 8 
hours as described in Materials and Methods.   
Panel A:  DRMs in cell extracts were isolated by flotation in sucrose gradients and proteins 
present in each gradient fraction were resolved by polyacrylamide gel electrophoresis and 
detected by autoradiography.  Shown are representative autoradiographs derived from cells 
subjected to non-radioactive chases of 1, 4 or 8 hours.  Each lane contains 12% of the 
corresponding gradient fraction except fraction 2 which contains 3% of the total.   
Panel B:  Radiolabeled proteins in virions purified from supernatants of cells subjected to 
non-radioactive chases were resolved by polyacrylamide gel electrophoresis and detected by 
autoradiography.  Shown is a representative autoradiograph containing radiolabeled viral 
proteins in virions released from cells at different times of non-radioactive chase indicated at 
the top of the panel.  Each lane contains 20% of the total virions isolated.   
Panels C-E:  Amounts of radiolabeled HN protein (panel C), NP protein (panel D) and M 
protein (panel E) in detergent-soluble/non-DRM gradient fractions, total DRMs (DRM-H + 
DRM-L) gradient fractions and in virions after different times of non-radioactive chase 
(shown at the bottom of each panel) were determined by densitometry of autoradiographs of 
polyacrylamide gels such as those shown in panels A and B.  Results are averages of 3 
separate experiments. 
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were reduced at later times of chase and virtually no labeled viral protein could be found in 
either class of DRMs after 8 hours of chase.   
 Quantification of the amounts of HN protein and NP protein in total DRMs 
(DRM-H and DRM-L) and in detergent-soluble fractions at different times of chase is shown 
in Figure 2.2C and Figure 2.2D, respectively.  After one hour of chase, 55% of total HN 
protein was found in DRM fractions while 35% of total NP was in DRM fractions.  With 
increasing chase times, a decline in the amounts of both HN protein and NP in DRMs was 
observed.  Nearly all the radiolabeled HN protein and NP found in DRMs in early chases was 
recovered in virions purified by 8 hours of non-radioactive chase.     
 The HN protein and NP not associated with DRMs (i.e. detergent-soluble material 
which remained in the bottom of the gradient in fractions 1 and 2) did not significantly 
contribute to the HN protein and NP packaged into released virus particles since the amounts 
of detergent-soluble HN protein and NP remained relatively constant during the course of the 
experiment.  However, a small amount of HN protein (approximately 15% of total HN 
protein) was found with detergent-soluble material at 4 hours of non-radioactive chase and 
then recovered in virions.  This result suggests that a transient association of HN protein with 
detergent-soluble membranes just prior to budding may have occurred.  Similar kinetics for 
DRM dissociation and virion incorporation as that of NP and HN protein were seen for the F 
protein (illustrated in Fig. 2.3C).  Thus, the disappearance of HN, F and NP proteins from 
DRMs coincides with their appearance in virus particles, a result that is consistent with the 
proposal that viral proteins are packaged into virus particles at cholesterol-rich membrane 
lipid raft domains. 
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 By contrast, the majority of M protein was detected in detergent-soluble fractions 
of the gradient throughout the pulse-chase protocol (Fig. 2.2E).  The amounts of M protein 
associated with either class of DRMs during the non-radioactive chases were minimal in 
comparison to the levels of detergent-soluble M protein.  Furthermore, the amounts of M 
protein found in DRMs were significantly less than amounts of M protein recovered in 
virions.  This result may indicate that M protein dissociates from DRMs during cell lysis or 
that M protein is packaged into virions from cytoplasmic pools.  Alternatively, M protein 
may associate transiently with DRMs prior to incorporation into virions.   
Kinetics of protein dissociations with DRM-H and DRM-L 
To determine if assembly occurred preferentially from DRM-H or DRM-L, the amounts of 
HN, NP and F proteins in each class of DRMs during the chase were analyzed (Fig. 2.3).  At 
early times of chase, the HN and F glycoproteins (Fig. 2.3A and 2.3C, respectively), were 
found in both DRM-H and DRM-L although both proteins were preferentially associated 
with DRM-L.  In contrast, DRM-associated NP primarily associated with DRM-H during 
early times of chase (Fig. 2.3B).  The kinetics of loss of HN and F proteins as well as NP 
from both DRM-H and DRM-L were similar.  These results suggest that both classes of 
DRMs participate in the incorporation of HN, F and NP proteins into virus particles. 
Effects of cholesterol extraction on DRMs 
If virus is assembled in membrane lipid rafts, then perturbation of raft integrity may affect 
that assembly.  The integrity of membrane lipid rafts was disrupted by utilizing the 
cholesterol-extracting agent methyl-β-cyclodextrin (mβCD) (73, 155, 167).  To accomplish  
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Legend to Figure 2.3:  Kinetics of viral protein dissociation with DRM-H and DRM-L. 
Amounts of radiolabeled HN (Panel A), NP (Panel B) and F proteins (Panel C) in DRM-H 
and DRM-L gradient fractions as well as in purified virions at non-radioactive chase time-
points were determined as described in legend to Figure 2.  Gradient fractions corresponding 
to DRM-H and DRM-L were defined in Figures 1 and 2. 
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cholesterol extraction, cells were treated for one hour with increasing concentrations of 
mβCD in the presence of lovastatin, which inhibits synthesis of endogenous cholesterol (72).  
Cells were then further incubated for either one or four hours in cholesterol- and serum-free 
medium in the presence of lovastatin only.  After one hour of incubation, the total cellular 
levels of cholesterol in cells incubated with lovastatin alone were reduced by 60% while 
cholesterol levels in cells treated with both lovastatin and increasing concentrations of mβCD 
were reduced up to 77% (Table 2.1).  After 4 hours of incubation in cholesterol/serum-free 
media, cholesterol levels in mβCD-treated cells remained at low levels (Table 2.1).   
 One hour treatment of cells with lovastatin alone or increasing concentrations of 
mβCD and lovastatin had no effect on cell number (data not shown).  However, treatment of 
uninfected cells with mβCD significantly decreased levels of detergent resistant, lipid raft-
associated proteins.  After cholesterol extraction, caveolin-1 was exclusively in the detergent-
soluble gradient fractions while the levels of DRM-H associated actin were significantly 
reduced (Fig. 2.4A).  Furthermore, the distribution of the glycolipid raft marker ganglioside 
GM1 on the surface of uninfected cells was significantly altered.  In untreated cells, GM1 
staining was relatively diffuse over the cell surface (Fig. 2.4B).  However, upon treatment 
with mβCD, distinct foci or patches enriched in GM1 formed on the cell surface (Fig. 2.4B).  
This result was consistent with those reported by Hao et al. (52) following cholesterol 
extraction.  The cellular distribution of actin in uninfected cells was also significantly altered 
upon cholesterol depletion (Fig. 2.4C).       
 After mβCD treatment of infected cells, the vast majority of NP, M, HN and F 
proteins were found in detergent-soluble gradient fractions with some residual  
 43
Table 2.1 Residual cholesterol in mβCD-treated avian ELL-0 cells 
 
 
 
a Uninfected avian ELL-0 cell monolayers were treated as indicated for 1 h at 
37°C. A recovery time of 1 h or 4 h consisted of incubation of treated cells in 
DMEM only at 37°C. Cells were then subjected to cholesterol quantification as 
described in Materials and Methods. Data are means ± standard deviations. 
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Legend to Figure 2.4:  Effects of cholesterol depletion on detection of lipid rafts. 
Panel A:  Uninfected cells were left untreated or incubated with 10 mM methyl-β-
cyclodextrin (mβCD) and lovastatin as described in Materials and Methods.  DRMs in 
extracts were isolated by flotation in sucrose gradients.  Actin and caveolin-1 present in each 
gradient fraction were detected by Western analysis as described in the legend to Figure 1.   
Panel B:  The surface distribution of ganglioside GM1 as visualized by fluorescence 
microscopy.  Uninfected cells were left untreated or treated with lovastatin alone (lovastatin), 
5 mM mβCD and lovastatin (5 mM mβCD) or 10 mM mβCD and lovastatin (10 mM mβCD) 
for 1 hour followed by a 1 hour incubation in DMEM.  Nuclei are visualized in the top panels 
while surface GM1 of the same cells, visualized as described in Materials and Methods, is 
shown in the bottom panels.   
Panel C:  The distribution of actin as visualized by fluorescence microscopy.  Uninfected 
cells were left untreated or treated with 10 mM mβCD and lovastatin (10 mM mβCD) for 1 
hour followed by a 1 hour incubation in DMEM.  Nuclei are visualized in the top panels 
while actin in the same cells, visualized as described in Materials and Methods, is shown in 
the bottom panels. 
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glycoprotein material detected in DRM-H gradient fractions (Fig. 2.5A).  Thus, treatment of 
cells with mβCD disrupts association of raft proteins with DRMs, alters the distribution of 
actin and surface ganglioside GM1 and disrupts or alters association of viral proteins with 
DRMs. 
Effects of cholesterol extraction on virus release 
To analyze the effects of mβCD on virus release, infected cells were [35S]-radiolabeled at 6 
hours post-infection for one hour followed by a one hour non-radioactive chase to allow 
transport of radiolabeled viral proteins to assembly sites.  Cell monolayers were then 
incubated with varying concentrations of mβCD for one hour in cholesterol/serum-free 
media and in combination with lovastatin.  Cells were then incubated for a final 4 hour non-
radioactive chase in the absence of mβCD but in the presence of lovastatin.  Virus particles 
were purified from culture supernatants and radiolabeled proteins present are shown in 
Figure 2.5B.  Based upon quantification of radiolabeled NP recovered in purified virus, 
particle release was enhanced approximately 2 fold with mβCD-cell treatment (Fig. 2.5C).  
However, particles released from untreated and mβCD-treated cells contained similar levels 
of M and F proteins and marginally lower amounts of HN protein (Fig. 2.5B).  These results 
suggested that particles released from cholesterol-extracted cells may be structurally 
abnormal.   
Particles released from mβCD-treated cells are structurally abnormal with reduced 
infectivity 
To determine if virus released from mβCD-treated cells possessed an intact lipid envelope, 
the sensitivities of NP and M core proteins to proteinase K were determined.  Both proteins 
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Legend to Figure 2.5:  Effects of cholesterol depletion on infected cell DRMs and virus 
release.  Infected cells were radioactively labeled in a pulse-chase protocol in the absence or 
presence of 10 mM mβCD and lovastatin as described in Materials and Methods.   
Panel A:  Representative autoradiographs of DRM gradient distribution for radiolabeled viral 
proteins derived from untreated cells (top) or cholesterol-extracted cells (bottom) at 1 hour 
following end of treatment.   
Panel B:  Virions were isolated from 2 x 106 cells radioactively labeled and left untreated (0) 
or treated with 10 mM mβCD.  Proteins present in purified virions were immunoprecipitated 
using a cocktail of antibodies specific for M and NP proteins (left panel) or HN and F 
proteins (right panel).   Excess antibody was used to insure precipitation of all virion 
proteins.   
Panel C:  The amounts of HN, F, NP and M proteins present in purified virions detected as 
shown in panel B.  Comparable experiments were quantified by densitometry and amounts of 
each protein are represented relative to amounts detected in virions from untreated cells.  
Black bars, untreated; gray bars, 10 mM mβCD-treated. 
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in cell extracts were digested by small amounts of proteinase K (Fig. 2.6A).  In contrast, the 
NP and M proteins in virions released from untreated cells were resistant, reflecting their 
protection by virion membrane.  Similarly, the M protein and most of the NP in particles 
released from mβCD-treated cells were resistant to protease digestion, indicating these 
particles were membrane enclosed and not released RNP structures (Fig. 2.6A).   
 That NP and M proteins were associated with lipid was also shown by their flotation 
in sucrose gradients (Fig. 2.6B).  However, in contrast to virions from untreated cells, which 
had a homogeneous density of 1.18 to 1.16 g/cm3 in sucrose, particles released from 5 mM 
and, particularly, 10 mM mβCD-treated cells had heterogeneous densities ranging from 1.23 
to 1.12 g/cm3 (Fig. 2.6B).   
 In contrast, sucrose gradient sedimentation of particles from untreated and mβCD-
treated cells showed no difference in sedimentation.  Radiolabeled particles released from 
mβCD-treated cells were present in the same fractions (5-7) of the sedimentation gradient as 
particles released from untreated cells (Fig. 2.6C).  This result suggests that particles released 
from cholesterol-extracted cells had a size and shape similar to virus released from untreated 
cells but had altered protein to lipid ratios. 
 The infectivity of particles released from mβCD-treated cells, as determined by 
plaque assay, was decreased by approximately one log (PFU/ml) when compared to particles 
released from the same number of untreated cells (Fig. 2.6D).  When virus titers were 
normalized to levels of NP, there was an even greater decrease in particle infectivity (Fig. 
2.6D).  To determine the infectivity of virions released from mβCD-treated cells that had  
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Legend to Figure 2.6:  Properties of virus particles released from mβCD-treated cells.   
Panel A: Protease resistance of virion-associated proteins.  Cellular extracts containing 
radiolabeled viral proteins or gradient-purified virions released from untreated or 10 mM 
mβCD-treated cells were incubated with the indicated amounts of proteinase K for 30 min on 
ice.  Reactions were stopped by addition of 0.1 mM PMSF, particles lysed and viral proteins 
immunoprecipitated and resolved on polyacrylamide gels.  NP, nucleocapsid protein; NP*, 
NP cleavage product; M, matrix protein; M*, M cleavage product.   
Panel B: Sucrose density flotation gradient analysis of virions.  Purified virions released from 
untreated, 5 mM mβCD- or 10 mM mβCD-treated cells were subjected to sucrose density 
flotation as outlined in Material and Methods.  Viral proteins in individual gradient fractions 
were immunoprecipitated and resolved by SDS-PAGE.  Gradient fraction numbers are 
indicated at the top and fraction densities are displayed as g/cc at the bottom.   
Panel C: Sucrose gradient sedimentation analysis of virions.   Purified virions released from 
untreated, lovastatin-only treated, 5 mM mβCD- or 10 mM mβCD-treated cells were 
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subjected to sedimentation in continuous sucrose gradients as outlined in Materials and 
Methods.  Viral proteins in individual gradient fractions were immunoprecipitated and 
resolved by SDS-PAGE.  The level of NP in each gradient fraction was quantified and is 
expressed as the percent of total NP in each gradient; gradient fraction numbers are indicated 
on the x-axis.   
Panel D: Infectivity, determined by plaque assay, of purified virions released from untreated 
cells or cells treated with varying concentrations of mβCD:  0, no treatment; Lova only, 
lovastatin only treated cells.  The absolute infectivity (PFU/ml released from 2 x 106 cells) is 
shown in the top graph (black bars) and the infectivity normalized to the levels of NP protein 
quantified in the corresponding virions is shown in the bottom graph (gray bars).  Infectivity 
is shown relative to values obtained for particles released from untreated cells, which was set 
to 1.   
Panel E: Infectivity of virus in different fractions of sucrose flotation gradients shown in 
panel B.  Infectivity in individual gradient fractions were determined by plaque assay and 
virus titer indicated in PFU/ml.  Infectivity is shown relative to values obtained for particles 
released from the same number of untreated cells, which was set to 1.  Untreated cells, black 
bars; 10 mM mβCD-treated cells, white bars; flotation gradient fraction numbers are 
indicated on the x-axis.   
Panel F: Negative-staining and transmission electron microscopy of particles released from 
un-treated (panels i and ii) and mβCD-treated cells (panels iii, iv and v); magnification is 
35,000.   
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normal particle density, the infectivity of particles in individual fractions of gradients similar 
to those shown in Figure 2.6B were determined.  The peak infectivity of virions from 
untreated cells was in fractions 4-6 (Fig. 2.6E).  Particles released from 10 mM mβCD-
treated cells, possessing either normal (fractions 5 and 6 primarily) or abnormal (fractions 4, 
7 and 8) particle density, exhibited decreased infectivity compared to control virus (Fig. 
2.6E).  Upon negative-staining and analysis by transmission electron microscopy, particles 
released from untreated cells were visibly homogeneous in size and spherical in shape (Fig. 
2.6F, panels i and ii).  However, particles released from mβCD-treated cells were 
heterogeneous in size and shape (Fig. 2.6F, panels iii and iv).  Interestingly, particles released 
from mβCD-treated cells tended to self-associate/aggregate (Fig. 2.6F, panel v).  Thus, 
particles released from mβCD-treated cells are structurally abnormal with significantly 
reduced infectivity. 
Effect of cholesterol extraction of virions on infectivity 
A direct measurement of cholesterol in particles released from untreated or 10 mM mβCD-
treated cells revealed an approximate 37% reduction in cholesterol in particles released from 
mβCD-treated cells (data not shown).  Since the decreased infectivity observed in Figure 2.6 
could be due to low cholesterol levels in virion membrane, the effect of cholesterol depletion 
of virions on infectivity was determined.  Egg-grown virus was depleted of cholesterol by 
incubation with increasing concentrations of mβCD.  Incubation with 2 mM mβCD removed 
approximately 70% of the virion-associated cholesterol while a higher concentration of 
mβCD removed approximately 90% (Fig. 2.7A).  However, no significant decrease in 
infectivity was observed for any of the mβCD-treated virus (Fig. 2.7B).  These results  
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Legend to Figure 2.7:  Effect of virion cholesterol extraction on infectivity.  Gradient-
purified, egg-grown virus was depleted of cholesterol with 2, 5 and 10 mM mβCD for 1 h at 
37oC, re-purified and virion-associated cholesterol in untreated and treated virus was 
measured as described in Materials and Methods.   
Panel A: Residual cholesterol in virions following treatment.   
Panel B: Infectivity of untreated and mβCD-treated virus as determined by viral plaque 
assay.  Infectivity is shown relative to values obtained for untreated particles, which was set 
to 1.  EtOH, ethanol-treated control virus.   
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suggest that the presence of cholesterol in the virus envelope is not important for infectivity 
of NDV particles and its reduction in particles released from mβCD-treated cells cannot 
account for the reduced infectivity of these particles. 
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D.  Discussion 
Membrane lipid rafts have been implicated in the assembly and release of many types of 
enveloped viruses although the precise roles of these domains remain obscure.  The 
incorporation of host cell lipid raft-associated proteins into the envelopes of viruses is 
indicative of preferential budding from these domains.  Indeed, purified NDV particles 
contain lipid raft-associated caveolin and flotillin but do not contain detectable levels of a 
non-raft plasma membrane protein, transferrin receptor.  The presence of viral proteins in 
detergent-resistant-membranes, a cell fraction that reflects lipid rafts (167), is also invoked as 
evidence for a role of lipid rafts in virus assembly [reviewed in (126)].  At steady-state, 
significant amounts of NDV proteins can be found in DRMs isolated from infected cells.  
Taken together, these results suggest that, similar to many enveloped viruses, NDV 
assembles and buds preferentially from lipid raft domains.  To extend these analyses, the 
relationship between the kinetics of viral protein dissociation from DRMs and incorporation 
into virus particles was determined while the importance of NDV assembly and release at 
these domains was explored by disrupting lipid rafts.   
Kinetics of viral protein dissociation with DRMs and incorporation into virions 
If NDV is assembled and released preferentially from lipid raft domains, then there should be 
an inverse kinetic relationship between the association of viral proteins with DRMs and with 
virions released from cells, i.e. pulse-labeled DRM-associated viral proteins should decrease 
during a non-radioactive chase as these proteins are packaged into virus particles.  However, 
for such an analysis to be meaningful, assembly and release of virions must be very efficient.  
Indeed, the release of NDV from avian cells, the natural host of the virus, is extremely 
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efficient.  Based on incorporation of pulse-labeled M protein into virions, efficiency of NDV 
release is 90% in avian cells (Fig. 2.2 and Pantua and Morrison, unpublished observations). 
 In addition, an accurate kinetic analysis of the roles of lipid rafts in NDV assembly 
requires inclusion of all forms of DRMs.  For the studies described here, a novel class of 
heavy density DRMs, DRM-H, associated with the cortical cytoskeleton was included (121).  
Many studies that include DRM isolation do not utilize conditions that would clearly separate 
this fraction from the detergent-soluble fraction of cells, which may lead to significant under 
representation of the amounts of each viral protein associated with DRMs.  Inclusion of 
DRM-H is also particularly important given that the actin cytoskeleton has been implicated 
in paramyxovirus assembly and actin is incorporated into paramyxovirus particles (83, 128, 
185).  In addition, the importance of this cell fraction is underscored by the finding that the 
majority of DRM-associated viral NP and M proteins and a significant amount of HN protein 
were associated with DRM-H. 
 Using NDV-infected avian cells, significant amounts of pulse-labeled NP, F and HN 
proteins were associated with DRMs after a short non-radioactive chase and loss of this 
material with longer chases was mirrored by the incorporation of these radiolabeled viral 
proteins into virus particles.  Indeed, the amounts of NP, F and HN proteins in DRMs were 
quantitatively recovered in virus at late times of chase while the pools of detergent-soluble 
viral proteins remained relatively constant during the non-radioactive chases.  This result is 
consistent with the proposal that lipid rafts, as defined by DRMs, are the assembly sites of 
released NDV particles and that non-lipid raft-associated viral proteins are not directly 
involved in virus release.   
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 However, in contrast, the DRM association of the M protein was minimal after a short 
non-radioactive chase (20% of the total radiolabeled M protein) and this material decreased 
to undetectable levels with longer chases.  In addition, the level of pulse-labeled detergent-
soluble M protein declined with times of chase and was quantitatively recovered in virus 
particles.  The low levels of M protein detected in DRMs may reflect an association with 
lipid rafts that is disrupted by the concentration of Triton X-100 used here.  Indeed, Ali and 
Nayak (3) have reported that the M protein of Sendai virus was dissociated from DRMs by 
1% Triton X-100 but could be detected with DRMs when lower Triton X-100 concentrations 
were used during DRM isolation.  Alternatively, results reported here may reflect a very 
transient association of the M protein with lipid rafts.  Paramyxovirus M proteins have been 
shown to have a pivotal role in virus release [reviewed in (183)].  Indeed, the M protein is 
both necessary and sufficient for the release of NDV virus-like particles (Pantua and 
Morrison, submitted) and this release is extremely efficient with 80 – 90% of pulse-labeled 
M protein released as virus-like particles.  Given this result, it is possible that when M 
protein associates with virion assembly sites, it immediately induces the release of a virion.  
In this case, the M protein would not be detected in significant amounts in DRMs since it 
would only be transiently associated with this cell fraction.  The M protein in detergent-
soluble fractions of the cell would, therefore, decrease as this pool of molecules bound 
assembly sites and then exited the cell in virus particles. 
 The finding that DRM-associated NP and M proteins were primarily in DRM-H 
suggests that assembly sites may be in or adjacent to lipid raft domains that are linked to the 
cortical cytoskeleton.  The cortical cytoskeleton is a meshwork of actin underlying the 
plasma membrane, which is often linked to the plasma membrane by interactions with lipid 
 56
raft-associated proteins (168).  As lipid rafts serve as sites of dynamic signaling events (167), 
rearrangements of proximal components of the cortical cytoskeleton often occur (54, 64).  
Further supporting the possible role of the actin cytoskeleton in paramyxovirus assembly and 
release is the interaction among many paramyxovirus M proteins with actin (47) and the 
ability of drugs affecting actin filaments to alter the release of some paramyxoviruses (22, 
117, 176).  Thus, association of viral proteins with DRM-H is consistent with an involvement 
of the actin cytoskeleton in NDV assembly.  Virus assembly and release from these domains 
may be facilitated by dynamic remodeling of the cortical cytoskeleton in these raft domains. 
 Similar to results reported here, Manie et al. (98) showed that a fraction of pulse-
labeled measles viral proteins was found in DRMs of infected cells.  This material 
disappeared with long chases, although it was not determined if this material could be 
recovered in released virus.  However, in contrast to results presented here, most of the 
radiolabeled measles viral proteins remained in the detergent-soluble fraction of cells 
throughout the chase.  It is possible that a significant fraction of this material was associated 
with DRM-H or that the efficiency of virus release was very low. 
Effects of disruption of lipid rafts on the release of infectious NDV 
While the kinetics of viral protein dissociation with DRMs and release into virions strongly 
supports the idea that NDV assembly occurs in lipid raft domains, these results do not 
address the functional significance of lipid rafts as assembly sites.  To explore the importance 
of lipid raft domains in assembly and release, lipid rafts were disrupted by the combined use 
of lovastatin, which inhibits synthesis of endogenous cholesterol (72), and methyl-β-
cyclodextrin, which extracts cholesterol from cellular membranes (73, 155, 167).  Hao et al. 
(52) have reported that mβCD-induced cholesterol depletion of several different cell types 
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resulted in the formation in the plasma membrane of large, micrometer-sized liquid-ordered 
(raft-like) domains distinct from the surrounding liquid-disordered (non-raft) membrane.  
These results indicate that reduction of cholesterol levels in the plasma membrane induces 
significant reorganization of plasma membrane lipids and coalescence of remaining liquid-
ordered domains.  Indeed, cholesterol extraction of avian cells resulted in large GM1-
enriched domains in stark contrast to a more uniform distribution of small punctuate regions 
of GM1 positive domains in untreated cells.  These observations suggest that in avian cells, 
there is also a reorganization of remaining liquid-ordered domains after cholesterol 
extraction.  Kwik et al. (79) have reported that cholesterol extraction results in reorganization 
of the actin cytoskeleton, resulting in a restriction in the lateral mobility of plasma membrane 
proteins.  Given the connections between lipid rafts and the cortical cytoskeleton, it is not 
surprising that this cytoskeleton should be affected by rearrangement of liquid-ordered lipid 
raft domains at the cell surface.  Indeed, the distribution of filamentous actin in cholesterol-
extracted avian cells was significantly altered.      
 Following depletion of cholesterol from infected cell membranes, there was a 
reduction in DRM association of both caveolin and actin, indicating that protocols effectively 
removed cholesterol and altered the properties of lipid rafts.  The association of viral proteins 
with DRMs was also significantly reduced.  Surprisingly, virus particle release from 
cholesterol-depleted cells was not inhibited.  Rather, particle release was somewhat 
stimulated, indicating that release is not strictly dependent upon proper organization of lipid 
raft domains.  However, the particles that were released were abnormal, displaying very 
heterogeneous density and increased levels of NP relative to other virion components.  Most 
interestingly, the infectivity of these particles, either normalized to numbers of virus-
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producing cells or normalized to NP protein content, was significantly reduced.  In contrast, 
Pickl et al. (132) reported a reduction in Moloney murine leukemia virus particle production 
as well as particle infectivity upon treatment of virus-producing cells with mβCD.     
 The reduced infectivity of these NDV particles was not likely due directly to their 
decreased content of cholesterol since extraction of cholesterol from intact, infectious virus 
had no effect on infectivity of these particles.  Furthermore, the virus particles released from 
cholesterol-depleted cells were all associated with lipid as indicated by flotation into sucrose 
gradients and by resistance of NP and M proteins to protease digestion.   
 There are several possible explanations for the reduction in infectivity of these 
particles.  The heterogeneous densities of these particles suggested significant alterations in 
protein to lipid ratios for a majority of the released particles.  Furthermore, the particles that 
were heavier or lighter than infectious NDV particles released from untreated cells had 
reduced levels of glycoproteins.  These particles would be unable to attach and fuse upon 
encountering a permissive cell, which could account for their reduced infectivity.  However, 
the particles released from cholesterol-extracted cells with normal NDV particle density had 
levels of glycoproteins comparable to particles released from untreated cells.  These particles 
also had significantly diminished infectivity indicating that loss of infectivity cannot be 
explained by loss of glycoproteins.  These normal density particles did, however, contain an 
increased amount of NP relative to glycoprotein, indicating structural abnormality. 
 It is possible that lipid rafts and their underlying cortical cytoskeleton provide a 
framework for specific and ordered viral protein-protein interactions required for proper 
assembly.  These domains may also contain host cell components required for virus 
assembly.  Disruption or disordering of these domains with extraction of cholesterol would, 
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therefore, result in disordered virus assembly and subsequent release of particles with 
abnormal viral protein ratios and perhaps abnormal viral protein interactions.   
 It has recently been reported that lipid raft domains have no role in the assembly of 
Sendai virus (49).  However, as noted by the authors, assembly and release of Sendai virus is 
extremely inefficient in the cell type used thereby making this investigation of the precursors 
to virus assembly and release problematic.  The authors also used mβCD to extract cellular 
cholesterol and perturb membrane lipid rafts.  However, their conditions did not disrupt lipid 
raft domains since viral proteins remained associated with DRMs.  They did note a slight 
reduction in infectivity of particles released from mβCD-treated cells, a result consistent with 
data presented here.   
 In summary, the results presented here demonstrate that lipid raft domains are the 
preferential site of NDV assembly and release.  Furthermore, the integrity of these domains is 
important in the ordered assembly and release of infectious progeny NDV particles.  The 
results also demonstrate involvement of a novel subset of lipid rafts, those associated with 
the cortical cytoskeleton, in NDV assembly and release and further implicate the actin 
cytoskeleton in this step of infection.  These results have implications on vaccine design and 
development of anti-viral agents.  Understanding how viral proteins associate with membrane 
lipid rafts and the importance of these domains in the organization of a particle could provide 
the basis for targeting foreign glycoproteins to these assembly sites for incorporation into 
budding NDV-based particles, thereby generating multi-valent vaccines.  Also, the 
perturbation of membrane lipid rafts by small molecules could provide a means for creating 
disordered virion assembly on infected cell surfaces, thereby inducing the release of non-
infectious particles. 
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CHAPTER III 
Incorporation of functional HN – F glycoprotein-containing complexes into Newcastle 
disease virus is dependent on cholesterol and membrane lipid raft integrity 
 
A.  Introduction 
Membrane architecture and lipid organization are important for many cellular and molecular 
processes, including protein trafficking, signal transduction and immunological synapse 
formation (175).  In recent years, the role of cholesterol and sphingolipids in forming distinct 
membrane microdomains, termed membrane lipid rafts, has become recognized as important 
in these processes.  The inclusion or concentration of specific molecules in these domains as 
well as the exclusion of others likely increases the specificity and efficiency of molecular 
events occurring at membrane surfaces (167). 
            The participation of membrane lipid raft domains in the assembly and release of 
many different enveloped RNA viruses, including retroviruses, filoviruses, orthomyxoviruses 
and paramyxoviruses, is well-documented (126).  Evidence for lipid raft involvement in virus 
assembly includes the presence of lipid raft-associated molecules in purified virions, co-
localization of viral structural proteins with lipid raft markers and the biochemical 
association of viral proteins with lipid raft membranes, as defined by detergent-resistant 
membranes (DRMs) (126, 180).  Furthermore, extraction of cholesterol from cellular plasma 
membranes using methyl-β-cyclodextrin (mβCD) resulted in altered release of several 
different viruses (132), including human immunodeficiency virus (HIV).  However, the 
biological significance of these observations has not been resolved. 
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 Newcastle disease virus (NDV), an avian paramyxovirus (19, 45), also assembles in 
membrane lipid raft domains (81).  Evidence for this conclusion was, first, that lipid raft 
protein markers caveolin-1 and flotillin-2 were found in purified NDV virions while a non-
lipid raft marker, transferrin receptor, was absent.  Second, three of the four main structural 
components of NDV, the nucleocapsid (NP), hemagglutinin-neuraminidase (HN) and fusion 
(F) proteins, fractionated with detergent-resistant membranes.   Third, a kinetic analysis of 
DRM association and virion incorporation of each of the viral proteins strongly suggested 
that assembly occurred in lipid raft domains.  The importance of these domains in NDV 
assembly was suggested by the observation that extraction of plasma membrane cholesterol 
with mβCD (73, 155, 167) stimulated the release of structurally abnormal particles with 
reduced infectivity (81).  Reduced particle infectivity could not be attributed to the lower 
levels of cholesterol in virus envelopes since direct cholesterol depletion of purified virion 
membranes had no significant effect on infectivity (81).  Together with previous results in 
other virus systems, these results implied that proper assembly was dependent on cholesterol 
in the assembly membrane.  However, the known side-effects of mβCD, most notably the re-
arrangement of the cortical membrane cytoskeleton (79), could not be excluded as the 
primary cause of effects of mβCD on assembly and release of infectious virus. 
           These studies were extended in order to clarify the functional role of cholesterol in 
NDV assembly.  First, characterization of virus released from Niemann-Pick syndrome type 
C (NPC) fibroblasts, which are deficient in functional membrane lipid rafts, showed that 
cholesterol depletion without effects on cytoskeleton resulted in abnormal NDV release.  
Cholesterol depletion of infected cell membranes resulted in the release of virions with 
normal virus-cell attachment activity but significantly reduced virus-cell fusion activity.  
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These results correlated with loss of detection of HN – F glycoprotein complexes in infected 
cells and with reduced detection of glycoprotein-containing complexes in virions released 
from cholesterol-depleted cells.  However, direct extraction of cholesterol from the virion 
envelope had no effect on detection of HN – F protein-containing complexes or virion 
attachment and fusion activities.  Taken together, the results show that intact lipid raft 
domains in assembly membranes of infected cells facilitate the proper viral glycoprotein 
interactions necessary for the generation of a functional and infectious virus particle. 
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B.  Materials and Methods 
Cells, virus and reagents 
Normal human embryonic lung (HEL) fibroblasts (a kind gift from Dr. Timothy Kowalik, 
University of Massachusetts Medical School) and Niemann-Pick syndrome type C (NPC) 
human fibroblasts (NIH Coriell Cell Repository GM03123) were maintained in Dulbecco's 
modified Eagle medium (DMEM) supplemented with penicillin-streptomycin, L-glutamine, 
vitamins, non-essential amino acids and 10% fetal calf serum (FCS).  East Lansing Line 
(ELL-0) avian fibroblasts from American Type Culture Collection were maintained in 
DMEM supplemented with penicillin-streptomycin and 10% FCS.  NDV, strain AV (under 
BSL-3 conditions) and NDV, strain B1, stocks were prepared by growth in eggs by standard 
protocols (105).  Methyl-β-cyclodextrin (Sigma-Aldrich) was re-suspended in DMEM.  
Lovastatin (Sigma-Aldrich) was prepared in H2O and activated as described previously (40).  
Triton X-100 was purchased from Pierce Biotechnology.   
Antibodies 
Anti-NDV antibody was raised against UV-inactivated NDV virions (106).  Anti-M protein 
antibody was a monoclonal antibody obtained from Dr. Mark Peeples (Ohio State 
University) (38).   HN protein-specific antibodies were anti-A (103), anti-AS (104) and anti-
H (160).  F protein-specific antibodies were anti-HR1 (102), anti-HR2 (33), anti-Ftail (188), 
anti-F2-96 (an anti-peptide antibody raised against amino acids 76-96) (103) and anti-Fu1a 
(118). 
Infections and radioactive labeling  
HEL and NPC cells seeded at approximately 3.0 x 104 cells per 35-mm plate and ELL-0 cells 
seeded at approximately 6.0 x 105 cells per 35-mm plate were grown overnight and then 
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infected with NDV at a multiplicity of infection (MOI) of 10 in 0.25 ml of medium (under 
BSL-3 conditions for strain AV).  After 45 min, one ml of medium was added and 
monolayers incubated for 5-8 hours.  For radioactive labeling, cells were radiolabeled at 6 h 
post infection for 1 h at 37oC in DMEM supplemented with 50 μCi of [35S] methionine and 
cysteine per ml (New England Nuclear).  At the end of the labeling period, cells were 
incubated with chase media (DMEM supplemented with 0.1 mM cold methionine without 
FCS) for indicated lengths of time.   
Virus purification 
Culture supernatants were clarified by centrifugation at 5,000 RPM for 5 min and then 
particles in the supernatant were sedimented through 20% sucrose (w/vol) to a 20-65% 
sucrose interface (24,000 RPM for 10-12 h at 4°C using a Beckman SW50.1 rotor).  For 
virion flotation, purified virus taken from 20-65% sucrose interface fractions was adjusted to 
~60% sucrose (w/vol) and overlaid on top of ~80% (1.24 g/cm3) sucrose.  The sucrose layer 
containing virus was then overlaid with 1 ml 50%, 1 ml 38% and 0.5 ml 10% sucrose in a 
SW50.1 tube.  Samples were subjected to centrifugation at 100,000 x g for 18 h at 4oC. 
Polyacrylamide gel electrophoresis and Western analysis 
To prepare cell extracts, cell monolayers were washed in cold PBS and lysed in TNE buffer 
(25 mM Tris-HCl pH 7.4, 150 mM NaCl2 and 5 mM EDTA) containing 1% Triton X-100 
and 2.5 mg/ml of N-ethylmaleimide (NEM).  Proteins were resolved on 8% polyacrylamide 
gels (SDS-PAGE) as previously described (18).  Proteins were detected by Western analysis 
as previously described (18).  Radioactively labeled proteins were detected by 
autoradiography as previously described (18).  Signals in autoradiographs were quantified 
using a Fluor-S phosphoimager (Bio-Rad). 
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Isolation of detergent-resistant membranes (DRMs) 
Cell monolayers were washed once in ice-cold PBS and cells lysed in ice-cold TNE 
containing 1% Triton X-100 and 2.5 mg/ml NEM.  Lysates were incubated on ice at 4oC for 
30 min and DRMs in extracts were isolated by flotation in sucrose gradients as previously 
described (18).  Gradient fractions were collected from the bottom of the gradient (each 
fraction was 0.25 ml except the second fraction which had a volume of 1 ml).  Proteins in 
each fraction were resolved by 8% SDS-PAGE and detected by Western analysis with the 
appropriate primary and secondary antibodies.  After centrifugation, the densities of all 
sucrose fractions were measured using a refractometer.  
Extraction of cholesterol 
ELL-0 cells seeded on 35-mm plates were infected and radiolabeled for 1 h as described 
above.  At the end of the labeling period, monolayers were incubated with chase media 
(DMEM supplemented with 0.1 mM cold methionine only) for 1 h.  Cells were then either 
left untreated or treated with 10 mM mβCD and 4 μg/ml lovastatin for 1 h in DMEM 
supplemented with 0.1 mM cold methionine at 37oC.  Media was then removed and replaced 
with complete DMEM containing lovastatin, and cells were further incubated for 1 h 
(immunoprecipitation experiments) or 4 h (virion experiments).  Excluding experiments 
depicted in Fig. 8, at no time were virus particles incubated in the presence of mβCD.  
For experiments in Fig. 8, extraction of cholesterol from NDV particles was 
performed as described previously (81).  Briefly, non-radiolabeled or [35-S]-radiolabeled, 
gradient-purified NDV (strain AV) virions from untreated ELL-0 cells were mixed with 
DMEM or with increasing concentrations of mβCD in DMEM and incubated for 1 h at 37oC.  
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The virus was purified away from mβCD:cholesterol complexes by sedimentation through 
20% sucrose as described above. 
Immunofluorescence of surface HN and F glycoproteins 
HEL, NPC and ELL-0 cells were grown to confluence on glass coverslips in 35-mm plates 
and infected with NDV (strain AV) for 7 h.  Cells were then left untreated or treated with 10 
mM mβCD and 4 μg/ml lovastatin for 1 h followed by a 1 h recovery in DMEM in the 
presence of lovastatin.  Cells were then washed twice with ice-cold IF buffer (PBS 
containing 1% bovine serum albumin, 0.02% sodium azide and 5 mM CaCl2), fixed with 2% 
paraformaldehyde for 10 min on ice and blocked with IF buffer overnight at 4oC.  Cells were 
then incubated for 1 h at 4°C in IF buffer containing HN protein-specific rabbit anti-H 
antibody or F protein-specific mouse anti-Fu1a antibody.  Following three washes with ice-
cold IF buffer, cells were incubated for 1 h at 4°C in IF buffer containing Alexa Fluor 488-
conjugated goat anti-rabbit antibody (Molecular Probes) or Alexa Fluor 568-conjugated goat 
anti-mouse antibody (Molecular Probes).  Monolayers were then washed three times with 
ice-cold IF buffer and incubated for 20 min on ice with IF buffer containing Hoechst nuclei 
stain (Molecular Probes).  Cells were washed twice with ice-cold IF buffer and mounted on 
slides using Vectashield Mounting Medium (Vector Laboratories) for fluorescence 
microscopy.  Fluorescence images were acquired using a Nikon fluorescence microscope and 
Openlab software. 
Co-immunoprecipitation of viral proteins  
Co-immunoprecipitation was done as described by McGinnes et al. (103).  Briefly, 
equivalent volumes of cellular extracts were incubated overnight at 4oC with either a cocktail 
of HN protein-specific antibodies (anti-A, anti-AS and anti-H), F protein-specific antibodies 
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(anti-HR1, anti-HR2, anti-Fu1a, anti-Ftail and anti-F2-96) or in the absence of antibody.  
Antibody complexes were precipitated with pansorbin cells (Calbiochem), washed three 
times in TNE containing 0.5% Triton X-100 and prepared for SDS-PAGE as described 
above.  For DRM gradient fractions, equivalent volumes of sucrose fractions were adjusted 
to 1% Triton and incubated overnight at 4oC with either the cocktail of HN protein-specific 
antibodies, F protein-specific antibodies or in the absence of antibody.  Antibody complexes 
were precipitated with pansorbin cells, washed three times in TNE containing 0.5% Triton X-
100 and prepared for SDS-PAGE.  The amount of each protein precipitated in the no 
antibody sample, due to protein aggregation or non-specific association of the proteins with 
pansorbin cells, was subtracted from the amount of glycoprotein specifically precipitated 
when NDV-specific antibody was present.   
Sorting of virions 
[35-S]-radiolabeled virus (strain AV) was purified by sedimentation through 20% sucrose and 
subsequently floated, as described above.  Equivalent amounts of intact virions with normal 
particle density (1.18 – 1.20 g/cm3) (81), were incubated overnight at 4oC with either 
polyclonal anti-NDV antibody, HN protein-specific anti-H antibody, a cocktail of F protein-
specific antibodies (anti-HR1, anti-HR2, anti-F2-96 and anti-Fu1a) or in the absence of 
antibody.  Antibody-virus complexes were precipitated with pansorbin cells and washed with 
cold TNE.  The precipitated virions were then adjusted to 1% Triton X-100 to lyse virions.  
All viral proteins were then immunoprecipitated with a cocktail of NDV-specific antibodies 
and pansorbin cells.  Precipitates were washed three times in PBS containing 0.4% sodium 
dodecyl sulfate (SDS) and proteins were prepared for SDS-PAGE as described above.  To 
calculate sorting efficiency, background (no antibody controls) values were subtracted and 
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then background-adjusted values were divided by the total amount precipitated with anti-
NDV antibody. 
Virus-cell binding  
[35-S]-radiolabeled, gradient-purified NDV (strain AV) virus from untreated or mβCD-
treated  ELL-0 cells was incubated with chilled, confluent ELL-0 cell monolayers for 1 h on 
ice at 4oC in cold Ca++-rich DMEM.  Monolayers were then washed gently three times with 
cold PBS and cell extracts prepared as outlined above.  All viral proteins were 
immunoprecipitated and prepared for SDS-PAGE as described above.  The specificity 
control consisted of pre-incubation of an equivalent amount of virions with neutralizing anti-
NDV antibody for 30 min at room temperature prior to binding with cell monolayers.  To 
calculate binding efficiency, an equivalent amount of virions were immediately lysed and all 
viral proteins immunoprecipitated for the assay input.   
Virus-cell fusion  
For visualization of R18 virus-cell fusion by fluorescence microscopy, gradient-purified 
NDV (strain AV) from untreated ELL-0 cells was incubated with R18 (octadecyl rhodamine 
B, Molecular Probes) for 1 h at room temperature in the dark.  R18-loaded particles were 
purified away from excess R18 by sedimentation through 20% sucrose as described above.  
ELL-0 cells, grown to confluence on glass coverslips in 35-mm plates, were incubated with 
R18-loaded virus for 60 min at 4oC on ice.  Unbound virions were removed and cell 
monolayers washed three times with cold PBS.  Cells were either immediately fixed with 2% 
paraformaldehyde after virus binding or shifted to 37oC for further incubation prior to 
fixation.  Nuclei were stained and fluorescence images acquired as outlined above.  The 
specificity control consisted of pre-incubation of an equivalent amount of virions with 
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neutralizing anti-NDV antibody for 30 min at room temperature prior to binding with cell 
monolayers.   
 For quantitative R18 virus-cell fusion, gradient-purified NDV (strain B1) from 
untreated or mβCD-treated avian ELL-0 cells was incubated with acetylated trypsin (Sigma-
Aldrich) to cleave virion F proteins for 15 min at 37oC as described by Connolly and Lamb 
(28).  Particles were then incubated with soybean trypsin inhibitor (Sigma-Aldrich) for 15 
min at room temperature.  Virions were then incubated with R18 for 1 h at room temperature 
in the dark and re-purified as described above.  Virions were then incubated with chilled 
guinea pig erythrocytes (Bio-Link, Inc.) in 24-well plates for 1 h on ice at 4oC in the dark.  
Upon incubation of plates at 37oC, R18 fluorescence (excitation 560 nm; emission 590 nm) 
from wells of virus-erythrocytes was read at 10 min intervals with a SpectraMax Gemini XS 
(Molecular Devices) and SoftMax Pro software (Molecular Devices).  At the end of 60 min 
at 37oC, wells were adjusted to 1% Triton X-100 to obtain maximum R18 fluorescence and 
experimental values normalized as described previously (28, 62, 151). 
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C.  Results 
Assembly of NDV in Niemann-Pick syndrome type C human fibroblasts 
We have previously reported that extraction of cholesterol from NDV-infected cell 
membranes with methyl-β-cyclodextrin (mβCD) resulted in the release of structurally 
abnormal virus particles with reduced infectivity (81).  However, incubation of cells with 
mβCD also results in alterations of the actin cytoskeleton (79).  To determine the importance 
of plasma membrane cholesterol in assembly of NDV in the absence of mβCD effects on the 
cytoskeleton, assembly of NDV in Niemann-Pick syndrome type C (NPC) cells was 
characterized.  NPC cells are human fibroblasts with mutations in one or two genes, NPC1 
and NPC2, which result in defective transport of cholesterol to cell plasma membranes and 
aberrant membrane lipid raft domains (66).  Normal human embryonic lung (HEL) 
fibroblasts were used as wild-type counterparts for comparison.  In contrast to comparisons 
of untreated and mβCD-treated avian cells (81), the actin cytoskeleton of NPC cells was 
similar to that of HEL cells (Fig. 3.1A).  HEL and NPC cells were equally permissive to 
NDV infection.  As shown in Figure 3.1B, when comparable numbers of HEL and NPC cells 
were infected with NDV, similar levels of viral protein expression were observed in cellular 
extracts at 8 h post-infection.         
 Plasma membrane cholesterol is primarily associated with liquid-ordered domains or 
membrane lipid rafts (167).  These specialized cell surface domains are thought to be 
experimentally reflected in detergent-resistant membranes (DRMs), which may be isolated 
by flotation into sucrose gradients after lysis of cells with non-ionic detergents, usually 
Triton X-100, at 4oC (167).  It has been recently recognized that two density classes of 
DRMs exist, classical DRMs (termed DRM-L with densities of 1.09-1.13  
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Legend to Figure 3.1:  Abnormal assembly and release of NDV from Niemann-Pick 
syndrome type C human fibroblasts.   
Panel A:  Actin distribution of normal human fibroblasts (HEL) and Niemann-Pick syndrome 
type C (NPC) fibroblasts.  Uninfected HEL and NPC cells, treated with 0.05% Triton X-100, 
were incubated with phalloidin (actin panels) for 1 h at 4oC prior to Hoescht staining (nuclei 
panels).   
Panel B:  Proteins in uninfected and NDV (B1)-infected HEL and uninfected and NDV (B1)-
infected NPC fibroblasts were resolved by SDS-PAGE under non-reducing conditions and 
viral proteins detected by Western analysis with anti-NDV specific antibodies.  M, matrix 
protein; NP, nucleocapsid protein; F0, uncleaved fusion protein; HN, hemagglutinin-
neuraminidase protein.   
Panel C:  DRMs in extracts of NDV (AV)-infected HEL and NPC cells were isolated by 
flotation in sucrose gradients as described in Materials and Methods.  Proteins present in 
DRM gradient fractions were detected by Western analysis using anti-NDV (NP), anti-AS 
(HN protein) or anti-HR2 (F protein).  Each lane contains 12% of the corresponding gradient 
fraction except fraction 2 which contains 3% of the total.  Densities of each gradient fraction 
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are indicated as g/cm3.  Sol, detergent-soluble gradient fractions; DRM-H, heavy density 
DRM gradient fractions; DRM-L, light density DRM gradient fractions; F1, cleaved fusion 
protein.   
Panel D:  The amounts of NP, HN and F1 protein present in purified virions released from 
equivalent numbers of NDV (AV)-infected HEL (black bars) and NPC (gray bars) cells 
detected by Western analysis as described for panel C.  Replicate experiments were 
quantified by densitometry and amounts of each protein are represented relative to amounts 
detected in virions from HEL cells.   
Panel E:  Infectivity (PFU/ml), determined by plaque assay as described previously (81, 105), 
of purified virions released from comparable numbers of NDV (AV)-infected HEL (black 
bar) and NPC cells (gray bar).   
Panel F:  The infectivity (PFU/ml) normalized for NP protein levels quantified in virions 
released from comparable numbers of NDV (AV)-infected HEL (black bar) and NPC (gray 
bar) cells.  Error bars indicate standard deviations. 
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g/cm3) and heavier density DRMs (DRM-H), which associate with cytoskeletal components 
and display buoyant densities of 1.14-1.18 g/cm3 (30).  The partitioning of the viral proteins 
with these DRMs from HEL and NPC cells is shown in Figure 3.1C.  In results very similar 
to those observed using infected avian cells, both classes of DRMs from HEL cells contained 
the hemagglutinin-neuraminidase (HN) glycoprotein and the nucleocapsid protein (NP), 
while the fusion (F) glycoprotein primarily fractionated with DRM-L domains (Fig. 3.1C).  
In contrast, significantly reduced amounts of HN and F proteins as well as NP in infected 
NPC cell extracts fractionated with DRMs (Fig. 3.1C).  These results are consistent with the 
abnormal lipid raft domains in NPC cells (95).   
 The release of virus particles from equivalent numbers of infected HEL and NPC 
cells is shown in Figure 3.1, panels D-F.  Based upon amounts of NP in purified virions, 
particle release from NPC cells was enhanced approximately three-fold over particle release 
from HEL cells (Fig. 3.1D).  However, particles released from NPC cells possessed 
comparable levels of HN protein and slightly reduced amounts of F protein compared to 
particles released from HEL cells, suggesting there was less glycoprotein per virion in 
particles released from NPC cells (Fig. 3.1D).   
 A comparison of the infectivity of particles released from equivalent numbers of 
infected HEL and NPC cells showed that infectivity of NPC cell-derived particles was 
reduced approximately one log (PFU/ml) compared to that of HEL cell-derived particles 
(Fig. 3.1E).  Upon normalizing the infectivity of particles for their NP content, the infectivity 
of NPC cell-derived particles was approximately 1.5 log (PFU/ml) lower than that of 
particles generated from HEL cells (Fig. 3.1F).  These results, which are very similar to those 
obtained with untreated and mβCD-treated avian cells (81), support the conclusion that 
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plasma membrane cholesterol and lipid raft domains have a role in the ordered assembly of 
infectious NDV particles.  The results also suggest that the mβCD-induced actin re-
arrangement is not likely the primary cause of the abnormal virus release from infected cells 
treated with mβCD (81).   
Functional properties of particles released from mβCD-treated cells  
To determine the reasons for the decreased infectivity of particles released from mβCD-
treated cells (81), attachment of these particles to cells and the fusion of these particles to cell 
membranes were quantified.  The binding activities of [35-S]-radiolabeled virions, released 
from untreated or mβCD-treated avian cells, is shown in Figure 3.2A and 3.2B.  
Approximately 21% of input particles released from untreated cells bound to target cells 
while prior incubation with neutralizing antibody (129) reduced binding to ~1% (Fig. 3.2B).  
Similarly, 28% of input particles released from mβCD-treated cells bound to target 
monolayers and prior incubation with neutralizing antibody also blocked this binding (Fig. 
3.2B).   Thus, cell binding efficiency of particles released from cholesterol-depleted cells was 
similar to that of normal virions. 
 The virus-cell membrane fusion activity of these particles was monitored with a R18 
fluorescence-based assay, similar to ones described previously (28, 62, 151).  The transfer of 
self-quenched R18 dimers from viral membranes to that of target erythrocyte membranes 
involves a hemi-fusion event, which is mediated by an activated, functional F protein on the 
viral membrane (116).  Fusion is measured by the dequenching of R18 as it spreads into the 
larger erythrocyte membrane, resulting in increased R18 fluorescence.   
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Legend to Figure 3.2:  Attachment and fusion activities of virions released from 
untreated and mβCD-treated cells. 
[35-S]-radiolabeled virions released from untreated or mβCD-treated NDV (AV)-infected 
ELL-0 cells were purified and their virus-cell attachment and virus-cell hemi-fusion activities 
were characterized as described in Material and Methods. 
Panel A:  Shown is a representative autoradiograph of cell binding of virions released from 
untreated and mβCD-treated cells.  Virus was bound to avian ELL-0 cells on ice at 4oC for 1 
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h.  Monolayers were washed, lysed, and viral proteins, immunoprecipitated with a cocktail of 
anti-NDV specific-antibodies, were resolved by SDS-PAGE under reducing conditions 
(+BME).  Radiolabeled viral proteins are indicated on the right.  Input, virions immediately 
lysed without cell binding and viral proteins immunoprecipitated with a cocktail of anti-
NDV-specific antibodies; α-NDV, equivalent amount of virions pre-incubated with 
neutralizing anti-NDV-specific antibody prior to incubation with cell monolayers.  Bound, 
virus bound to cell monlayers. 
Panel B:  Binding efficiency of particles represented as percent of total input radiolabeled 
HN protein among particles released from untreated (black bar) and mβCD-treated (gray bar) 
cells bound to cell monolayers.  Results are averages of three experiments and error bars 
indicate standard deviations. 
Panel C:  NDV-cell fusion visualized by dequenching of R18 upon fusion of R18-loaded 
virions with ELL-0 cells.  Virus (strain AV – generated from untreated ELL-0 cells) was 
incubated with cells at 4oC for 60 min only (panel ii), virus was bound at 4oC for 60 min then 
incubated at 37oC for 30 min or 60 min (panels iii and iv, respectively), or virus, pre-
incubated with neutralizing anti-NDV antibody, was incubated at 4oC for 60 min and then at 
37oC for 30 min (panel v).  
Panel D:  Kinetics of R18 dequenching and fluorescence upon incubation of R18-loaded 
NDV (strain B1), released from untreated or mβCD-treated cells, with untreated and 
neuraminidase (NA)-treated target erythrocytes at 37oC.  Results are averages of three 
experiments and error bars indicate standard deviations.  Results with open symbols were 
identical and overlap. 
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 The demonstration that this assay can be used to monitor NDV particle fusion with 
avian cells is shown in Figure 3.2C.  When virus was bound to cells at 4oC only, no transfer 
or dequenching of R18 into cell monolayers was observed (Fig. 3.2C, panel ii).  However, 
incubation of virus-bound cells at 37oC for 30 min or 60 min (Fig. 3.2C, panels iii and iv, 
respectively) resulted in transfer and dequenching of R18 into cell monolayers.  The transfer 
of R18 from virions to cells was specific as pre-incubation of virus with neutralizing anti-
NDV antibody significantly reduced the number of R18-positive cells (Fig. 3.2C, panel v). 
 These results were quantified and the kinetics of virus-cell fusion was determined 
using a fluorescence plate-reader.  The hemi-fusion kinetics of virions released from 
untreated cells with target cells commenced at approximately 10 min following incubation at 
37oC and reached maximal at 40-60 min (Fig. 3.2D).  At 60 min at 37oC, the extent of hemi-
fusion of particles released from untreated cells was approximately three-fold higher than 
that of particles released from mβCD-treated cells (Fig. 3.2D).  Both hemi-fusion events 
were specific, as incubation of particles with neuraminidase-treated cells did not result in 
transfer or dequenching of R18 (Fig. 3.2D).  Thus, particles released from mβCD-treated 
cells are deficient in virus-cell hemi-fusion. 
Incorporation of HN – F glycoprotein-containing complexes into virions 
Reduced virus-cell hemi-fusion could be due to reduced virion incorporation of F protein or 
the packaging of non-functional F protein into particles.  To address the former possibility, 
virions were "sorted" with mono-specific antibody and levels of one glycoprotein were 
quantified following precipitation of intact particles with antibody specific for the other 
glycoprotein.  [35-S]-radiolabeled virions, released from untreated and mβCD-treated avian 
cells, were incubated with antibody specific for the HN protein or a cocktail of antibodies 
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specific for the F protein.  Total particles were precipitated with anti-NDV antibody and 
nonspecific precipitation was monitored by omission of antibody.  Representative 
autoradiographs of proteins in precipitated particles are shown in Figure 3.3A along with 
quantification of HN and F protein levels (Fig. 3.3B and 3.3C, respectively) within antibody-
sorted particles. 
 Specific precipitation of virion HN protein with HN protein-specific antibody resulted 
in recovery of approximately 100% of HN protein-containing particles released from 
untreated cells (Fig. 3.3B) and the majority of HN protein-containing particles released from 
untreated cells were precipitated with F protein-specific antibodies (Fig. 3.3B).  Very similar 
results were obtained with virions released from mβCD-treated cells (Fig. 3.3B) indicating 
that all particles contained some level of HN protein.  Precipitation of particles with anti-HN 
protein antibody resulted in a similar recovery of virion-associated F protein as precipitation 
with anti-F protein antibodies among virions released from either untreated or mβCD-treated 
cells (Fig. 3.3C).  Taken together, these results suggested that the majority of particles 
released from mβCD-treated cells possessed both HN and F glycoproteins within the same 
virus particle.   
HN – F protein-containing complexes in virion envelopes  
Given that most particles contain at least some of both the HN and F proteins, we next 
addressed the effects of cellular cholesterol depletion on packaging of HN – F glycoprotein-
containing complexes into virions (Fig. 3.4).  Virions released from untreated or mβCD-
treated cells were lysed and the extent of co-immunoprecipitation of the HN and F proteins 
was quantified.  A representative result of HN and F protein co-immunoprecipitation is  
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Legend to Figure 3.3:  Precipitation of intact particles with glycoprotein-specific 
antibodies. 
Intact [35-S]-radiolabeled virions released from untreated or mβCD-treated NDV (AV)-
infected ELL-0 cells were purified and immunoprecipitated by either polyclonal anti-NDV 
antibody, HN protein-specific antibody, a mix of F protein-specific antibodies or no antibody 
as described in Material and Methods. 
Panel A:  Shown is a representative autoradiograph of the HN and F protein content of 
particles released from untreated and mβCD-treated cells precipitated with anti-NDV 
antibody, no antibody (–), anti-HN protein antibody or anti-F protein antibodies.  Indicated 
above is the virus particle origin and radiolabeled viral proteins on the right.  HN protein 
lanes were from polyacrylamide gels electrophoresed under reducing conditions while F 
protein lanes were from polyacrylamide gels electrophoresed under non-reducing conditions. 
Panel B:  Amounts of radiolabeled HN protein in particles released from untreated (black 
bars) and mβCD-treated (gray bars) cells.  Particles were precipitated or ‘sorted’ with 
antibodies as indicated at bottom of panel and as described in Material and Methods.  Data is 
represented as percent of total HN protein precipitated with anti-NDV.  The no antibody (–) 
values were subtracted from each precipitation.   
Panel C:  Amounts of radiolabeled F0 + F1-F2 protein in particles released from untreated 
(black bars) and mβCD-treated (gray bars) cells.  Particles were ‘sorted’ with antibodies as 
indicated and as described in Material and Methods.  Data is represented as percent of total 
F0 + F1-F2 protein precipitated with anti-NDV.  The no antibody (–) values were subtracted 
from each precipitation.  Results are averages of three experiments and error bars indicate 
standard deviations. 
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depicted in Figure 3.4A with quantifications shown in Figure 3.4B and 3.4C.  Approximately 
40% of the total virion HN protein in particles released from untreated cells was precipitated 
with F protein-specific antibodies (Fig. 3.4B), while in the reciprocal immunoprecipitation, 
35% of the total F protein was precipitated with HN protein-specific antibodies (Fig. 3.4C).  
In contrast, only 20% of the total HN protein in particles released from mβCD-treated cells 
was precipitated with F protein-specific antibodies (Fig. 3.4B).  In the reciprocal 
immunoprecipitation, the amount of total F protein precipitated with HN protein-specific 
antibodies was reduced three-fold (Fig. 3.4C).  The significant reduction in virion associated 
HN – F protein-containing complexes in particles released from cholesterol-depleted cells 
could account for their reduced infectivity since F protein activation is thought to require 
interactions with HN protein.   
Cell surface distribution of viral glycoproteins after cholesterol depletion 
To explore the mechanisms for reduction in HN and F protein complexes in virions released 
from mβCD-treated cells, these glycoprotein complexes in infected cells were characterized.  
First, the effects of cholesterol depletion on the cell surface distribution of HN and F proteins 
were examined by immunofluorescence microscopy.  Both the HN and F glycoproteins (Fig. 
3.5A and 3.5B, respectively) formed small, distinct foci across the surfaces of untreated 
avian cells.  However, upon treatment of avian cells with mβCD, there was a dramatic 
redistribution of both proteins.  Several large HN protein-specific patches formed (Fig. 
3.5A).  In contrast, F protein redistributed primarily to the cell periphery (Fig. 3.5B).  On the 
surfaces of infected HEL cells, the HN and F proteins (Fig. 3.5C and 3.5D, respectively) each 
formed discrete foci.  The HN protein on surfaces of NPC cells localized in distinct foci, 
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Legend to Figure 3.4:  Co-immunoprecipitation of HN and F proteins from virions 
released from untreated and mβCD-treated avian cells. 
Purified [35-S]-radiolabeled virions released from untreated and mβCD-treated ELL-0 cells 
were lysed and proteins precipitated with a mix of anti-HN protein-specific antibodies or a 
mix of anti-F protein-specific antibodies as outlined in Material and Methods.    
Panel A:  Shown is a representative autoradiograph of virions from untreated or mβCD-
treated cells precipitated with no antibody (–), anti-HN protein or anti-F protein antibodies.  
Radiolabeled, precipitated viral proteins are indicated on the right.  HN protein lanes were 
from polyacrylamide gels electrophoresed under reducing conditions while F protein lanes 
were from polyacrylamide gels electrophoresed under non-reducing conditions.  
Panel B:  Amounts of radiolabeled HN protein specifically precipitated with anti-HN protein- 
or anti-F protein-specific antibodies from solubilized virions released from untreated (black 
bars) or mβCD-treated (gray bars) cells.  Data is represented as percent of total HN protein 
precipitated with anti-HN protein-specific antibodies set to 100% for each virus. 
Panel C:  Amounts of radiolabeled F protein specifically precipitated with anti-F protein- or 
anti-HN protein-specific antibodies from solubilized virions released from untreated (black 
bars) or mβCD-treated (gray bars) cells.  Data is represented as percent of total F protein 
precipitated with anti-F protein-specific antibodies set to 100% for each virus.  Results are 
averages of three experiments and error bars indicate standard deviations. 
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but the F protein stained diffusely over the cell surface (Fig. 3.5C and 3.5D, respectively).  
Qualitatively, the surface localizations of HN and F proteins on infected NPC cells differed 
from the surface localizations of the glycoproteins on mβCD-treated avian cells.  These 
differences may be due to additional effects that mβCD has on the avian cell cytoskeleton.  
In any event, loss of plasma membrane cholesterol alters the glycoprotein surface distribution 
in both types of cells and this alteration results in the same reduction of virus infectivity 
when particles are assembled and released from these two cell types.  The redistribution of 
surface glycoproteins when levels of plasma membrane cholesterol were decreased, due 
either to mβCD treatment or to endogenous cholesterol transport defects, suggested that the 
viral protein-protein interactions in the plasma membrane may be altered in cells depleted of 
cholesterol.   
Effects of cholesterol depletion on viral glycoprotein complexes in cell extracts  
The effect of cholesterol depletion on detection of HN and F protein complexes in infected 
avian cells was characterized by quantifying the extent of co-immunoprecipitation of the two 
proteins as in Figure 3.4.  A representative co-immunoprecipitation is shown in Figure 3.6A 
with quantifications of multiple experiments shown in Figure 3.6B and 3.6C.  Nearly 75% of 
the total cell-associated HN protein in untreated cell extracts was precipitated with F protein-
specific antibodies (Fig. 3.6B), while in the reciprocal immunoprecipitation, approximately 
70% of the total F protein was precipitated with HN protein-specific antibodies (Fig. 3.6C).  
In contrast, only 35% of the total HN protein in mβCD-treated cell extracts was precipitated 
with F protein-specific antibodies (Fig. 3.6B).  In the reciprocal immunoprecipitation, the  
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Legend to Figure 3.5:  HN and F glycoprotein surface distribution on untreated and 
mβCD-treated avian cells, HEL cells and NPC cells. 
Panels A and B:  The surface distribution of HN protein (panel A) or F protein (panel B) on 
ELL-0 cells as visualized by fluorescence microscopy.  Uninfected cells were left untreated.  
At 7 h post-infection, NDV (AV)-infected cells were left untreated or treated with 10 mM 
mβCD and lovastatin for one hour followed by a one hour recovery incubation in DMEM.  
Cells were fixed, incubated with antibodies specific for HN protein or F protein and 
processed for immunofluorescence microscopy as described in Materials and Methods.   
Panels C and D:  The surface distribution of HN protein (panel C) or F protein (panel D) on 
uninfected and NDV (AV)-infected HEL and NPC cells as visualized by fluorescence 
microscopy.  At 8 h post-infection, cells were fixed, stained for surface HN protein or F 
protein and processed for immunofluorescence microscopy as described in Materials and 
Methods.   
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amount of F protein precipitated with HN protein-specific antibodies was 20% of the total F 
protein (Fig. 3.6C).  The significant reduction in co-immunoprecipitation of HN and F 
proteins after cholesterol depletion strongly indicated that viral protein-protein interactions in 
the cells were altered when cellular cholesterol levels were depleted. 
HN – F glycoprotein complexes in cellular DRM fractions  
We have previously reported that NDV assembly occurs in lipid raft domains (81).  If the HN 
and F protein complexes detected in total cellular extracts are assembled into virions, then 
these complexes should be detected in the cellular DRM fractions previously characterized 
(81).  Indeed, in untreated cell extracts, the HN protein in DRM fractions was precipitated 
with F protein-specific antibodies, although the majority of HN and F protein complexes 
were detected in DRM-L fractions (Fig. 3.7D).  Only F protein in DRM-L fractions was 
precipitated with HN protein-specific antibodies (Fig. 3.7E).  Importantly, there was little 
significant co-immunoprecipitation of the two proteins from detergent-soluble, non-raft 
fractions of untreated cells (Fig. 3.7) indicating that the HN-F protein complexes reside in 
lipid raft domains.   
 As previously reported, in mβCD-treated cells, there was a reduced association of HN 
and F proteins with DRM-L fractions and an increase of the proteins in detergent-soluble 
fractions of the cell (81) (Fig. 3.7B and 3.7C, respectively).  Most importantly, there was 
very little co-immunoprecipitation of either protein from DRM-L, DRM-H or, significantly, 
in detergent-soluble fractions of mβCD-treated cells (Fig. 3.7D and 3.7E).  These results 
indicate that detection of HN and F protein complexes by co-immunoprecipitation depend 
upon the presence of cholesterol and membrane raft integrity.       
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Legend to Figure 3.6:  Co-immunoprecipitation of viral glycoproteins from cellular 
extracts of untreated and mβCD-treated avian cells. 
Monolayers of NDV(AV)-infected ELL-0 cells were pulse-labeled with [35-S] 
methionine/cysteine at 6 hours post-infection and then subjected to a one hour non-
radioactive chase.  Cells were then left untreated or treated with 10 mM mβCD and lovastatin 
for one hour, incubated in DMEM for one hour and then lysed as described in Material and 
Methods.  Proteins in extracts were precipitated with a mix of anti-HN protein-specific 
antibodies or a mix of anti-F protein-specific antibodies as outlined in Material and Methods.  
To detect total F (F0 + F1-F2) protein, proteins were electrophoresed in absence of reducing 
agent. 
Panel A:  Shown is a representative autoradiograph of cell extracts from untreated or mβCD-
treated cells precipitated with no antibody (–), anti-HN protein or anti-F protein antibodies.  
Radiolabeled viral proteins are indicated on the right.  
Panel B:  Amounts of radiolabeled HN protein specifically precipitated with anti-HN protein- 
or anti-F protein-specific antibodies from cellular extracts of untreated (black bars) or 
mβCD-treated (gray bars) cells.  Data is represented as percent of total HN protein 
precipitated with anti-HN protein-specific antibodies set to 100% for each cell extract.   
Panel C:  Amounts of radiolabeled F protein precipitated with anti-F protein- or anti-HN 
protein-specific antibodies from cellular extracts of untreated (black bars) or mβCD-treated 
(gray bars) cells.  Data is represented as percent of total F protein precipitated with anti-F 
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protein-specific antibodies set to 100% for each cell extract.  Results are averages of three 
experiments and error bars indicate standard deviations. 
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Legend to Figure 3.7:  Co-immunoprecipitation of viral proteins from DRM cell 
fractions derived from untreated and mβCD-treated avian cells. 
Cellular extracts of NDV(AV)-infected ELL-0 cells, untreated or treated with 10 mM mβCD 
and lovastatin, were prepared as described in legend to Fig. 3.6 and separated into DRM-L, 
DRM-H and detergent-soluble fractions as described in legend to Fig. 3.1C.  Gradient 
fractions corresponding to the three cellular fractions as indicated in Fig. 3.1C were pooled 
and proteins precipitated with mono-specific antibodies. 
Panel A:  Shown is a representative autoradiograph of proteins precipitated from gradient 
fractions (Sol, detergent-soluble gradient fractions; DRM-H, heavy density DRM gradient 
fractions; DRM-L, light density DRM gradient fractions) derived from untreated or mβCD-
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treated cells precipitated with no antibody (–), anti-HN protein- or anti-F protein-specific 
antibodies.  Radiolabeled viral proteins are indicated on the right.  
Panel B:  Radiolabeled HN protein specifically precipitated with anti-HN protein-specific 
antibodies from indicated cellular fractions of untreated (black bars) or mβCD-treated (gray 
bars) cells.  Data is represented as absolute HN protein levels (arbitrary densitometer units) 
precipitated with anti-HN protein-specific antibodies.   
Panel C:  Radiolabeled F protein specifically precipitated with anti-F protein-specific 
antibodies from indicated cellular fractions of untreated (black bars) or mβCD-treated (gray 
bars) cells.  Data is represented as absolute F protein levels (arbitrary densitometer units) 
precipitated with anti-F protein-specific antibodies.   
Panel D:  Radiolabeled HN protein specifically precipitated with anti-F protein-specific 
antibodies from indicated cellular fractions of untreated (black bars) or mβCD-treated (gray 
bars) cells.  Data is represented as absolute HN protein levels (arbitrary densitometer units) 
precipitated with anti-F protein-specific antibodies.   
Panel E:  Radiolabeled F protein specifically precipitated with anti-HN protein-specific 
antibodies from indicated cellular fractions of untreated (black bars) or mβCD-treated (gray 
bars) cells.  Data is represented as absolute F protein levels (arbitrary densitometer units) 
precipitated with anti-HN protein-specific antibodies.  Results are averages of three 
experiments and error bars indicate standard deviations. 
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Effects of virion envelope cholesterol depletion  
Although extraction of cholesterol from virion membranes had no effect on NDV infectivity 
(81), the importance of cholesterol in virion membranes for detection of virion-associated 
HN – F protein-containing complexes and in glycoprotein functions was tested.  [35-S]-
radiolabeled virions, generated from untreated avian cells, were depleted of cholesterol by 
incubation with increasing concentrations of mβCD and then re-purified (Fig. 3.8).  
Incubation of particles with 10 mM mβCD removed approximately 90% of virion-associated 
cholesterol as previously reported (81).  Approximately 40% of the total HN protein from 
untreated particles was precipitated with F protein-specific antibody (Fig. 3.8A) while in the 
reciprocal co-immunoprecipitation, ~40% of total F protein was precipitated with HN 
protein-specific antibody (Fig. 3.8B).  Cholesterol extraction of virion membranes had no 
effect on the precipitation of HN protein with F protein-specific antibody (Fig. 3.8A).  The 
amount of F protein precipitated with HN protein-specific antibody was not decreased but 
rather somewhat increased (~55% of the total) (Fig. 3.8B).   
 The cell binding efficiency of untreated particles was approximately 20% and 
cholesterol extraction had no significant effect on virus binding efficiencies (Fig. 3.8C).  
Cholesterol extraction of virions did not inhibit virus-cell membrane fusion as measured in 
the R18 hemi-fusion assay described above (Fig. 3.8D).  Indeed, the hemi-fusion of mβCD-
treated particles was increased by cholesterol extraction.  These results indicate that 
extraction of cholesterol from the virion envelope did not affect the association of the HN 
and F glycoproteins nor was it inhibitory to activities of the two glycoproteins. 
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Legend to Figure 3.8:  Effect of cholesterol extraction from virions on viral glycoprotein 
interactions and activities. 
[35-S]-radiolabeled virions released from untreated NDV (AV)-infected ELL-0 cells were left 
untreated or depleted of cholesterol with 2.5, 5 or 10 mM mβCD for 1 h at 37oC and then re-
purified as described in Material and Methods.   
Panel A:  Levels of co-immunoprecipitation of HN protein from solubilized particles either 
untreated (black bars) or treated with 10 mM mβCD (gray bars) as described in legend to 
Fig. 3.4 and in Material and Methods.  Results are averages of three experiments and error 
bars indicate standard deviations. 
Panel B:  Levels of co-immunoprecipitation of F protein from solubilized particles either 
untreated (black bars) or treated with 10 mM mβCD (gray bars) as described in legend to 
Fig. 3.4 and in Material and Methods.  Results are averages of three experiments and error 
bars indicate standard deviations. 
Panel C:  Virus-cell binding efficiency, measured as described in legend to Fig. 3.2, of 
particles left untreated (black bar) or treated with 10 mM mβCD (gray bar).  Inhibition of cell 
binding by pre-incubation of virions with anti-NDV antibody is shown in white bars.  Results 
are averages of three experiments and error bars indicate standard deviations. 
Panel D:  Extent of virus-cell membrane hemi-fusion, measured as described in legend to 
Fig. 3.2 and Material and Methods, for particles left untreated or treated with increasing 
concentrations of mβCD.  The R18 fluorescence of target erythrocytes at 1 h at 37oC is  
shown for each sample.  Results are averages of three experiments and error bars indicate 
standard deviations. 
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D.  Discussion 
Results presented here and previously indicate that perturbation of membrane lipid raft 
domains either by extraction of cholesterol with mβCD or by their aberrant formation in 
Niemann-Pick syndrome type C fibroblasts resulted in the abnormal assembly and release of 
relatively non-infectious Newcastle disease virus particles.  Particles released from mβCD-
treated cells had normal attachment activity but were defective in fusion of viral and cellular 
membranes.  This reduced fusion correlated with a significant reduction in detection of HN – 
F protein-containing complexes in the virion envelopes of these particles and with loss of HN 
and F protein-containing complexes in mβCD-treated cells.  However, extraction of 
cholesterol from virion membranes did not affect these pre-formed HN and F protein 
complexes.  Taken together, these results suggest that membrane lipid rafts facilitate the 
necessary viral protein-protein interactions for the proper assembly of infectious NDV 
particles. 
Assembly and release of virus from Niemann-Pick syndrome type C cells 
Because mβCD has been shown to not only disrupt membrane lipid rafts but also to affect 
cytoskeleton organization (79), it was important to characterize assembly and release of 
particles from cells with membrane lipid rafts disordered by another mechanism.  Niemann-
Pick syndrome type C cells are reported to have altered membrane lipid raft domains (43, 44, 
95, 164, 186).  These cells were derived from humans with a specific lysosomal storage 
disorder (66).  The NPC disease is primarily due to mutation(s) in the NPC1 gene, which 
encodes a protein involved in the transport of LDL-derived cholesterol (66, 189), and likely 
endogenously synthesized cholesterol (141), to various organelles, including the plasma 
membrane.  In NPC cells, cholesterol, as well as raft-associated sphingolipids (164), 
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accumulate in late endosomes and lysosomes.  The actual level of cholesterol in the plasma 
membranes of NPC cells is controversial (14, 30, 85, 186) but it is clear that the lipid 
organization and function of membrane rafts at the plasma membrane of these cells are 
abnormal (14, 60, 74, 186).   
 NPC cells and wildtype counterpart (HEL) cells were equally permissive to NDV 
infection and both NDV glycoproteins were found at comparable levels on the surfaces of 
infected HEL and NPC cells.  Importantly, the actin cytoskeleton of NPC cells was similar to 
that observed for the control HEL cells.  However, there was reduced association of the viral 
proteins with DRMs from NPC cells compared to HEL cells, consistent with altered 
membrane lipid rafts in NPC cells.  Similar to previous results with mβCD-treated avian cells 
(81), particles released from NPC cells were characterized by irregular protein composition 
and reduced infectivity when compared to particles released from control HEL cells.  These 
results suggest that abnormal membrane lipid rafts, due to mutation in cholesterol transport, 
have similar effects on assembly of infectious virus as disruption of membrane lipid rafts by 
cholesterol extraction with mβCD.  The results are consistent with the conclusion that the 
integrity of membrane lipid rafts is important for the proper assembly and release of 
infectious virions. 
Effects of infected cell cholesterol depletion on released virions 
Disruption of infected cell lipid raft domains resulted in release of virions with reduced 
infectivity and the results shown here suggest that reduced infectivity was not due to loss of 
virus-cell attachment but may be attributed to defects in virus-cell membrane fusion.  The 
fusion defect may be due to either insufficient levels of F protein incorporation into particles 
or due to packaging of inactive F proteins.  Experiments ‘sorting’ particles with HN protein- 
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or F protein-specific antibodies showed that most virions, whether derived from untreated or 
mβCD-treated cells, contained both glycoproteins.  Furthermore, that all particles contained 
HN protein was shown by the observation that the cell binding of particles released from 
untreated and mβCD-treated cells was identical.  One limitation to this experimental sorting 
approach is the inability to determine the relative levels of each glycoprotein packaged into a 
single particle.  It is possible that there are particles with low levels of incorporated HN 
protein or F protein, which could potentially impact the overall infectivity of the virion 
population.  Nonetheless, most particles released from mβCD-treated cells possessed both 
HN and F glycoproteins suggesting that the packaged F proteins may be inactive. 
Studies of cell-cell membrane fusion mediated by paramyxovirus glycoproteins have 
shown that fusion requires activation of the F protein by the homologous viral attachment 
protein following cell attachment (82).  The activated F protein then proceeds through a 
series of conformational changes that initiate hemi-fusion, pore formation and pore 
expansion (82).  Because virions released from cholesterol-deficient cells were defective in 
hemi-fusion, the first step in membrane fusion, it was possible that these virions were 
defective in F protein activation.  Failure to activate the F protein could be due to loss of 
necessary HN and F protein-containing complexes required for membrane fusion.  To test the 
possibility that virus released from mβCD-treated cells had reduced HN and F protein 
complexes, the levels of these complexes in particles released from untreated cells were first 
determined.  There have been numerous reports of paramyxovirus attachment protein and 
fusion protein complexes in infected and transfected cells (1, 31, 90, 133, 177).  Indeed, 
NDV HN and F protein complexes were efficiently detected in transiently-transfected HN 
and F protein-expressing cells (103).  However, there has been very little characterization of 
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associations between glycoproteins within paramyxovirus particles.  Using conditions 
previously utilized to detect NDV HN and F protein complexes in cellular extracts of 
transfected cells (103), HN and F protein complexes were detected in virions.  However, 
while 70% and 60% of total HN and F protein, respectively, in infected cell extracts were 
precipitated with heterologous antibody, only 40% of the total virion-associated HN protein 
and 35% of the total virion-associated F protein could be precipitated with heterologous 
antibody.  These results suggest that virion-associated glycoproteins are heterogeneous and 
that packaging of glycoproteins into virions selects individual glycoprotein oligomers along 
with HN and F protein complexes.  
 The detection of HN and F protein-containing complexes in envelopes of particles 
released from mβCD-treated cells was significantly reduced.  As it is well-documented that 
paramyxovirus cell-cell fusion is dependent on F protein interactions with homologous viral 
attachment proteins (65), the reduction in hemi-fusion between particles released from 
mβCD-treated cells and target cell membranes may be attributed to the reduction of HN and 
F protein complexes.  While it cannot be ruled out that HN and F protein complexes are 
reduced due to altered ratios of HN and F proteins in individual particles, given the existence 
of near normal levels of virion F1 protein in particles released from mβCD-treated cells (81) 
it seems more likely that virion-incorporated F protein is non-functional due to loss of 
interactions with virion-incorporated HN protein.      
Effects of cholesterol depletion on glycoprotein complexes in infected cells 
The reduction of HN and F protein complexes in virus released from mβCD-treated cells as 
well as the altered cell surface distribution of the two glycoproteins after cholesterol 
extraction suggested that membrane lipid raft integrity may have a role in detection of HN 
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and F protein complexes in cell extracts.  In fact, cell-associated HN – F protein-containing 
complexes were detected exclusively in cellular DRM fractions and were not detected in 
detergent-soluble fractions of cells.  Strikingly, cholesterol extraction resulted in significantly 
reduced detection of glycoprotein complexes in total extracts and in residual DRM domains.  
Significantly, HN and F protein complexes did not shift to detergent-soluble fractions of 
mβCD-treated cells, suggesting that the integrity of membrane lipid raft domains is important 
for the formation or maintenance of these complexes.  Preliminary data also demonstrated a 
significant loss in detection of these complexes specifically from cellular DRM fractions of 
infected NPC cells (J. Laliberte and T. Morrison, unpublished). 
Recently, Ono et al. described a role for cholesterol in facilitating viral protein-
protein interactions at membrane raft domains (127).  Depletion of cellular cholesterol by 
mβCD treatment reduced the ability of human immunodeficiency virus type 1 (HIV-1) Gag 
protein to multimerize and fractionate with DRMs, resulting in impaired virus release (127).  
These results are consistent with those presented here and suggest that cholesterol and 
membrane lipid raft integrity are important for viral protein interactions and assembly of 
infectious virions.     
Effects of cholesterol depletion on virion-associated glycoprotein complexes 
To address the role of membrane lipid rafts in the formation and maintenance of glycoprotein 
complexes, cholesterol was extracted from normal virions.  Removal of approximately 90% 
of virion-associated cholesterol (81) did not affect detection of HN and F protein complexes 
indicating that, once formed and incorporated into virions, these complexes were not 
dependent upon membrane lipid raft integrity.  Supporting this conclusion was the 
observation that cholesterol extraction of virion envelopes had no effect on particle 
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infectivity (81), virus-cell attachment or virus-cell hemi-fusion.  Also consistent with this 
conclusion are results reported by Dolganiuc et al. examining the role of cholesterol in cell-
cell fusion by NDV HN and F protein-expressing cells (33).  HN and F protein-expressing 
cells, which were acutely depleted of cholesterol with mβCD, fused R18-loaded target 
erythrocytes to similar levels as HN and F protein-expressing cells left untreated (33).  Thus, 
extraction of cholesterol had no effect on F protein activation and therefore, perhaps, the 
integrity of these preformed HN and F protein complexes.  Together these results suggest 
that once formed, HN and F protein complexes in virions, and perhaps in cells, are stable and 
functional after cholesterol removal.   
 Although the stability of these glycoprotein complexes in cells is under investigation, 
the results support the hypothesis that formation, and not maintenance, of the NDV HN and F 
protein complex is cholesterol/membrane lipid raft-dependent.  Detection of HN and F 
protein complexes in the mutant NPC cells is significantly reduced in comparison to the 
wildtype HEL cells (J. Laliberte and T. Morrison, unpublished).  This result suggests that 
proper association of the glycoproteins with normal membrane lipid rafts may be essential 
for the formation of the glycoprotein complex following biosynthesis.  The residual fusion 
activity and low levels of HN and F protein complexes detected in virus released from mβCD 
treated cells could be due to complexes formed during the two hours of pulse-chase labeling 
prior to cholesterol extraction of infected cell membranes.       
In conclusion, the results presented here show that extraction of cholesterol from 
infected cell membranes, but not virion envelopes, decreases the infectivity of released virus 
by hindering the packaging of functional F proteins into virions.  Results are consistent with 
the proposal that cholesterol, and its role in maintaining membrane lipid raft domains in 
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NDV-infected cells, facilitates the formation or maintenance of HN – F protein complexes 
and, therefore, the virion incorporation of glycoprotein complexes capable of initiating virus-
cell membrane fusion. 
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CHAPTER IV 
The role of cholesterol and membrane lipid raft domains in the formation and 
maintenance of the Newcastle disease virus HN – F glycoprotein-containing complex 
 
A.  Introduction 
Newcastle disease virus (NDV) initiates virus infection through virus-to-cell and cell-to-cell 
membrane fusion events.  For paramyxoviruses like NDV, fusion of virion envelopes with 
target cell plasma membranes (virus-cell) and fusion of infected cell plasma membranes with 
neighboring, uninfected cell plasma membranes (cell-cell) is mediated by two virally-
encoded proteins: an attachment protein and a fusion protein.  The NDV hemagglutinin-
neuraminidase (HN) protein serves as the viral attachment protein and binds sialic acid-
containing receptors on the surfaces of cells (82).  The NDV fusion (F) protein is directly 
responsible for membrane fusion (82).  Based upon several structural studies, paramyxovirus 
F proteins have been classified as type I viral fusion proteins, which undergo major 
conformational changes during their activation and progression through membrane fusion 
(84). 
 For many viral fusion proteins, like the influenza HA protein, the acidic pH of the 
endosome initiates the conformational changes in the fusion protein required to initiate 
membrane fusion (82).  However, paramyxovirus F protein-mediated membrane fusion 
occurs at the plasma membrane and is a pH independent event (82).  For most 
paramyxoviruses, the presence of the homologous viral attachment protein is absolutely 
necessary for both virus-cell and cell-cell membrane fusion (116).  This virus-specific 
requirement for the attachment protein in membrane fusion is compelling evidence for a 
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specific interaction between the attachment protein and the fusion protein.  Moreover, 
multiple studies have shown that attachment proteins and fusion proteins co-
immunoprecipitate, a finding which suggests the existence of HN and F glycoprotein 
complexes (32, 96, 103, 109, 177, 193).  However, the exact spatial and temporal details of 
this interaction are undefined and controversial.   
 Studies of the assembly of NDV in infected cells, described in Chapters II and III, 
have shown that the virus assembles in cholesterol-enriched membrane lipid raft domains and 
that disruption of these domains results in the release of particles with significantly reduced 
infectivity.  Furthermore, it was shown that membrane raft integrity in the assembly 
membrane is important for the detection of cell- and virion-associated HN – F glycoprotein-
containing complexes.  Loss of these complexes correlated with the reduced infectivity of 
virus released from cholesterol-deficient, membrane raft-perturbed cells. 
 Given the importance of cellular cholesterol and membrane lipid raft integrity in the 
detection of functional HN – F protein-containing complexes in infected cells (Chapter III), 
the studies described here were undertaken to determine if membrane raft domains are 
necessary for the stability of pre-formed HN – F glycoprotein-containing complexes or if 
these domains are important for the formation of these complexes.  The results presented 
here suggest that cholesterol and membrane lipid raft domains are necessary for the 
generation of HN – F glycoprotein-containing complexes, which are critical for assembly of 
infectious virions.  
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B.  Materials and Methods 
Cells, virus and reagents 
East Lansing Line (ELL-0) avian fibroblasts from American Type Culture Collection were 
maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with penicillin-
streptomycin and 10% fetal calf serum (FCS).  Normal human embryonic lung (HEL) 
fibroblasts (a kind gift from Dr. Timothy Kowalik, University of Massachusetts Medical 
School) and Niemann-Pick syndrome type C (NPC) human fibroblasts (NIH Coriell Cell 
Repository GM03123) were maintained in DMEM supplemented with penicillin-
streptomycin, L-glutamine, vitamins, non-essential amino acids and 10% FCS.  NDV, strain 
AV (under BSL-3 conditions), stocks were prepared by growth in eggs by standard protocols 
(105).  Methyl-β-cyclodextrin (Sigma-Aldrich) was re-suspended in DMEM.  Lovastatin 
(Sigma-Aldrich) was prepared in H2O and activated as described previously (40).  
Cholesterol and lanosterol (Sigma-Aldrich) were complexed with methyl-β-cyclodextrin as 
described by Leppimaki et al (86, 87).  Triton X-100 was purchased from Pierce 
Biotechnology.   
Antibodies 
Anti-NDV antibody was raised against UV-inactivated NDV virions (106).  HN protein-
specific antibodies were anti-A (103), anti-AS (104) and anti-H (160).  F protein-specific 
antibodies were anti-HR1 (102), anti-HR2 (33), anti-Ftail (188), anti-F2-96 (an anti-peptide 
antibody raised against amino acids 76-96) (103) and anti-Fu1a (118). 
Infections and radioactive labeling  
Avian ELL-0 cells, seeded at approximately 6.0 x 105 cells per 35-mm plate, and HEL and 
NPC cells, seeded at approximately 3.0 x 104 cells per 35-mm plate, were grown overnight 
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and then infected with NDV at a multiplicity of infection (MOI) of 10 in 0.25 ml of medium 
(under BSL-3 conditions for strain AV).  After 45 min, one ml of medium was added and 
monolayers incubated for 5-8 hours.  For radioactive labeling, cells were radiolabeled at 6 h 
post infection for 1 h (Fig. 4.4) or 5 min (Fig. 4.5) at 37oC in DMEM supplemented with 50 
μCi of [35S] methionine and cysteine per ml (New England Nuclear).  At the end of the 
labeling period, cells were incubated with chase media (DMEM supplemented with 0.1 mM 
cold methionine without FCS) for indicated lengths of time.   
Extraction of cholesterol 
For experiments quantifying infectious virus particle release (Fig. 4.1 – 4.2), equivalent 
numbers of avian ELL-0 cells were seeded on two 35-mm plates and infected as described 
above.  At 7 h post infection, the first cell monolayer was treated with 10 mM mβCD + 4 
μg/mL lovastatin for 1 h in DMEM only.  The mβCD-containing media was then removed 
from the cell monolayer and designated as the drug hr sample.  Fresh DMEM was then 
added to this cholesterol-depleted cell monolayer for 2 h and then collected as sample 0 ? 2 
hr.  This removal of DMEM and addition of fresh DMEM was repeated two more times to 
generate culture supernatant samples 2 ? 4 hr, 4 ? 6 hr, and 6 ? 8 hr.  The second 
monolayer of infected cells was left untreated in DMEM for the 1 h during which the first 
cell monolayer was treated with mβCD.  The collection/addition of media was performed in 
the exact same manner as to that described above.  Prior to the drug hr, culture supernatants 
were collected from both cell monolayers for a one hour block of time to generate sample – 1 
hr.  All culture supernatants were then used to make serial dilutions for viral plaque 
formation assays to quantify the number of plaque forming units (PFU) released from each 
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cell monolayer during each block of time assayed.  Excluding the drug hr sample in Fig. 4.1 
and Fig. 4.2, at no time were the titered virus particles incubated in the presence of mβCD.  
 For experiments examining infectious virus release upon sterol addition to 
cholesterol-depleted cells (Fig. 4.3), equivalent numbers of avian ELL-0 cells seeded on 35-
mm plates were infected as described above.  At 7 h post infection, the cell monolayers were 
then either left untreated or treated with 10 mM mβCD + 4 μg/mL lovastatin for 1 h in 
DMEM.  Media was then removed and replaced with DMEM with or without the indicated 
amounts of exogenous sterol.  Small volumes (20 μl) of culture supernatant were removed 
from each cell monolayer at 4, 6 and 8 h of incubation with sterols.  All culture supernatants 
were then used to make serial dilutions for viral plaque formation assays to quantify the 
number of plaque forming units released from each cell monolayer at each time-point 
analyzed.   
 For co-immunoprecipitation experiments (Fig. 4.4), avian ELL-0 cells seeded on 35-
mm plates were infected and radiolabeled for 1 h as described above.  At the end of the 
radiolabeling period, cell monolayers were incubated with chase media for 1 h.  Cells were 
then either left untreated or treated with 10 mM mβCD and 4 μg/ml lovastatin for 1 h in 
DMEM supplemented with 0.1 mM cold methionine at 37oC.  Media was then removed and 
replaced with DMEM with or without the indicated amounts of exogenous sterol.  Cells were 
then incubated for 2 h at which point cellular extracts were made for co-immunoprecipitation 
experiments. 
Viral plaque assay 
Culture supernatants were clarified of cellular debris with two successive, low speed 
centrifugations.  Virus in clarified culture supernatants were serially diluted in Ca++-rich 
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media and allowed to adsorb to confluent monolayers of avian ELL-0 cells for 45 min.  Agar 
diluted to 1% in DMEM and supplemented with nonessential amino acids, vitamins, 
penicillin-streptomycin, sodium bicarbonate, and 10% FCS was then placed over monolayers.  
After 48 hours of incubation, viral plaques were counted.   
Co-immunoprecipitation of viral proteins  
Co-immunoprecipitation was done as described previously (Chapter III) and by McGinnes et 
al. (103).  Briefly, to prepare cell extracts, cell monolayers were washed in cold PBS and 
lysed in TNE buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl2 and 5 mM EDTA) containing 
ice-cold 1% Triton X-100 and 2.5 mg/ml of N-ethylmaleimide (NEM).  Equivalent volumes 
of cellular extracts were incubated overnight at 4oC with either a cocktail of anti-HN protein-
specific antibodies (anti-A, anti-AS and anti-H), anti-F protein-specific antibodies (anti-HR1, 
anti-HR2, anti-Fu1a, anti-Ftail and anti-F2-96) or in the absence of antibody.  Antibody 
complexes were precipitated with pansorbin cells (Calbiochem), washed three times in TNE 
containing 0.5% Triton X-100 and prepared for SDS-PAGE as described below.     
Preparation of protein-containing samples for SDS-PAGE  
All protein-containing samples were diluted in 2X sample buffer (125 mM Tris-HCl, pH 6.8, 
2% SDS, 10% glycerol) with or without 0.7 M ß-mercaptoethanol and boiled for 2-5 min 
prior to loading on 8% polyacrylamide gels.  Polyacrylamide gels containing radiolabeled 
proteins were fixed in acetic acid, treated with 2,5-diphenyloxazole (Sigma-Aldrich), dried 
for 1.5 – 2 h and placed on X-ray film at -80oC.  Signals in autoradiographs were quantified 
using a Fluor-S phosphoimager (Bio-Rad). 
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C.  Results 
Kinetics of infectious particle release from cholesterol-depleted cells  
To address the role of cholesterol and membrane lipid raft domains in the formation, stability 
or both the formation and stability of the HN – F glycoprotein-containing complex in cells, 
we first determined the number of infectious virions released into the culture supernatants of 
infected cells at various times after acute depletion of cellular cholesterol.  Because we know 
that dissociated HN and F glycoproteins can be packaged into virions (Chapter III), we can 
quantify the infectivity of released particles to determine if functional HN – F glycoprotein-
containing complexes were present and incorporated into infectious particles. 
 If pre-formed HN – F glycoprotein-containing complexes are dissociated upon 
cholesterol depletion, then the titre of virus released during and just after cholesterol 
depletion should be reduced.  If the stability of these pre-formed glycoprotein complexes is 
unaffected by cholesterol depletion then no decrease in virus titre should be observed.  
However, if the formation of newly synthesized HN – F glycoprotein-containing complexes 
is negatively affected by cholesterol depletion then a reduction in virus titre should be seen at 
later times.  This late reduction in virus titre would be due to virus incorporation of 
glycoproteins that were never complexed with one another due to cellular cholesterol 
depletion. 
 The protocol for this experiment is shown in Figure 4.1 and as depicted, virus was 
harvested from the supernatant of infected cells at various times before, during, and after 
cholesterol extraction.  The infectivity of particles released at each time point from untreated 
and mβCD-treated cells is shown in Figure 4.2.  These results show that virus released during 
or immediately after cholesterol extraction have near normal infectivity while virus released  
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Legend to Figure 4.1:  Kinetics of infectious virus release – experimental scheme.  
Equivalent numbers of avian ELL-0 cells were seeded on two 35-mm plates and infected 
with NDV (strain AV) for 7 hours.  One monolayer of cells was treated with 10 mM mβCD 
+ 4 μg/mL lovastatin for 1 hr in DMEM.  The mβCD-containing media was then removed 
from the cell monolayer and designated as the drug hr sample.  Fresh DMEM was then 
added to the cholesterol-depleted cell monolayer for 2 hrs and then collected as sample 0 ? 
2 hr.  This removal of DMEM and addition of fresh DMEM was repeated two more times to 
generate culture supernatant samples 2 ? 4 hr, 4 ? 6 hr, and 6 ? 8 hr.  The second 
monolayer of infected cells was left untreated in DMEM for the 1 hr during which the first 
cell monolayer was treated with mβCD.  The collection/addition of media was performed in 
the exact same manner as to that described above.  Prior to the drug hr, culture supernatants 
were collected from both monolayers for a one hour block of time to generate sample – 1 hr.  
All culture supernatants were then used to make serial dilutions for viral plaque formation 
assays to quantify the number of plaque forming units (PFU) released from each cell type 
during each block of time indicated above in blue.  ∆, media change.   
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Legend to Figure 4.2:  Kinetics of infectious virus release.   
Panel A:  Absolute virus titre (PFU/mL – log scale) released from untreated cells (black line) 
for the indicated blocks of time on the x-axis as described in Figure 4.1.  Absolute virus titre 
released from mβCD-treated cells (gray line) for the indicated blocks of time.   
Panel B:  Virus titre, represented as percent of virus titre released from untreated cells (set to 
100% - black bars) during the indicated block of time, released from mβCD-treated cells 
(gray line). 
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after two hours following cholesterol extraction have significantly reduced titre.  This result 
suggests that those pre-formed HN – F glycoprotein-containing complexes present at virus 
assembly sites prior to mβCD treatment are resistant to cholesterol depletion and are 
packaged into infectious virions.  At 4, 6 and 8 hours post mβCD treatment, the number of 
infectious virus particles released from cholesterol-depleted cells was reduced approximately 
one log (Fig. 4.2A and Fig. 4.2B).  These results are most consistent with the proposal that 
cellular cholesterol depletion detrimentally affected the formation of newly synthesized HN 
and F glycoproteins into complexes, thereby rendering virions released at later times of 
cholesterol extraction relatively non-infectious (Fig. 4.2A and Fig. 4.2B).  
 Utilizing release of infectious virions as an experimental readout, these results 
suggest that there is a temporal requirement for cholesterol and membrane lipid raft domains 
in the proper formation of newly synthesized HN and F proteins into the HN – F 
glycoprotein-containing complex necessary for the assembly of an infectious virus particle.  
These results suggest that once cellular cholesterol levels are depleted and membrane lipid 
raft integrity is compromised then all newly synthesized and processed HN and F 
glycoproteins will not form complexes.  Virions containing these dissociated glycoproteins 
will, therefore, be relatively non-infectious as described in Chapter III. 
Rescue of infectious virus release from cholesterol-depleted cells  
We next asked if virus infectivity could be restored by adding back exogenous cholesterol to 
mβCD-treated cells.  Lanosterol, structurally very similar to cholesterol, does not partition 
with liquid-ordered membranes like membrane lipid raft domains (112) and was used as a 
control in these experiments.  
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 Following an acute one hour mβCD treatment of infected avian cells, increasing 
amounts (≤ 75 μM final concentration) of exogenous sterol was added to culture media for 8 
hours post mβCD treatment.  At different time points following addition of sterols to cells, 
small volumes of culture supernatants were taken for viral plaque assays to determine levels 
of infectious virus particle release.  Similar to previous data (Chapter II), mβCD treatment of 
infected cells resulted in an approximate 60 – 80% reduction in virus titres over the time-
course analyzed (Fig. 4.3).  Addition of exogenous cholesterol (25 μM – 75 μM final 
concentration) to mβCD-treated cells resulted in an approximate 40 – 50% reduction in virus 
titres over the time-course analyzed (Fig. 4.3A and Fig. 4.3C).  These results suggest that 
restoration of cellular cholesterol levels may partially rescue the assembly defect of 
infectious virus at later times following cellular cholesterol depletion.  In contrast to this 
partial rescue of infectivity, addition of exogenous lanosterol (25 μM – 75 μM final 
concentration) to mβCD-treated cells resulted in no increase in virus titres over the time-
course analyzed (Fig. 4.3B and Fig. 4.3D).  These results show that virus infectivity is only 
rescued in the presence of a sterol molecule, cholesterol, which preferentially promotes the 
formation of liquid-ordered membrane domains (167). 
Rescue of HN – F protein-containing complex detection from cholesterol-depleted cells  
We next determined the effect of cholesterol or lanosterol addition to cholesterol-depleted 
cells on detection of HN – F glycoprotein-containing complexes in the cellular extracts as 
assayed by co-immunoprecipitation (co-IP).  Briefly, at 6 hr post infection, avian cells were 
35S-radiolabeled for 1 hr and then non-radioactively chased for 1 hr.  Cells were then left 
untreated or treated with mβCD for 1 hr and then incubated in the presence or absence of 
exogenous sterol for 2 hr at which point cellular extracts were made for co-IP experiments as  
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Legend to Figure 4.3:  Partial rescue of infectious virus release from cholesterol-
depleted cells.   
Panel A:  Absolute virus titre (PFU/mL – log scale) released from untreated cells (black line), 
mβCD-treated cells (gray line), and mβCD-treated/cholesterol-rescued cells (red lines – 
different symbols indicate different cholesterol concentrations as noted in graph legend) for 
the indicated time-point on the x-axis.   
Panel B: Absolute virus titre (PFU/mL – log scale) released from untreated cells (black line), 
mβCD-treated cells (gray line), and mβCD-treated/lanosterol-rescued cells (blue lines – 
different symbols indicate different lanosterol concentrations as noted in graph legend) for 
the indicated time-point on the x-axis.   
Panel C: Virus titre, represented as percent of virus titre released from untreated cells (set to 
100% - black line), from mβCD-treated cells (gray line) and mβCD-treated/cholesterol-
rescued cells (red lines – different symbols indicate different cholesterol concentrations as 
noted in graph legend) for the indicated time-point on the x-axis.   
Panel D: Virus titre, represented as percent of virus titre released from untreated cells (set to 
100% - black line), from mβCD-treated cells (gray line) and mβCD-treated/lanosterol-
rescued cells (blue lines – different symbols indicate different lanosterol concentrations as 
noted in graph legend) for the indicated time-point on the x-axis. 
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described previously and in Materials and Methods.  
 Similar to previous observations (Chapter III), anti-F protein-specific antibodies 
precipitated approximately 55% of total HN protein from the untreated control cells (Fig. 
4.4A); while only ~7% of total HN protein was precipitated with anti-F protein-specific 
antibodies from mβCD-treated cells (Fig. 4.4A).  However, addition of increasing amounts (≤ 
75 μM final concentration) of exogenous cholesterol or lanosterol did not significantly 
enhance the detection of HN – F protein-containing complexes from mβCD-treated cells 
(Fig. 4.4A).  Similar results were obtained for both sterols in the reciprocal co-IP of F protein 
with anti-HN protein-specific antibodies (Fig. 4.4B).  
 Given the partial restoration of infectious virus release from mβCD-
treated/cholesterol-rescued cells (Fig. 4.3A and Fig. 4.3C), the absence of HN – F 
glycoprotein-containing complexes in these same cells was unexpected.  However, the partial 
rescue of infectious virus release from mβCD-treated cells was not observed until after four 
hours of exogenous cholesterol incubation (Fig. 4.3A and Fig. 4.3C).  The inability to detect 
HN – F glycoprotein-containing complexes in these mβCD-treated/cholesterol-rescued cells 
is likely a result of assaying for the presence of the glycoprotein complexes by co-IP at only 
two hours of exogenous cholesterol incubation.  If glycoprotein co-IP was assayed from 
mβCD-treated/cholesterol-rescued cell extracts at times when infectious virus release was 
partially restored (i.e. ≥ 4 hrs of cholesterol incubation) then perhaps detection of HN – F 
glycoprotein-containing complexes would be increased.  
Kinetics of HN – F glycoprotein-containing complex formation in infected cells  
To determine when the HN – F glycoprotein-containing complex is formed following 
biosynthesis of the individual HN and F polypeptides in infected cells, a pulse-label protocol  
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Legend to Figure 4.4:  No rescue of HN – F glycoprotein-containing complex detection 
in cholesterol-depleted cells.   
Panel A:  Amounts of radiolabeled HN protein specifically precipitated with anti-F protein-
specific antibody from cellular extracts of untreated (UT) cells, mβCD-treated (mβCD) cells, 
mβCD-treated/cholesterol-rescued cells and mβCD-treated/lanosterol-rescued cells.  Data are 
represented as percentages of total HN protein precipitated with anti-HN protein-specific 
antibodies set at 100% for each cell extract.   
Panel B:  Amounts of radiolabeled F protein specifically precipitated with anti-HN protein-
specific antibody from cellular extracts of untreated (UT) cells, mβCD-treated (mβCD) cells, 
mβCD-treated/cholesterol-rescued cells and mβCD-treated/lanosterol-rescued cells.  Data are 
represented as percentages of total F protein precipitated with anti-F protein-specific 
antibodies set at 100% for each cell extract.  Specific cholesterol (increasing concentrations 
indicated by red triangles) and lanosterol (increasing concentrations indicated by blue 
triangles) concentrations are noted in Figure 4.3.  
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was utilized.  At 6 hours post infection, infected avian cells were 35S-radiolabeled for 5 min 
and non-radioactively chased for varying lengths of time.  At each chase time-point, cellular  
extracts were made for co-IP experiments with a mix of anti-F protein-specific antibodies.  
 A representative experiment is depicted in Figure 4.5 and shows the levels of 
radiolabeled HN protein precipitated with anti-F protein-specific antibodies over the course 
of 2 hours of non-radioactive chase.  Importantly, no specific precipitation of HN protein 
with F protein was observed until after 100 min of chase (Fig. 4.5).  This result suggests that 
the HN – F glycoprotein-containing complex detected by co-IP in normal cells only begins to 
form at 100 minutes after the biosynthesis of the individual HN and F polypeptides.  This 
result is consistent with the hypothesis that complexes form between HN and F protein at late 
times and that increased levels of these complexes may be detected at later times of chase. 
Detection of HN – F protein-containing complexes in mutant NPC cells  
To further establish that the cholesterol- and membrane lipid raft-dependency of the HN and 
F protein complex is its formation, we analyzed the presence of the HN – F glycoprotein-
containing complexes in the cellular extracts of the membrane lipid raft-defective Niemann-
Pick syndrome type C (NPC) cells.  As discussed earlier (Chapter III), inherent genetic 
defects in NPC cells result in the defective transport of cellular cholesterol to the plasma 
membrane and subsequently result in aberrant formation and function of membrane lipid raft 
domains (66).  NDV-infected NPC cells were shown to assembly and release virions 
displaying significantly reduced infectivity in comparison to wild-type control HEL cells 
(Fig. 3.1E and Fig. 3.1F); the reduced levels of infectious particle release was attributed to 
differential association of the NDV proteins with detergent-resistant membranes (DRMs) in 
NPC cells (Fig. 3.1C).  
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Legend to Figure 4.5:  Co-immunoprecipitation kinetics of HN protein with F protein in 
untreated cells. 
Monolayers of NDV(AV)-infected avian ELL-0 cells were [35-S]-radiolabeled at 6 hours 
post-infection for 5 min and then subjected to non-radioactive chases of varying time lengths.  
At the end of each non-radioactive chase, cells were lysed and proteins in extracts 
precipitated with a mix of anti-F protein-specific antibodies as outlined in Materials and 
Methods.  Amounts of precipitated HN protein were determined from polyacrylamide gels 
electrophoresed under reducing conditions.  Shown is a representative quantification of the 
amounts of radiolabeled HN protein (arbitrary densitometer units) specifically precipitated 
with anti-F protein-specific antibodies from cellular extracts at different times of non-
radioactive chase. 
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 We hypothesized that the failure of the viral glycoproteins to properly associate with 
DRMs following their biosynthesis in NPC cells would result in an inability to form and 
experimentally detect HN – F glycoprotein-containing complexes in these cells.  A 
representative HN and F protein co-immunoprecipitation result is shown in Figure 4.6, where 
mβCD treatment of wild-type HEL cells was used as a positive control.  From the extracts of 
the three cell populations (untreated HEL cells, mβCD-treated HEL cells and untreated NPC 
cells), the precipitation efficiencies of HN protein with anti-HN protein-specific antibody 
was comparable (Fig. 4.6A); similar levels of F protein precipitation with anti-F protein-
specific antibodies were observed from all three cell extracts (Fig. 4.6B).  However, in 
comparison to untreated HEL cells, a significant reduction in the levels of HN protein 
precipitation with anti-F protein-specific antibodies was observed in mβCD-treated HEL and 
untreated NPC cells (Fig. 4.6A).  In the reciprocal co-IP, a comparable reduction in the levels 
of F protein precipitation with anti-HN protein-specific antibody was seen in mβCD-treated 
HEL and untreated NPC cells (Fig. 4.6B).  This result is very similar to that obtained with 
mβCD-treated avian cell extracts (Fig. 3.6).  
 Together with the kinetics of infectious virus release and cholesterol rescue data 
presented here, the inability to detect any significant levels of HN – F glycoprotein-
containing complexes in the extracts of these intrinsically membrane raft-defective NPC cells 
strongly suggested that formation of newly synthesized HN and F polypeptides into 
glycoprotein complexes is dependent on cholesterol and membrane lipid raft integrity.  
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Legend to Figure 4.6:  Co-immunoprecipitation of HN and F proteins from cellular 
extracts of HEL and NPC cells.   
Monolayers of NDV(AV)-infected HEL and NPC cells were pulse-labeled with [35-S] 
methionine/cysteine at 6 hours post-infection for 1 hr and then subjected to a 1 hr non-
radioactive chase.  Cells were then left untreated or treated with 10 mM mβCD and lovastatin 
for one hour, incubated in DMEM for 2 hr and then lysed as described in Material and 
Methods.  Proteins in extracts were precipitated with a mix of anti-HN protein-specific 
antibodies or a mix of anti-F protein-specific antibodies as outlined in Material and Methods.  
HN protein lanes were from polyacrylamide gels electrophoresed under reducing conditions 
while total F protein (F0 + F1-F2) lanes were from polyacrylamide gels electrophoresed under 
non-reducing conditions.  Radiolabeled viral proteins are indicated on the right.   
Panels A and B: Shown is a representative autoradiograph of HN and F protein precipitation 
from cell extracts of untreated HEL cells, mβCD-treated HEL cells and untreated NPC cells 
immunoprecipitated (IP) with anti-HN protein-specific (α-HN), no antibody or anti-F 
protein-specific (α-F) antibodies. 
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D.  Discussion  
The presence of HN – F glycoprotein-containing complexes in infected cells was previously 
shown to be critical for the assembly of a functional and infectious progeny virion.  
Furthermore, the detection of these glycoprotein complexes in cells was dependent on 
cellular cholesterol and, subsequently, the integrity of membrane lipid raft domains (Chapter 
II).  However, it was unknown how cholesterol and membrane lipid raft domains facilitated 
the presence of the HN – F glycoprotein-containing complexes.  Results obtained with 
several approaches and two experimental systems are most consistent with the hypothesis 
that maintenance of pre-formed glycoprotein complexes in cells is not dependent on cellular 
cholesterol.  However, in the absence of normal cellular cholesterol levels, the formation of 
the newly synthesized HN – F glycoprotein-containing complexes is aberrant.  
Role of cholesterol in the stability of HN – F glycoprotein-containing complexes  
At early times following cholesterol extraction when pre-formed HN – F glycoprotein-
containing complexes were available for virion incorporation, virus infectivity was not 
significantly reduced.  These kinetics of infectious virus release suggested that assembling 
virions were packaging functional glycoprotein complexes during cellular cholesterol 
depletion and for at least two hours following removal of the cholesterol-extracting drug.  
These results suggested that cholesterol is not required for the maintenance of pre-formed 
glycoprotein complexes in cells.  
 Previous data, described in Chapters II and III, also suggest that cholesterol is not 
required for the maintenance of an assembled HN – F protein-containing complex.  In 
Chapter III, depletion of cholesterol from virion envelopes had no detrimental effect on the 
ability to efficiently co-immunoprecipitate glycoprotein complexes (Fig. 3.8A and 3.8B).  
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Further supporting the conclusion that maintenance of glycoprotein complexes is not 
dependent on cholesterol are the observations that cholesterol depletion of virions did not 
reduce the glycoprotein-related functions of these particles.  Cholesterol-depleted virions 
displayed normal attachment capability (Fig. 3.8C) and were membrane fusion-competent 
(Fig. 3.8D).  Moreover, in Chapter II, extraction of > 90% of virion-associated cholesterol 
did not significantly decrease particle infectivity (Fig. 2.7).  
 Taken together, these results suggest that once formed in the cell, and later upon 
incorporation into budding virions, the HN – F glycoprotein-containing complex is no longer 
sensitive to cholesterol depletion and becomes resistant to dissociation.  
Role of cholesterol in the formation of HN – F glycoprotein-containing complexes  
The significant decrease in the release of infectious virus at later times following cellular 
cholesterol depletion suggested that the formation of newly synthesized HN – F 
glycoprotein-containing complex was impaired. The attempt to rescue glycoprotein complex 
formation and infectious particle assembly in cholesterol-depleted cells by addition of 
exogenous cholesterol provided mixed results.  
 A partial restoration in the levels of infectious particle release was achieved with 
addition of cholesterol to mβCD-treated cells only after 4 hours of incubation.  Assaying for 
the presence of HN – F glycoprotein-containing complexes in these mβCD-
treated/cholesterol-rescued cells at only 2 hours of cholesterol incubation yielded no recovery 
of the complex – likely for reasons explained earlier.  However, these results suggested a 
temporal component regarding the requirement for cellular cholesterol and membrane lipid 
raft integrity in the detection of the HN – F glycoprotein-containing complex.  
 Consistent with this conclusion, it was determined that under circumstances when 
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cellular cholesterol levels were normal, the HN – F glycoprotein-containing complex is not 
detected until approximately 100 minutes after biosynthesis of the two glycoproteins.  
Therefore, it is during this ~100 min time-frame that cholesterol and membrane lipid raft 
integrity appeared critical to the formation of a single glycoprotein complex or small 
population of glycoprotein complexes.  On the whole, it is likely that glycoprotein complexes 
only begin to form at 100 min post biosynthesis and continuously form thereafter when 
cholesterol levels are normal. 
 Studies in the Niemann-Pick syndrome type C (NPC) cell system suggested that 
cholesterol and membrane lipid raft integrity are essential immediately following translation 
of the HN and F polypeptides.  In the NPC cellular background, membrane lipid raft 
formation and function are intrinsically abnormal due to genetic mutations that affect 
cholesterol transport.  In comparison to wild-type control HEL cells, expression of both HN 
and F proteins in infected NPC cells resulted in the complete absence of HN – F 
glycoprotein-containing complexes as determined by co-immunoprecipitation.  
 Mechanistically, it is possible that association of the newly synthesized HN and F 
polypeptides individually with cholesterol-enriched membranes in the Golgi apparatus is a 
critical first step towards the formation of an HN – F protein-containing complex.  In the 
future, it will be of interest to refine the time-course of normal HN – F glycoprotein-
containing complex formation as well as employ inhibitors of membrane protein transport to 
determine the sub-cellular location where the two glycoproteins first associate as a complex.  
 Physiologically, whether in the virus-cell or cell-cell membrane fusion context, the 
interaction of the paramyxovirus attachment protein with the homologous viral fusion protein 
is critical for membrane fusion to occur.  Although the exact molecular details of this 
 119
interaction remain undefined and controversial, it is clear that the presence of an HN – F 
glycoprotein-containing complex is biologically relevant to promoting an efficient membrane 
fusion event.  Through the work presented here, it also becomes apparent that cellular 
cholesterol and the integrity of cholesterol-rich membrane lipid raft domains are important 
during the formation the HN – F glycoprotein-containing complex in NDV-infected cells. 
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CHAPTER V 
Dissection of Newcastle disease virion architecture: identification of a novel complex of 
RNP-associated NP and HN protein 
 
A.  Introduction 
Newcastle disease virus (NDV) is the prototypic avian member of the Paramyxoviridae, a 
large family of enveloped viruses with non-segmented, negative-sense RNA genomes (82).  
NDV particles contain six structural proteins: the nucleocapsid protein (NP), phosphoprotein 
(P), matrix (M), fusion (F), hemagglutinin-neuraminidase (HN), and large (L) proteins (82).  
Embedded in the virion envelope are two transmembrane glycoproteins, the HN attachment 
protein and the F protein, which mediates virus-to-cell membrane fusion during virus entry 
(82).  Underlying the virion envelope, which is acquired during the budding of virions 
through the host cell plasma membrane, is the peripheral membrane-associated M protein.  
Situated within the lumen of the virion envelope is the ribonucleoprotein (RNP) structure 
composed of viral genomic RNA abundantly encapsidated by NP and associated with the 
viral polymerase complex proteins P and L (82).   
 The details of paramyxovirus assembly and release remain poorly characterized.  
Many questions regarding the viral protein-protein interactions in infected cells and those 
required for the formation of an infectious virion have yet to be fully resolved.  While 
incorporation of the viral RNA genome as the RNP structure is of utmost importance during 
virus assembly, no experimental results have suggested a direct interaction between the viral 
glycoproteins and components of the RNP structure (82).  Rather, the paramyxovirus M 
protein is thought to be the key organizer of virus assembly in cells due to its interactions 
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with NP and its location near and interaction with the viral transmembrane glycoprotein tails.  
The NP and M protein interaction is thought to tether the RNP complex to the attachment and 
fusion glycoproteins during virus assembly (82).  This hypothesis is supported by the reduced 
co-localization of viral RNP structures with viral glycoproteins in cells infected with a 
recombinant measles virus lacking the M gene (23).   
 However, evidence for interactions between paramyxovirus M proteins and the viral 
glycoproteins varies from study to study.  The G attachment protein of respiratory syncytial 
virus (RSV) was found to specifically bind to the M protein in cells (46); similarly, in NDV 
virus-like particles (VLP), the HN attachment protein was found to interact with M protein 
(130).  However, some reports suggest an interaction between paramyxovirus M proteins 
specifically with the F protein (3, 153, 154, 156, 158).      
 Recently, technological advances in electron microscopy-based imaging techniques 
have provided unexpected insights into the molecular organization of virion components 
among several pleiomorphic-shaped enveloped RNA viruses, such as human 
immunodeficiency virus type 1 (HIV-1) (191), simian immunodeficiency virus (SIV) (196) 
and influenza virus (55).  Recent studies of influenza have revealed several classes of virions, 
based on arrangement of RNP structures, the peripheral membrane-associated matrix M1 
protein and the surface distribution of the transmembrane HA and NA glycoproteins within 
the virion envelope (55).  Moreover, from particle to particle, many influenza virions 
displayed non-uniform distribution of virion proteins, particularly in the case of the M1 
protein (55).  These intriguing results underscore the need to fully characterize the 
interactions present in virions in order to elucidate the viral determinants of enveloped RNA 
virus assembly.   
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 We have previously reported that approximately one third of virion-associated HN 
and F proteins exist as a complex, defined by co-immunoprecipitation, and that assembly of 
particles in cholesterol-deficient cells resulted in the loss of these complexes in released 
particles (80).  While characterizing HN – F protein-containing complexes in NDV particles 
released from untreated and cholesterol-depleted cells, sedimentation gradient analysis of 
lysed virions uncovered other virion-associated protein-protein complexes which are 
described here.  In addition to the previously described glycoprotein complex (80), we 
detected a novel complex consisting of the HN protein and the RNP structure, which was 
characterized as possessing a high NP to HN protein ratio and also consisting of the RNP-
associated P and L proteins.  Furthermore, unlike the cholesterol-sensitive HN – F 
glycoprotein-containing complex (80), the interaction of NP with HN protein in virions was 
not affected by cellular cholesterol depletion during virus assembly.  In contrast, after 
detergent lysis, no substantial interaction of the M protein with either glycoprotein was 
observed although M protein multimers were detected.  Our results indicate that small 
amounts of virion-incorporated M protein are detected in a complex with NP but not with 
any other virion components. 
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B. Materials and Methods 
Cells, virus and reagents 
East Lansing Line (ELL-0) avian fibroblasts from American Type Culture Collection were 
maintained in DMEM supplemented with penicillin-streptomycin and 10% fetal calf serum.  
NDV, strain AV (under BSL-3 conditions), stocks were prepared by growth in eggs by 
standard protocols (105).  Methyl-β-cyclodextrin (Sigma-Aldrich) was re-suspended in 
DMEM.  Lovastatin (Sigma-Aldrich) was prepared in H2O and activated as described 
previously (40).  Triton X-100 was purchased from Pierce Biotechnology.  Octyl-β-glucoside 
was purchased from Sigma-Aldrich.   
Antibodies 
Polyclonal anti-NDV antibody was raised against UV-inactivated NDV virions (106).  Anti-
M protein-specific antibody has been described previously (38).  Anti-HN protein-specific 
antibody used for immunoprecipitation experiments was anti-H (160).  Anti-F protein-
specific antibodies were anti-HR1 (102), anti-HR2 (33), anti-Ftail (188), anti-F2-96 (an anti-
peptide antibody raised against amino acids 76-96) (103) and anti-Fu1a (118).  Anti-P 
protein-specific antibody has been described previously (100, 114).   
Infections and radioactive labeling  
ELL-0 cells seeded at approximately 6.0 x 105 cells per 35-mm plate were grown overnight 
and then infected with NDV at a multiplicity of infection (MOI) of 10 in 0.25 ml of medium 
(under BSL-3 conditions for strain AV).  After 45 min, one ml of medium was added and 
monolayers incubated for an additional 5 hours.  For radioactive labeling, cells were 
radiolabeled at 6 h post infection for 1 h at 37oC in DMEM supplemented with 50 μCi of 
[35S] methionine and cysteine per ml (New England Nuclear).  At the end of the labeling 
 124
period, cells were incubated with chase media (DMEM supplemented with 0.1 mM cold 
methionine without FCS) for indicated lengths of time.   
Virus purification 
Culture supernatants were clarified by centrifugation at 5,000 RPM for 5 min and then 
particles in the supernatant were sedimented through 20% sucrose (w/vol) to a 20-65% 
sucrose interface (24,000 RPM for 10-12 h at 4°C using a Beckman SW50.1 rotor).   
Sedimentation of virion-associated protein complexes 
Purified virus taken from 20-65% sucrose interface fractions was first adjusted to either 1% 
cold Triton X-100 or 1% cold Triton X-100 + 60 mM octyl-β-glucoside and then adjusted to 
~10% sucrose (w/vol).  The lysed virions were then overlaid on top of a 20-80% continuous 
sucrose gradient.  Samples were subjected to rate-zonal centrifugation at 85,000 x g for 20 h 
at 4oC.  Sixteen fractions of 0.5 ml in volume were collected from the bottom of the gradient.  
Proteins in each fraction were resolved by 8% SDS-PAGE and radiolabeled proteins detected 
by autoradiography as previously described (81).  The densities of all sucrose fractions were 
measured using a refractometer and are indicated as g/cm3 (inset of Fig. 5.1D).  
Isolation of virion-associated RNP structures 
A modification of protocols described previously (8, 71, 124) was used for virion 
fractionation.  Briefly, purified virus taken from 20-65% sucrose interface fractions was first 
adjusted to 2% room temperature Triton X-100 and then adjusted to ~10% sucrose (w/vol) 
and overlaid on top of 3.5 ml of 55% sucrose.  Samples were subjected to centrifugation at 
100,000 x g for 4 h at 4oC using a Beckman SW50.1 rotor.  Following sedimentation, the top 
2 ml were collected as the viral membrane-containing (S) fraction.  The remaining 3 ml of 
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55% sucrose was discarded and the pelleted material (P) was re-suspended in protein sample 
buffer.  Equivalent amounts of the S fraction and P material were used for SDS-PAGE.   
Polyacrylamide gel electrophoresis and Western analysis 
Protein-containing samples were resolved on 8% polyacrylamide gels (SDS-PAGE) as 
previously described (81).  Radioactively labeled proteins were detected by autoradiography 
as previously described (81).  Signals in autoradiographs were quantified using a Fluor-S 
phosphoimager (Bio-Rad). 
Extraction of cholesterol 
ELL-0 cells seeded on 35-mm plates were infected and radiolabeled for 1 h as described 
above.  At the end of the labeling period, cell monolayers were incubated with chase media 
(DMEM supplemented with 0.1 mM cold methionine only) for 1 h.  Cells were then either 
left untreated or treated with 10 mM mβCD and 4 μg/ml lovastatin for 1 h in DMEM 
supplemented with 0.1 mM cold methionine at 37oC.  Media was then removed and replaced 
with complete DMEM containing lovastatin, and cells were further incubated for 4 h.  At no 
time were recovered virus particles incubated in the presence of mβCD.  
Co-immunoprecipitation of viral proteins  
Co-immunoprecipitation was done as described by Laliberte et al. (80).  Briefly, equivalent 
volumes of lysed virions or pooled sedimentation gradient fractions were incubated overnight 
at 4oC with either the polyclonal anti-NDV antibody, HN protein-specific antibody (anti-H), 
a cocktail of F protein-specific antibodies (anti-HR1, anti-HR2, anti-Fu1a, anti-Ftail and anti-
F2-96), M protein-specific antibody (anti-M), P protein-specific antibody (anti-P) or in the 
absence of antibody.  Antibody complexes were precipitated with pansorbin cells 
(Calbiochem), washed three times in TNE buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl2 
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and 5 mM EDTA) containing 0.5% Triton X-100 and prepared for SDS-PAGE as described 
above.  The amount of each protein precipitated in the no antibody sample, due to protein 
aggregation or non-specific association of the proteins with pansorbin cells, was subtracted 
from the amount of that protein specifically precipitated when NDV-specific antibody was 
present.   
 For experiments in which Triton X-100 (1.0%, 0.5% and 0.1% final) and salt (250 
mM NaCl, 500 mM NaCl and 750 mM NaCl final – all at 0.1% Triton final) concentrations 
were altered, the appropriate adjustments were made to the buffers used for: the initial virus 
lysis, incubation with primary antibodies, incubation with pansorbin cells and final TNE-
based washes.   
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C. Results 
Sedimentation analysis of virion-associated proteins 
To explore the role of cholesterol in assembly of both HN and F protein complexes as well as 
other virion protein complexes, we characterized the sedimentation profile of virion proteins 
in linear sucrose gradients.  Virions released from normal, untreated cells were lysed in ice 
cold 1% Triton X-100 (Fig. 5.1A).  Because these conditions will preserve any virion-
associated detergent-resistant membranes, which could affect the sedimentation of proteins 
associated with these membranes, we also lysed virions in octyl-β-glucoside (Fig. 5.1B), a 
detergent that solubilizes all membranes (110, 172).  Proteins in particles released from 
cholesterol-depleted cells were similarly analyzed (Fig. 5.1G and 5.1H).  Representative 
gradients are shown in Figure 5.1, panels A, B, G, and H while quantitative analyses of each 
protein in gradients from three independent experiments are shown in Figure 5.1, panels C – 
F and I – L. 
 Quantitative comparisons of the sedimentation pattern of proteins from normal 
virions after lysis in Triton X-100 or octyl-β-glucoside (Fig. 5.1A – F) showed no significant 
differences in sedimentation profiles for HN, F, NP, and P proteins.  Similarly, comparisons 
of the sedimentation of proteins from particles released from cholesterol-extracted cells 
showed few differences in the sedimentation of HN, F, NP, and P proteins using different 
detergent lysis conditions (Fig. 5.1G – L).  However, M protein from both sets of particles 
lysed in Triton X-100 sedimented significantly slower than M protein from octyl-β-
glucoside-lysed virions (Fig. 5.1F and 5.1L).  These results suggest that the sedimentation of 
virion-associated M protein complexes is sensitive to detergent lysis conditions. 
 
 128
 
 129
Legend to Figure 5.1:  Sedimentation profiles of viral proteins from virions released 
from untreated and cholesterol-depleted cells.   
Panels A and B:  Representative autoradiographs of virion protein sedimentation into linear 
sucrose gradients of Triton X-100 lysed (panel A) and octyl-β-glucoside (panel B) lysed 
virions released from untreated avian ELL-0 cells.  Radiolabeled viral proteins are indicated 
on the right: HN, hemagglutinin-neuraminidase protein; F1-F2, disulfide-linked, cleaved 
fusion protein; NP, nucleocapsid protein; P, phosphoprotein; M, matrix protein.  HN and M 
protein lanes were from polyacrylamide gels electrophoresed under reducing conditions 
while NP, P and F protein lanes were from polyacrylamide gels electrophoresed under non-
reducing conditions in order to resolve NP and F protein.  Film exposure times of all panels 
were identical.  Each lane contained 0.5% of the total gradient fraction.      
Panels C to F:  Percent of total radiolabeled HN protein (panel C), F protein (panel D), NP 
(panel E) and M protein (panel F) in sedimentation gradient fractions following lysis of 
native virions released from untreated cells with cold 1% Triton X-100 (black bars) or 60 
mM octyl-β-glucoside (black lines).  Gradient fractions containing peak amounts of 
sedimentation protein markers are indicated by black arrows: F, ferritin (450 kDa); C, 
catalase (240 kDa); A, aldolase (158 kDa); B, BSA (68 kDa).  Results are averages of three 
experiments and error bars indicate standard deviations.     
Inset to Panel D:  Densities (g/cm3) of all 16 sedimentation gradient fractions.  Results are 
averages of > 6 experiments and error bars indicate standard deviations.   
Panels G and H:  Representative autoradiographs of virion protein sedimentation into linear 
sucrose gradients of Triton X-100 lysed (panel G) and octyl-β-glucoside (panel H) lysed 
virions released from mβCD-treated avian ELL-0 cells.  Radiolabeled viral proteins are 
indicated on the left.  HN and M protein lanes were from polyacrylamide gels 
electrophoresed under reducing conditions while NP, P and F protein lanes were from 
polyacrylamide gels electrophoresed under non-reducing conditions in order to resolve NP 
and F protein.  Film exposure times of all panels were identical to one another and to those 
depicted in Panels A to B.       
Panels I to L:  Percent of total radiolabeled HN protein (panel I), F protein (panel J), NP 
(panel K) and M protein (panel L) in sedimentation gradient fractions following lysis of 
virions released from mβCD-treated cells with cold 1% Triton X-100 (gray bars) or 60 mM 
octyl-β-glucoside (gray lines).  Results are averages of three experiments and error bars  
indicate standard deviations. 
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 After particle lysis in Triton X-100 or octyl-β-glucoside (Fig. 5.1E and 5.1K), the 
majority of NP sedimented to the bottom of the gradient (fractions 4 – 8); a result consistent 
with the role of NP in forming the ribonucleoprotein (RNP) super-structure along with viral 
genomic RNA, the P protein, and the large (L) polymerase protein (82).  The P protein was 
found exclusively in fractions 4 – 6, which is also consistent with RNP structures in those 
specific fractions (Fig. 5.1A, 5.1B, 5.1G, and 5.1H).  Interestingly, NP was also found in 
fractions 8 – 16 of all gradients, suggesting that either non-RNP associated NP exists and/or 
that NP multimers, as intermediates of RNP assembly (16), are incorporated into budding 
virions.   
 In virions released from untreated cells, HN protein-containing complexes were 
found in fractions 4 – 16, where the peak of the HN protein within the gradient was in 
fraction 11 (Fig. 5.1A – C).  The HN protein in particles released from cholesterol-extracted 
cells was shifted slightly into larger complexes (Fig. 5.1G – I).  Using protein standards as 
size markers in the gradient, the majority of HN protein-containing complexes in both sets of 
virions were found in fractions corresponding to HN protein dimers (approximately 148 kDa) 
and  tetramers (approximately 296 kDa) (177).   
 The F protein-containing complexes from normal virions were primarily in fractions 
11 – 16 with the peak of F protein in fractions 12 or 13 (Fig. 5.1A, 5.1B and 5.1D).  The 
sedimentation of F protein into fractions containing aldolase (158 kDa) and BSA (66 kDa) 
markers (Fig. 5.1D) suggests that the F protein exists as trimers, and perhaps dimers and 
monomers.  The F protein derived from particles released from cholesterol-extracted cells 
sedimented similarly (Fig. 5.1G, 5.1H and 5.1J).  
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 As determined by co-immunoprecipitation, 30% of total F protein in normal virions 
was detected in a complex with HN protein and these glycoprotein complexes were 
significantly reduced in virions released from cholesterol-deficient cells (80).  Indeed, 
fractions 11 – 16 from both sets of virions contained both HN and F protein (Fig. 5.1A – D, 
5.1G – J), thus it is likely that HN and F protein complexes found in normal virus sediment to 
this part of the gradient.  It is clear that HN and F protein complexes do not sediment to 
regions of the gradient that would correspond to an HN protein tetramer and an F protein 
trimer, fractions 8 – 10, since no F protein was detected in these fractions (Fig. 5.1D and 
5.1J). 
 A surprising result was the small amount of HN protein (approximately 8.8% of 
total), from both normal virions and virions released by cholesterol-deficient cells, found in 
fractions 4 – 8, which are fractions that contained virion proteins associated with RNP 
structures (Fig. 5.1A – C and 5.1G – I).  This result suggested the possibility that there might 
be a complex formed between the HN protein and a RNP-associated protein.  This 
observation led to investigation of HN protein interactions with virion core proteins and M 
protein, described below. 
Virion fractionation 
To explore the observation that HN protein was found in the gradient fractions containing 
RNP structures, virions were fractionated using a more stringent protocol similar to those 
previously documented to separate RNP material from membrane proteins.  Normal virions 
were lysed in room temperature Triton X-100 and the RNP structures were pelleted through 
dense sucrose while membrane-associated material remained buoyant in the sucrose gradient.  
The proteins in the pellet (P) and the supernatant (S) were analyzed by polyacrylamide gel 
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electrophoresis (Fig. 5.2).  Most of the NP and virtually all the P protein were recovered in 
the pellet fraction, although there were residual amounts of NP in the supernatant (Fig. 5.2).  
While the majority of the HN protein was found in the supernatant fraction, there was a small 
amount of HN protein in the pellet (Fig. 5.2).  In contrast, essentially all the F protein was 
found in the supernatant (Fig. 5.2).  M protein was equally distributed between the pellet and 
supernatant (Fig. 5.2). 
 These results are consistent with the possibility that a small population of HN protein 
is physically associated with RNP structures, directly or perhaps through M protein, to form a 
novel complex characterized by a high NP to HN protein ratio.  Alternatively, HN protein 
may form a very large complex that is not associated with the core structure. 
Co-immunoprecipitation of NP with HN protein 
To determine if HN protein forms a complex with NP or with M protein in NDV particles 
released from normal and cholesterol-extracted cells, we asked if HN protein in lysed virions 
could be co-immunoprecipitated with NP or M protein.  A representative result is shown in 
Figure 5.3A, and the results of three similar experiments are quantified in Figure 5.3B.  
Immunoprecipitation with anti-HN protein-specific antibody resulted in the recovery of 50% 
of the total NP in virions released from either untreated or mβCD-treated cells (Fig. 5.3B).  
In contrast, anti-HN antibody did not precipitate M protein (Fig. 5.3A).  Thus, an NP – HN 
protein complex mediated by M protein is unlikely.   
 Supporting this conclusion was the failure to detect substantial amounts of NP – M 
protein complexes (Fig. 5.3).  Although previous studies have documented an interaction 
between paramyxovirus NP and M proteins in both infected cells and virus particles (82), 
specific precipitation of NP with anti-M protein-specific antibodies only recovered  
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Legend to Figure 5.2:  Virion fractionation and ribonucleoprotein (RNP) structure 
isolation.   
Radiolabeled virions released from untreated cells (input) were lysed with 2% Triton at 
room-temperature and subjected to centrifugation through 55% sucrose as described in 
Material and Methods.  Equivalent amounts of pelleted virus material (P) and viral 
membrane-associated material (S) were subjected to SDS-PAGE under non-reducing (– 
BME) and reducing (+ BME) conditions.  Representative autoradiographs are shown with 
radiolabeled virion proteins indicated on the right.  Film exposure times of all protein lanes  
were identical.    
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Legend to Figure 5.3:  Co-immunoprecipitation of NP with HN protein from lysed 
virions released from untreated and mβCD-treated avian cells. 
Purified [35-S]-radiolabeled virions released from untreated and mβCD-treated ELL-0 cells 
were lysed and proteins immunoprecipitated (IP) with NDV-specific antibodies as described 
previously (80) and in Materials and Methods.   
Panel A:  Representative autoradiographs of cold 1% Triton X-100 lysed virions released 
from untreated or mβCD-treated cells precipitated with polyclonal anti-NDV antibody, no 
antibody (–), anti-M protein-, anti-HN protein- or anti-F protein-specific antibodies.  
Radiolabeled, precipitated viral proteins are indicated on the right.  HN and M protein lanes 
were from polyacrylamide gels electrophoresed under reducing conditions while NP and F 
protein lanes were from polyacrylamide gels electrophoresed under non-reducing conditions.  
Film exposure times of each protein panel were identical.   
Panel B:  Percent of total radiolabeled NP specifically precipitated with the indicated 
antibodies from virions released from untreated (black bars) or mβCD-treated (gray bars) 
cells and solubilized with cold 1% Triton X-100.  Data is represented as percent of total NP 
precipitated with anti-NDV antibody set to 100% for each virus.  The amount of background, 
non-specific NP precipitated in the absence of primary antibody, due to protein aggregation 
or non-specific association of the proteins with pansorbin cells, was subtracted from the 
amount of NP specifically precipitated when primary antibodies were present.  Results are 
averages of three experiments and error bars indicate standard deviations. 
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approximately 10% and 5% of the total NP in virions released from untreated and mβCD-
treated cells, respectively (Fig. 5.3B).   
 The complex containing virion NP and HN protein did not include the F protein.  
Precipitation with anti-F protein-specific antibodies did not recover any NP from either 
population of virions (Fig. 5.3B).  This result also suggested that the population of HN 
protein associated with NP is distinct from the population of HN protein associated with F 
protein in NDV particles.  As previously documented, there is co-immunoprecipitation of HN 
and F proteins from normal virions but not from virions released from cholesterol-extracted 
cells (Fig. 5.3A) (80).      
 These results are consistent with the existence of a NP – HN protein-containing 
complex, which is not affected by cellular cholesterol depletion during virus assembly as it is 
similarly recovered in particles released from untreated and cholesterol-extracted cells.   
Other viral components of the NP – HN protein-containing complex in virions 
Co-immunoprecipitation of NP with anti-HN protein-specific antibody may be due to HN 
protein interactions with the viral RNP or with the non-RNP-associated NP found in lighter 
density fractions (10 – 16) of the gradients shown in Figure 5.1.  If the small population of 
HN protein found in gradient fractions 4 – 8 physically associates with virion-associated 
RNP structures, then the NP – HN protein-containing complex should also contain P and L 
proteins, which serve to make up the virion-associated polymerase complex (82).  The 
binding of paramyxovirus P proteins to both NP and L proteins is well-documented (82) and, 
as mentioned earlier, the P protein is exclusively found in fractions 4 – 6 corresponding to 
the viral RNP structure (Fig. 5.1A – B) but not in lighter fractions of the gradient.  As 
expected, immunoprecipitation with anti-P protein-specific antibody from Triton-lysed 
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virions resulted in significant recovery of P protein as well as NP and L proteins (Fig. 5.4B, 
lane 1).  Importantly, anti-P protein-specific antibody also resulted in the specific 
precipitation of HN protein (Fig. 5.4B, lane 1).  Strikingly, precipitation of Triton-lysed 
virions with anti-HN protein-specific antibody resulted in a similar recovery of NP, P and L 
proteins (Fig. 5.4C, lane 1) as precipitation with anti-P protein-specific antibody.  However, 
precipitation of HN protein with anti-P protein-specific antibody did not precipitate the 
majority of HN protein as determined by HN protein precipitation with anti-HN protein-
specific antibody (compare Fig. 5.4B, lane 1 with Fig. 5.4C, lane 1).  The small amount of 
total HN protein precipitated with anti-P protein-specific antibody suggests that this P – NP – 
HN protein-containing complex has a high NP to HN protein ratio and that most of the HN 
protein in virions is not in a complex with NP and P protein.  The results also show that the 
NP – HN protein-containing complex contains the RNP-associated P and L proteins.    
 NP may be precipitated with anti-HN protein-specific antibody due to direct 
interactions with HN protein or due to an interaction of HN protein with either P or L 
proteins, which both bind to NP (82).  To determine which mechanism accounts for the 
complex, the effects of high salt concentrations on the precipitated complex were determined.  
It is well known that high salt concentrations will detach P and L proteins from RNP 
structures (82).  Co-immunoprecipitation of RNP-associated proteins with anti-HN protein-
specific antibody was performed in increasing concentrations of sodium chloride (Fig. 5.4, 
150 mM [lane 3], 250 mM [lane 4], 500 mM [lane 5] or 750 mM [lane 6]).  The only protein 
not significantly reduced in the precipitate by increasing the salt concentration was NP 
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Legend to Figure 5.4:  Effects of detergent and salt concentrations on co-
immunoprecipitation of HN, NP, P and L proteins from virions. 
Purified [35-S]-radiolabeled virions released from untreated ELL-0 cells were lysed with 
different concentrations of cold Triton X-100 and proteins immunoprecipitated with anti-HN 
protein-specific antibody or anti-P protein-specific antibody under varying Triton X-100 and 
salt concentrations as described in Materials and Methods. 
Panels A to C:  Representative autoradiographs of Triton X-100 lysed virions from untreated 
cells precipitated in the absence of primary antibody (panel A) or with anti-P protein-specific 
antibody (panel B) and anti-HN protein-specific antibody (panel C).  Virion lysis and 
immunoprecipitation conditions: lane 1 (1.0% Triton X-100, 150 mM NaCl); lane 2 (0.5% 
Triton X-100, 150 mM NaCl); lane 3 (0.1% Triton X-100, 150 mM NaCl); lane 4 (0.1% 
Triton X-100, 250 mM NaCl); lane 5 (0.1% Triton X-100, 500 mM NaCl); lane 6 (0.1% 
Triton X-100, 750 mM NaCl).  Radiolabeled, precipitated viral proteins are indicated on the 
right.  HN and L protein lanes were from polyacrylamide gels electrophoresed under 
reducing conditions while NP and P protein lanes were from polyacrylamide gels 
electrophoresed under non-reducing conditions.  Film exposure times of all protein panels 
were identical. 
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(Fig. 5.4C, lanes 3 – 6).  The levels of P and L protein precipitated with anti-HN protein-
specific antibody were drastically reduced when salt concentrations exceeded 250 mM (Fig. 
5.4C, lanes 3 – 6).   
 The inability to fully compete off the NP protein from HN protein with increasing salt 
concentrations suggests that the HN protein interacts directly and very tightly with a 
population of RNP-associated NP.   
Isolation of the NP – HN protein-containing complexes from sedimentation gradient 
fractions containing Triton-solubilized virion proteins 
To confirm that the HN protein interacts with RNP-associated NP material, the co-
immunoprecipitation of NP and HN protein from different regions of the gradient was 
characterized.  Individual fractions of gradients similar to those shown in Figure 5.1 were 
combined into two pools, bottom (fractions 3 – 7;  box in Fig. 5.1A) and top (fractions 10 – 
14;  box in Fig. 5.1A), and used for co-immunoprecipitation with NDV protein-specific 
antibodies for the detection of viral protein complexes.  Representative autoradiographs of 
these experiments are shown in Figure 5.5.   
 Consistent with the HN protein sedimentation profile in Figure 5.1, the anti-HN 
protein-specific antibody precipitated the majority of HN protein from the top gradient 
fractions but also precipitated a detectable amount of HN protein from the bottom portion of 
the gradient (Fig. 5.5).  Significantly, a substantial amount of NP was precipitated by anti-
HN protein-specific antibody only from the bottom fractions of the gradient (Fig. 5.5).  
Furthermore, the anti-HN protein-specific antibody also precipitated P protein from the 
bottom gradient fractions (Fig. 5.5) but not the top.  Of note, no significant NP or P protein   
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Legend to Figure 5.5:  Co-immunoprecipitation of NP and HN protein from heavy and 
light density sedimentation gradient fractions. 
Purified [35-S]-radiolabeled virions released from untreated ELL-0 cells were lysed with cold 
1% Triton X-100 and subjected to sedimentation into linear sucrose gradients as shown in 
Figure 5.1 and described in Materials and Methods.  Following sedimentation, individual 
gradient fractions 3 – 7 were pooled and designated as the bottom gradient portion while 
pooled gradient fractions 10 – 14 were designated as the top portion of the gradient (depicted 
with light gray boxes in Figure 5.1A).  Equivalent volumes of each gradient portion were 
then precipitated in the absence of primary antibody (no Ab) or with anti-HN protein-, anti-F 
protein-, and anti-M protein-specific antibodies.  Representative autoradiographs are shown 
with radiolabeled, precipitated viral proteins indicated on the right.  HN protein lanes were 
from polyacrylamide gels electrophoresed under reducing conditions while NP and P protein 
lanes were from polyacrylamide gels electrophoresed under non-reducing conditions.  Film 
exposure times of each protein lane were identical.  
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precipitation from either the top or bottom gradient fractions was observed when anti-F 
protein- or anti-M protein-specific antibodies were employed (Fig. 5.5).  
 The significant levels of NP and P protein precipitation from the bottom 
sedimentation fractions 3 – 7, where the majority of the NP and P proteins were found to 
sediment (Fig. 5.1A), by anti-HN protein-specific antibody strongly suggests that the small 
amount of HN protein in these gradient fractions represents an authentic complex between 
RNP-associated NP and the HN protein in normal NDV particles.  
M protein-containing complexes in virions 
Matrix-like proteins of enveloped RNA viruses typically drive the release of virion and virus-
like particles (157).  Because this finding suggests that specific interactions between matrix-
like proteins and other structural proteins are required for full virus assembly, we sought to 
identify any potential interactions of the M protein with other viral proteins within the NDV 
virion.  After detergent lysis and sedimentation, the majority of M protein in both sets of 
virions was found in gradient fractions also containing HN and F proteins and non-RNP 
associated NP (Fig. 5.1A – B and 5.1G – H), raising the possibility that M protein complexes 
containing some combination of these proteins may exist.  The association of other viral 
proteins with M protein was examined by co-immunoprecipitation (Fig. 5.3A and 5.6A).  
Anti-M protein-specific antibody specifically precipitated approximately 80% of the total M 
protein detected by the polyclonal anti-NDV antibody (Fig. 5.3A and 5.6A).  However, anti-
M protein-specific antibody did not precipitate significant amounts of F protein or HN 
protein (Fig. 5.3A).  In the reciprocal co-IP reactions, no significant amount of M protein 
(<10% of total) was precipitated with either anti-HN protein- or anti-F protein-specific 
antibodies (Fig. 5.3A and 5.6A).  These results suggest that virion-associated M protein does 
 141
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend to Figure 5.6:  Interactions of M protein with other virion components.   
Panel A:  Percent of total radiolabeled M protein specifically precipitated with the indicated 
antibodies from cold 1% Triton X-100-solubilized virions released from untreated (black 
bars) or mβCD-treated (gray bars) cells; representative autoradiographs are shown in Figure 
5.3A.  Data is represented as percent of total M protein precipitated with anti-NDV antibody 
set to 100% for each virus.  The amount of background, non-specific M protein precipitated 
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in the absence of primary antibody was subtracted from the amount of M protein specifically 
precipitated when primary antibodies were present.  Results are averages of three 
experiments and error bars indicate standard deviations.   
Panel B:  Representative autoradiographs of cold 1% Triton X-100 lysed virions from 
untreated cells precipitated in the absence of primary antibody or with anti-M protein-, anti-P 
protein-, anti-HN protein-, and anti-F protein-specific antibodies.  Lysis and 
immunoprecipitation conditions: lane 1 (1.0% Triton X-100, 150 mM NaCl); lane 2 (0.5% 
Triton X-100, 150 mM NaCl); lane 3 (0.1% Triton X-100, 150 mM NaCl); lane 4 (0.1% 
Triton X-100, 250 mM NaCl); lane 5 (0.1% Triton X-100, 500 mM NaCl); lane 6 (0.1% 
Triton X-100, 750 mM NaCl).  Radiolabeled M protein lanes were from polyacrylamide gels 
electrophoresed under reducing conditions.  Film exposure times of all protein panels were 
identical. 
Panel C:  Pooled gradient fractions 3 – 7 (designated as the bottom gradient portion) and 
pooled gradient fractions 10 – 14 (top gradient portion) of cold 1% Triton X-100 lysed 
virions released from untreated cells (representative autoradiographs shown in Figure 5.1A) 
were precipitated in the absence of primary antibody (no Ab) or with anti-M protein-, anti-
HN protein- and anti-F protein-specific antibodies.  Radiolabeled M protein lanes were from 
polyacrylamide gels electrophoresed under reducing conditions.  Film exposure times of all 
protein lanes were identical. 
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not interact with the HN and F glycoproteins, at least after detergent lysis. 
 To determine if any M protein-glycoprotein complexes could be detected after lysis in 
lower Triton X-100 concentrations, M protein was precipitated with anti-glycoprotein 
antibodies after lysis in 1.0% (Fig. 5.6B, lane 1), 0.5% (Fig. 5.6B, lane 2) and 0.1% Triton X-
100 (Fig. 5.6B, lane 3).  As shown in a representative result (Fig. 5.6B), only background 
levels (i.e. no primary antibody) of M protein was precipitated with anti-HN protein- and 
anti-F protein-specific antibodies (Fig. 5.6B, lanes 1 – 3), irrespective of Triton 
concentrations.  Furthermore, no M protein was precipitated with anti-P antibody (Fig. 5.6B).  
Thus, reducing the stringency of virion lysis and the co-immunoprecipitation conditions by 
decreasing Triton concentrations did not enhance recovery of M protein, above background 
levels, by antibodies specific to the HN, F, or P proteins (Fig. 5.6B, lanes 1 – 3).  Increasing 
salt concentrations after lysis in 0.1% Triton reduced the nonspecific M protein precipitation 
but did not result in the detection of any specific complexes of M protein with glycoproteins 
or P protein (Fig. 5.6B, 150 mM NaCl [lane 3], 250 mM NaCl [lane 4], 500 mM NaCl [lane 
5] or 750 mM NaCl [lane 6]).  Taken together, these results suggest that the M protein does 
not bind to RNP structures or the HN and F glycoproteins in virions after lysis in Triton X-
100. 
 Co-immunoprecipitation from bottom and top portions of the sedimentation gradients 
was performed to corroborate the absence of M protein complexes with other viral proteins 
(Fig. 5.6C).  Confirming the individual M protein sedimentation profile from native virions 
(Fig. 5.1A and 5.1F), the majority of M protein was precipitated with anti-M protein-specific 
antibody from top portions of the gradient (Fig. 5.6C).  Although there was an abundance of 
both HN and F glycoproteins in top sedimentation gradient fractions (Fig. 5.1A – D), no M 
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protein from this top gradient portion was precipitated to levels above background by anti-
HN protein- or anti-F protein-specific antibodies (Fig. 5.6C).  All together, these results 
strongly suggest that M protein does not form detergent-resistant complexes with any other 
viral components in the native NDV particle.  
 145
D.  Discussion 
Assembly of paramyxovirus particles requires specific viral protein-protein interactions and, 
likely, specific viral protein interactions with host cell components; however, both sets of 
interactions are incompletely understood.  We have previously reported that Newcastle 
disease virus particle assembly takes place in cell domains with properties of membrane lipid 
raft domains and that the integrity of these assembly domains is important for detection of 
HN and F protein-containing complexes in virions.  These results led us to investigate the 
role of membrane lipid raft domains in the assembly of other virion protein complexes.  We, 
therefore, characterized the protein complexes in NDV particles released from untreated and 
cholesterol deficient cells by sucrose gradient sedimentation, virion fractionation, and co-
immunoprecipitation.  Our results detected no additional effects of cellular cholesterol 
depletion on virus assembly.  However, we did detect a novel interaction between HN protein 
and NP in the virion RNP structure.  Surprisingly, no complexes containing M protein and 
either HN or F protein were detected in virions, while only a small amount of NP – M protein 
complex was detected.  Most of the M protein in detergent lysed virions does not appear to 
be in a complex with any other virion protein but does appear to form large homo-oligomers. 
HN and F proteins in virions 
The majority of HN protein was detected in the top half of the gradient and sedimented with 
sizes smaller than the ferritin marker protein (450 kDa) while all the F protein was detected 
in the top half of the gradient.  It has been previously shown that the NDV F protein 
expressed in transfected cells in the absence of other viral proteins sedimented in gradients as 
a discrete species with a size corresponding to a trimer (142).  The HN protein expressed in 
transfected cells in the absence of other viral proteins sedimented into two discrete peaks 
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corresponding to an HN protein dimer and tetramer (101).  In contrast, both the virion-
associated HN and F proteins sedimented as very broad peaks.  As previously shown and 
confirmed here, approximately one-third of the HN and F proteins in virions is in a HN – F 
protein-containing complex.  This complex, co-sedimenting with trimers of F protein and 
dimers and tetramers of HN protein, may account for the very broad peaks of glycoproteins 
across sedimentation gradient fractions.   
 The sedimentation data suggests that the virion HN – F glycoprotein-containing 
complex is not likely to be composed of an HN protein tetramer (~296 kDa) with an F 
protein trimer (~198 kDa).  The composition of such a glycoprotein complex (approximately 
494 kDa) would result in the presence of both HN and F proteins in gradient fractions 
containing the size maker ferritin (450 kDa), which is found in gradient fraction 8.  Although 
small amounts of HN protein were found below fraction 8, no F protein was found below 
fraction 11.  If the HN – F glycoprotein-containing complex were to consist of an HN protein 
dimer (~148 kDa) and an F protein trimer (~198 kDa) then the resulting glycoprotein 
complex (~346 kDa) should sediment between gradient fractions 8 – 10, where 
approximately 18% and 7% of the total virion HN and F protein, respectively, were found.  
These values cannot account for the levels of detection of the HN and F protein-containing 
complex.  Thus, it is possible that HN – F protein-containing complexes are composed of 
forms of HN and F protein smaller than dimers or trimers, respectively.  Alternatively, the 
glycoprotein complexes may not be stable in the sucrose gradient.  However, we have been 
able to co-immunoprecipitate HN and F protein from gradient fractions following 
sedimentation (data not shown). Thus the actual oligomeric state of the HN and F 
glycoproteins in the HN – F protein-containing complex needs to be further investigated. 
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 Our data here and those previously presented (80) indicate heterogeneous populations 
of F protein in virions, including F protein complexed with HN protein and F protein not 
complexed with HN protein (Fig. 5.7, complexes 1 and 2, respectively).  Recently, different 
conformational forms of the F protein of human parainfluenza virus type 3 were detected in 
virions by cryo-electron microscopy (94).  Pre- and post-fusion forms of F protein were 
detected and a third form, F protein complexed with HN protein, was proposed (94).  Thus 
there may be at least three different forms of F protein in paramyxovirus particles.  
Virion incorporation of nucleocapsid protein 
As expected, the bulk of the total NP was found in dense gradient fractions along with P 
protein, indicative of the presence of the virion RNP structure in these fractions.  However, 
NP was also found in lighter density fractions containing HN, F and M proteins.  Following 
sedimentation, the heterogeneous distribution of virion NP throughout the gradient suggested 
that different populations of the nucleocapsid protein are found in virions.  In addition, after 
fractionation of virions into soluble and core components, approximately 31% of total virion 
NP was in the soluble fraction.  In paramyxovirus-infected cells, NP exists as both a 
monomeric form and an assembled form (82).  In the absence of genomic RNA, the P protein 
binds to monomeric NP to prevent un-regulated self-assembly of NP subunits.  The slower 
sedimentation of approximately 35% of total virion NP to gradient fractions not possessing P 
protein (Fig. 5.1A and 5.1E, fractions 9 – 16) suggests that monomeric NP not associated 
with the RNP structure or, alternatively, NP multimers as intermediates of RNP assembly are 
packaged into virions.  The data presented here also indicate that this lower-order oligomeric 
form of NP does not complex with either the HN or F proteins.   
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Legend to Figure 5.7:  Schematic model of proposed viral protein complexes at the 
virion envelope of the Newcastle disease virus particle. 
Complex 1: Approximately 33% of the total HN protein in virions is in complex with 
approximately 33% of the total virion-incorporated F protein as described previously (80).  
Complex 2: The remaining approximate 67% of total virion-associated F protein is not found 
detectably in association with any other virion component(s).  
Complex 3: Approximately 60% of total virion-associated HN protein is not found detectably 
in complex with any other virion component(s).   
Complex 4: The remaining 7% of total virion-incorporated HN protein is found associated 
with membrane-proximal RNP structures consisting of NP, P and L proteins. 
Complex 5: The majority of virion-associated M protein underlying the virion envelope is 
not detectably found associated with any other virion component(s) other than small amounts 
of NP. 
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Characterization of an NP – HN protein-containing complex in virions 
There is, however, an interaction of RNP-associated NP with HN protein.  Evidence for a NP 
– HN protein-containing complex in virions consisted of, first, HN protein sedimentation into 
dense gradient fractions containing RNP components NP, P and L proteins, second, isolation 
of HN protein with purified RNP structures upon virion fractionation, third, specific 
precipitation of NP with anti-HN protein-specific antibody, and fourth, specific precipitation 
of HN protein along with RNP components by anti-P protein-specific antibody.  
Furthermore, the resistance of NP – HN protein-containing complexes to high salt 
concentrations, conditions that remove P and L proteins from the precipitate, indicates that 
HN protein associates with NP. 
 Approximately 7% of the total HN protein in the virus particle co-fractionated with 
pelleted RNP structures (Fig. 5.2).  A similar result was found after sedimentation of virion 
proteins in sucrose gradients.  Approximately 8.8% of total HN protein in virions was found 
below fraction 7, where the majority of the RNP structure sedimented (Fig. 5.1A – C).  The 
specific immunoprecipitation of NP and HN protein with anti-P protein-specific antibody 
showed that RNP-associated HN protein was not due to non-specific contamination of the 
RNP fractions with aggregates of HN protein.  These results suggest that a small, but 
reproducible, fraction of HN protein associates with RNP structures in virions.   
 The stoichiometry of the NP – HN protein-containing complex was calculated in 
several different ways, all of which yielded similar results.  The HN protein co-fractionating 
with pelleted RNP structures (Fig. 5.2) suggests the ratio is approximately 28 NP subunits to 
1 HN protein molecule.  Consistent with this result is the finding that specific 
immunoprecipitation of NP with HN protein resulted in the stoichiometry of the NP – HN 
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protein-containing complex to be approximately 30 NP subunits to one HN protein molecule.  
Taken together, these results are consistent with the very small amount of total HN protein 
found to sediment with the majority of virion NP to dense gradient fractions. 
 The identification of a virion NP – HN protein-containing complex raises several 
intriguing questions regarding NDV assembly and release.  The first of which is whether 
there are specific NP subunits of the RNP structure that interact with the HN protein (Fig. 
5.7, complex 4).  It is well-established that paramyxovirus RNP structures are quite flexible 
and exist in several different conformations (11, 12, 36, 56, 57, 159).  It is possible that 
individual stretches of the ~2600 NP subunits within the approximate 1 μm-long helical RNP 
structure (82) adopt a particular conformation to facilitate an interaction between the HN 
protein cytoplasmic (CT) domain and the local NP subunits.  Therefore, it will be of interest 
to examine the organization of the virion RNP structure by cryo-electron microscopy of 
paramyxovirus particles.  Data presented here lead to the prediction that small regions of the 
RNP structure would be in close proximity to the inner leaflet of the virion envelope, where 
an HN protein molecule would be embedded (Fig. 5.7, complex 4).  We would further 
speculate that this particular HN protein would be distinct from an HN protein molecule in 
complex with an F protein molecule in the virion envelope (Fig. 5.7, complexes 4 and 1, 
respectively).     
 A second interesting question concerns the mechanisms involved in forming different 
HN protein-containing complexes.  Approximately 33% of total HN protein is complexed 
with F protein in virions (80) while 7 – 8.8% of total HN protein is in a complex with RNP 
structures, and the remaining 60% of total HN protein is in homo-oligomeric complexes (Fig. 
5.7, complexes 1, 4 and 3, respectively).  The mechanisms involved in forming these three 
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populations of HN protein are unknown.  Since there are no documented modifications of the 
CT domain of the NDV HN protein, it is conceivable that specific conformations of the HN 
protein CT or transmembrane (TM) domain regulate the interactions of the HN protein with 
other components (NP or F protein) of the assembling virion.  Alternatively, unidentified 
host cell factors could contribute to HN protein interactions during virus assembly.      
 In addition to the results presented here, experimental observations from other studies 
have indirectly supported both the presence and physiological relevance of a complex 
between NP and the HN protein in paramyxovirus particles.  Schmitt et al. investigated the 
role of the simian virus 5 (SV5) HN protein CT domain in virus assembly (156).  Utilizing 
recombinant viruses encoding HN proteins with deletions of the CT domain, the yield of 
virus particle release was significantly reduced (7 – 12 fold) depending on the length of the 
HN protein CT deletion (156).  Interestingly, in comparison to full-length HN protein, the 
levels of CT deleted HN protein incorporation into virions were equivalent but the packaging 
of NP was significantly reduced when CT deleted HN protein was expressed (156).   
 Furthermore, the decreased levels of NP in virions correlated with a significant 
increase in the levels of actin in SV5 virions upon assembly of CT deleted HN proteins 
(156).  This result may hint at a role for the cortical actin membrane cytoskeleton in the 
formation of the NP – HN protein-containing complex during virus assembly and release.  
Intriguingly, a high degree of association of both NP and HN protein with a subset of 
membrane lipid raft domains enriched in actin has been observed in NDV-infected cells (81).  
 Taken together, these results suggest the formation of the NP – HN protein-
containing complex during virus assembly is important for efficient incorporation of NP into 
virus particles.  Moreover, our present results also suggest that the formation of the NP – HN 
 152
protein-containing complex is not dependent on cellular cholesterol and membrane lipid raft 
integrity, in contrast to the HN – F glycoprotein-containing complex.  The recovery of the 
NP – HN protein-containing complex in virions was unaffected when particles were 
assembled in cholesterol-depleted cells.  
M protein interactions in virions 
Sedimentation of virion M protein revealed large M protein multimers, which sedimented to 
denser gradient fractions when virions were extracted with octyl-β-glucoside.  This result 
supports previous studies of M protein oligomerization (7, 58) and M protein association 
with membrane lipids (37, 146, 162, 178).      
 However, in contrast to several previous studies (3, 46, 130, 154, 156, 158), no 
significant interaction was observed between the M protein and the HN and F glycoproteins 
in the NDV particle.  Several mechanisms could possibly explain the absence of M protein 
interactions with other proteins in NDV particles.   
 The Sendai virus M protein was only detected with cellular membranes when viral 
glycoproteins were expressed and when lower concentrations (< 1%) of Triton X-100 
detergent were used for extraction of cells (3).  However, in the present study, co-
immunoprecipitation experiments performed at 0.1% Triton X-100 did not increase specific 
precipitation of M protein with HN or F proteins (Fig. 5.6).  These results suggest that 
complexes between the M protein and either of the glycoproteins do not exist in the NDV 
particle.  Alternatively, if these complexes do exist in virions, then the biochemical isolation 
of M protein-glycoprotein complexes is highly sensitive to even mild detergent lysis.   
 In the absence of dynamic re-arrangements of core virion components like that seen 
in the Retroviridae (48), the protein complexes observed within the paramyxovirus particle 
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should reflect the protein complexes formed during virus assembly in the cell. Indeed, 
several data suggest that M protein does not interact with either HN or F glycoproteins 
during virus assembly.  Direct co-immunoprecipitation of M protein with HN or F proteins 
from infected cell lysates was negative for the presence of a complex between the M protein 
and either the HN or F glycoproteins (data not shown).  Furthermore, in pulse-chase 
experiments, radiolabeled M protein was efficiently incorporated into virions despite not 
accumulating with viral assembly sites, where radiolabeled NP, HN and F proteins 
accumulated prior to packaging into virions (81).  These results were interpreted as the M 
protein displaying either a weak affinity or a transient affinity for the viral assembly 
membrane.  Considering the high efficiency of the M protein release from infected cells 
(130), it is possible that the M protein only needs to be briefly situated near, but not 
interacting with, the glycoproteins for efficient glycoprotein incorporation and virus particle 
release.   
 In contrast to these results with infected cells and virions, our laboratory has reported 
an interaction between the M and HN proteins within NDV virus-like particles (VLPs) by co-
immunoprecipitation (130).  Several differences between infected cells and the transfected 
cells used to generate VLPs may account for the conflicting data.  For example, the VLPs 
were formed in the absence of other virus-encoded proteins, including the L protein, P 
protein and the P gene-derived protein(s).  Interestingly, Sendai VLP release was enhanced 
upon expression of P protein (182).  Furthermore, in the context of an infected cell, the 
expression of P gene-derived proteins may have dramatic consequences on cellular pathways, 
such as the intracellular IFN-α/β responses.  In addition, paramyxovirus infection has 
significant effects on host cell RNA transcription and host cell protein synthesis (82).  
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Therefore, the differences in M protein interactions obtained with NDV VLPs (130) and 
virions could result from the expression of these minor structural proteins, which may be 
important determinants of viral protein-protein interactions during paramyxovirus assembly.  
Alternatively, the differences may be due to rearrangements in virion structural proteins after 
assembly and release, rearrangements which may not occur in VLPs. 
   Taken together, these results support a model in which the M protein transiently 
localizes to glycoprotein-enriched viral assembly sites and then drives the budding of a 
progeny virion through the plasma membrane from these sites.  Within the released NDV 
particle, the M protein remains associated with the newly acquired virion envelope, in which 
the HN and F glycoproteins are embedded, but not in direct contact with the glycoproteins 
themselves (Fig. 5.7, complex 5). 
 155
CHAPTER VI 
GENERAL DISCUSSION 
 
Utilizing the avian paramyxovirus Newcastle disease virus (NDV) as a model system for the 
study of host cell membrane lipid raft domains in the assembly and release of enveloped 
RNA viruses, we found:  
 1. NDV assembly occurs within membrane lipid raft domains, 
 2. membrane raft domain integrity is important for the release of infectious virions, 
 3. formation and virion incorporation of functional HN – F glycoprotein-containing 
 complexes is dependent on membrane lipid raft domains, and  
 4. a novel protein complex composed of the nucleocapsid protein (NP) and 
 hemagglutinin-neuraminidase (HN) protein exists in virions. 
Since detailed discussions were provided for each of these findings as addressed in Chapters 
II – V, the general discussion presented here will integrate the major points in the thesis 
work, highlight the remaining questions and potential future directions, and frame the 
relevance and implications of the thesis work. 
 
A. Paramyxovirus assembly at membrane lipid raft domains 
In the highly dynamic context of an infected cell, specific mechanisms must be in place to 
ensure proper assembly of progeny virions.  Paramyxoviruses assemble in the plasma 
membrane of infected cells (82).  Following transport through the cellular secretory pathway, 
the viral transmembrane HN and fusion (F) glycoproteins are embedded in the surface 
plasma membrane.  The matrix (M) protein and ribonucleoprotein (RNP) structure remain in 
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the cytosol until virus assembly commences.  The need to coordinate the interactions of 
different virion components, all displaying varying sub-cellular localizations, is of utmost 
importance towards achieving efficient virus assembly.       
 Experimental results, including those presented here, support several non-mutually 
exclusive mechanisms by which membrane lipid raft domains would participate in and 
promote paramyxovirus assembly. 
 
Targeting of viral glycoproteins to assembly sites  
The targeting of the NDV HN and F glycoproteins to membrane raft domains and formation 
of the HN – F glycoprotein-containing complex are crucial for the release of functional and 
infectious virions.  However, several key aspects as to the mechanisms in which the viral 
glycoproteins localize to membrane raft domains during virus assembly remain uncertain.   
 Like the NDV HN and F glycoproteins, many other paramyxovirus transmembrane 
(TM) glycoproteins associate with detergent-resistant membrane (DRM) fractions of cells 
(59, 147, 152, 187).  However, when and how viral TM glycoproteins interact with 
membrane lipid raft domains is unclear.  Cholesterol is synthesized in the endoplasmic 
reticulum (ER) and then transported to the Golgi apparatus (165).  It is generally accepted 
that the formation of membrane lipid raft domains first occurs in the Golgi membranes, 
where sphingolipids are synthesized (165).  At the earliest time of non-radioactive chase 
analyzed (1 hour, Fig. 2.3), significant amounts of HN and F protein were recovered in DRM 
cell fractions, suggesting the two glycoproteins associate with membrane raft domains upon 
arrival at the Golgi membranes.  Indeed, this observation is consistent with those studies 
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showing the hemagglutinin (HA) TM protein of influenza virus was incorporated into DRM 
cell fractions after transport from the ER to the Golgi (169). 
 In general, both HN and F proteins display similar, but relatively slow, transport rates 
to the cell surface (119, 115).  However, the length of time each protein requires to reach 
each component of the secretory pathway differs significantly.  The F protein reaches the 
trans Golgi faster than the HN protein; however, the transport of F protein from the trans 
Golgi to the cell surface is slower than that of the HN protein (119, 115).  These results could 
have implications for the temporal component of how the HN – F glycoprotein-containing 
complex is formed and the role membrane lipid raft domains play in this process.   
 It is possible that, upon its arrival at the Golgi membranes, the HN protein associates 
with membrane raft domains in which previously transported F protein is already embedded.  
Alternatively, the HN and F proteins may individually associate with membrane raft domains 
upon arrival at the Golgi and a coalescence of HN protein-enriched and F protein-enriched 
membrane raft domains takes place.  Although not mutually exclusive, either mechanism 
would conceivable promote the formation of the HN – F glycoprotein-containing complex.  
As suggested in Chapter IV, a series of carefully synchronized kinetic experiments along 
with inhibitors of membrane protein transport would begin to tease apart when and where the 
HN and F proteins associate with membrane lipid raft domains and subsequently form the 
glycoprotein complex. 
 It is thought that the NDV HN protein specifically activates the NDV F protein for 
membrane fusion by regulating conformational changes of the F protein.  Although the 
presence of the NDV HN protein is required for NDV F protein-mediated membrane fusion, 
the exact details of F protein regulation by HN protein remain unclear.  Through the use of 
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point mutants and the generation of chimeric proteins, many studies have mapped regions of 
the HN protein which interact with the F protein, including the HN protein globular head 
domain, heptad repeat-like domains within the HN protein stalk region and the HN protein 
TM domain (reviewed in 82).  Reciprocally, regions within the stalk domain of the F protein, 
specifically the heptad repeat 2 domain, have been shown to interact with the homologous 
viral HN protein (reviewed in 116).  However, it is largely unknown whether these mutant 
proteins properly associate with membrane raft domains. 
 A second un-resolved aspect of the extensive membrane raft association observed 
among many viral TM glycoproteins is the exact raft-targeting determinant(s).  Several 
explanations are possible.  Results from the influenza virus system suggest that the viral TM 
protein amino acids spanning the outer leaflet of the lipid bilayer regulate the inclusion of the 
viral glycoproteins into membrane raft domains (77).  However, within the TM domain of 
viral integral proteins, the identities of specific amino acids or motifs which impart raft-
targeting ability have not been described.  Additional work with both viral and host cell 
proteins has shown specific post-translational modifications, such as  palmitoylation of 
cysteine residues located within TM and cytoplasmic tail (CT) domains, to promote 
membrane raft association (92, 111, 155, 197).  Furthermore, the presence of the CT domain 
is often necessary for raft association of viral glycoproteins.  It is conceivable that the CT 
domain orients the TM domain in a conformation necessary for insertion and stability of the 
protein in membrane lipid raft domains.     
 However, mutation of putative palmitoylation sites within the NDV F protein TM and 
CT domains had no effect on DRM association of the F protein in cells (33); no such 
modifications are known to occur with the NDV HN protein.  The raft association of viral 
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TM glycoproteins lacking currently known raft-targeting signals possibly suggests that the 
biophysical properties of membrane raft domains themselves are regulating the association of 
select integral proteins with these membrane domains.  As cholesterol preferentially 
partitions with membrane lipid raft domains, it increases the thickness of the lipid bilayer 
(165).  The increased thickness of membrane raft domains would allow incorporation of 
integral proteins with longer TM domains, which is energetically favorable for those 
hydrophobic amino acids making up the TM domain.  Such a mechanism would segregate 
longer TM domain-containing proteins from other integral proteins with shorter TM domains 
(17).       
 Additionally, the boundaries of lateral diffusion for molecules within a lipid bilayer 
are determined, in large part, by the phase separation of raft (liquid-ordered phase) and non-
raft (liquid-disordered, fluid phase) membrane (165).  It is also possible that viral TM 
glycoproteins do not possess an intrinsic affinity for membrane raft domains per se, as in a 
protein motif or modification, but merely congregate at the phase interface of raft and non-
raft membrane.  In the future, TM domain truncations or the replacement of TM domains 
with those of known non-raft integral membrane proteins would begin to test the idea that the 
biophysical properties of membrane raft domains may regulate the NDV glycoproteins’ 
affinity for these domains.  
 
RNP structure and M protein localization to assembly sites 
The targeting of the RNP structure and M protein to the glycoprotein-enriched viral assembly 
site at membrane lipid raft domains is critical.  The RNP structure harbors the viral genome 
and the M protein drives the release of the assembling virion.  However, the exact raft-
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targeting determinants of these two peripheral membrane-associated components are also 
unclear.   
 For both cellular and viral peripheral membrane-associated proteins, specific post-
translational modifications [e.g. addition of glycosylphosphatidylinositol (GPI)-anchors (93), 
myristoylation, palmitoylation (144)] or the presence of particular lipid-interacting domains 
within proteins [e.g. BAR domains (107), pleckstrin homology domains (175)] have been 
shown to facilitate the interactions of proteins with lipid bilayers.  In the case of the NDV 
nucleocapsid (NP) and M protein, no such modifications or domains have been documented 
thus far.  However, both NP and M protein form complexes with one another and the 
paramyxovirus M proteins have been shown to have extensive interactions with membranes 
and cellular actin (82).   
 The significance of an interaction between the M protein and actin is important 
because a specific subset of membrane lipid raft domains (DRM-H) enriched in actin and 
other components of the membrane cytoskeleton have been identified (121).  Our work here 
(Chapter II) established a role for the actin-enriched DRM-H domains in NDV assembly as 
both NP and, to a more transient extent, M protein displayed an increased affinity for DRM-
H fractions of both infected (Chapter II) and transfected cells (data not shown).  How these 
DRM-H cell fractions interact with the classically-defined raft (DRM-L) cell fractions during 
virus assembly is of particular interest.   
 It is possible that actin or other components of the membrane cytoskeleton serve as a 
scaffold for the interactions of NP and M protein with membrane lipid raft domains.  This 
mechanism would serve to localize and concentrate the RNP structure and M protein to the 
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viral assembly site near surface membrane lipid raft domains, where the HN and F 
glycoproteins are embedded.     
 Although the reduced infectivity of NDV particles released from cholesterol-depleted 
cells was attributed primarily to the decreased levels of functional HN – F glycoprotein-
containing complexes, another possibility could be the effects of mCD treatment on NP 
association with DRM cell fractions.  Pulse-chase experiments showed that the NP associated 
with DRM cell fractions was exclusively assembled into released virions, while non-raft 
associated NP was not packaged into virions (Fig. 2.2D).  The observed loss of NP 
association with DRM cell fractions upon acute mCD treatment (Fig. 2.5A) may result in 
the inefficient incorporation of RNP structures into budding virions; thereby rendering 
particles released with no viral genomes and, therefore, not infectious.  To address this 
possibility, quantification and comparison of genomic vRNA copy number within the 
population of virions released from untreated and cholesterol-depleted cells would be 
informative.   
 
Viral protein concentration in membrane raft domains and protein-protein interactions 
Paramyxovirus assembly requires the congregation of several components so that a defined 
series of specific, and necessary, interactions occurs in order to promote the recognition and 
assembly of those components into a progeny virion (183).  In addition to concentrating viral 
structural proteins as described above, membrane lipid raft domains would also serve to 
segregate host cellular components from the virus assembly site.  Both events would increase 
the likelihood of viral protein-protein interactions at membrane raft domains.   
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 It has been estimated that the plasma membrane of cells possesses approximately 
30,000 membrane proteins per square micron (50, 140, 163).  It is possible that incorporation 
of certain surface cell molecules could be detrimental for the biology of the released virion.  
As we have described, the manner in which the HN and F glycoproteins are assembled and 
packaged into NDV particles has significant consequences on the functionality and 
infectivity of the released virion.  Therefore, both the identity and number of molecules 
within virus assembly sites needs to be tightly regulated.  Such regulation would ensure that 
the proper amounts of each viral protein, and in the correct ratio, are incorporated into 
assembling virions.  All experimental evidence obtained thus far suggests that this high 
degree of selectivity may be achieved, in part, by the ability of membrane lipid raft domains 
to specifically include and concentrate molecules. 
 However, the specific viral protein-protein interactions taking place at membrane 
lipid raft domains and those necessary for the proper assembly of an infectious 
paramyxovirus particle are only now being identified and characterized.  As described in 
Chapter I, the recent development of virus-like particle (VLP) and recombinant virus systems 
have contributed to our current understanding of the viral determinants of enveloped RNA 
virus assembly and release.  Several key questions remain though, most notably is whether 
the paramyxovirus M proteins interact with the viral glycoproteins during virus assembly.   
 Given the importance of paramyxovirus M proteins as the “driving” force of particle 
budding (157), it is generally thought that this peripheral membrane-associated protein must 
interact with one or both of the glycoprotein CT domains.  For reasons cited and explained in 
Chapter I regarding previous experimental systems, this conclusion is not entirely supported.  
The thesis work presented here, specifically in Chapter V, suggest that the NDV M protein 
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needs only to display a transient affinity for the glycoprotein-enriched virus assembly site at 
membrane raft domains in infected cells.  Although in contrast with the steady-state findings 
from other groups using different experimental systems, the data taken together highlight the 
need to further pursue and define the viral protein-protein interactions taking place in 
paramyxovirus-infected cells. 
 Indeed, the formation of the NP – HN protein-containing complex could aid in the 
incorporation of the RNP structures into released virions.  Although initial experiments 
suggest that this complex is intact and efficiently recovered in virions released from 
cholesterol-depleted/raft-perturbed cells (Chapter V), the importance of membrane raft 
integrity in the formation of the NP – HN protein-containing complex in cells is unknown.  
In contrast to formation of the HN – F glycoprotein-containing complex (approximately 100 
min until detection), the co-immunoprecipitation of NP and HN protein complexes from 
infected, 35S-radiolabeled cells suggested that the complex forms soon (< 30 min) after 
biosynthesis of NP (data not shown).  Therefore, to test the role of cholesterol and membrane 
raft domains in the formation of the NP – HN protein-containing complex, the short 
radiolabel period would have to be followed by an immediate depletion of cellular 
cholesterol.  Alternatively, the potential for a membrane raft-dependent formation of the NP 
– HN protein-containing complex could be studied in infected NPC cells, similar to those 
studies with the glycoprotein complex (Chapter IV).   
 As an extension of this work, it will also be of interest to understand the temporal 
sequence and hierarchy of viral protein-membrane raft association in infected cells, i.e. 
which viral protein associates first with these membrane domains, which viral protein 
second, third, etc.  Determination of the assembly order of the virion components at 
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membrane lipid raft domains could help in further defining the viral protein-protein 
interactions necessary for proper virion assembly. 
Spatial aspects of membrane lipid raft domains as sites of virus assembly 
One issue with the model of membrane raft domains as sites of virus assembly is the spatial 
scale of how these relatively small microdomains accommodate the large collection of viral 
components destined for virion incorporation.  The general thought is that the size of 
membrane raft domains ranges from 5 to 50 nm in diameter, which is beyond the light 
microscopy resolution (approximately 300 nm) (137) and also much smaller than 
paramyxovirus particles (150 – 300 nm diameter) (82).  Depending on the concentration of 
sphingolipids and cholesterol, a raft diameter of 50 nm would accommodate between 10 and 
30 proteins (166).  However, as described earlier, if integral proteins display an affinity for 
the phase interface between raft and non-raft membranes then the number of proteins able to 
associate with a 50 nm-diameter raft domain would increase significantly.  It remains to be 
investigated whether DRM-associated viral TM glycoproteins utilize and reside at these 
lateral membrane boundaries.   
 Furthermore, the proteins associated with membrane raft domains influence the 
dynamic nature of these microdomains (45).  Although membrane raft domains are thought 
to possess short half-lives (in the range of 100 nanoseconds) (161), the coalescence and 
stabilization of larger membrane raft domains has been observed both artificially by antibody 
cross-linking of raft-associated proteins (167) and in vivo by multimerization of raft-
associated proteins (45).  Although not yet tested, it is possible that the association of the HN 
protein with RNP-associated NP in cells could serve to tether or induce the coalescence of 
many individual HN protein-containing raft domains into a larger viral protein-enriched 
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membrane raft domain.  Such a mechanism would ensure the incorporation of the RNP 
structure into a virion possessing viral proteins embedded in the newly acquired virion 
membrane.  Additionally, the oligomerization of the M protein in cells could potentially 
contribute to the coalescence of many individual viral protein-containing raft domains and 
serve as a final step in the assembly and release processes – discussed below. 
 The initial association of viral proteins with membrane raft domains could also lead 
to the recruitment and enrichment of more membrane raft-associated lipids in the vicinity of 
the raft-associated viral proteins, thereby providing space for incoming viral proteins to 
occupy the assembly site (18).  This cumulative effect would serve to concentrate and 
accommodate the many viral components, while also stabilizing the membrane raft domain 
as the viral assembly site.  This model would propose that a single viral protein, or a small 
collection of viral proteins, first serves to set-up the assembly site at membrane lipid raft 
domains and nucleate the virus assembly process. 
 Upon steady-state analysis of protein expression, we have observed the NDV F 
protein to display the highest affinity among the four main structural proteins for membrane 
raft domains; approximately 70% of the total F protein accumulated in DRM fractions of 
both infected and transfected cells.  Therefore, one could speculate that the F protein may 
serve to set-up the viral assembly site at membrane lipid raft domains.       
 
B. Budding and release of paramyxoviruses from membrane raft domains     
Once assembled in the plasma membrane, progeny paramyxovirus particles are released by 
the budding process, which involves membrane curvature and a “pinching off” reaction 
(183).  Although the details of particle budding are not known, the M protein is thought to 
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play a major role in the budding process for many paramyxoviruses (82).  The interactions 
between membrane lipid raft domains and M proteins are likely important if these domains 
contribute to the budding of progeny virions. 
 
Lipid composition of the NDV particle membrane 
The unique lipid composition of many enveloped RNA virus membranes has been attributed 
to the lipid composition of the viral assembly site within the infected cell membrane.  
Consistent with membrane lipid raft domains serving as sites of NDV budding are the 
relatively high levels of membrane raft-associated lipids and cholesterol found in the NDV 
particle envelope; cholesterol comprised 6.5% of the total molecular weight of the NDV 
particle (15).  Similar results were obtained upon quantitative lipid analysis of the viral 
membrane of human immunodeficiency virus type 1 (HIV-1), another enveloped RNA virus 
proposed to extensively utilize membrane rafts for virus assembly and budding (21).  
Furthermore, the specific incorporation of host cell membrane proteins associated with raft 
domains into released NDV (Chapter II) and HIV-1 (122, 125) particles further suggests that 
budding of virions occurs at these particular membrane domains. 
 
The M protein in NDV particle budding – the host VPS pathway and self-budding capacity 
As mentioned earlier, the M proteins of several paramyxoviruses, including NDV (130), 
display self-budding capacity, i.e. sole expression of M protein in transfected cells results in 
the release of M protein-containing membrane particles.  For several individual 
paramyxoviruses, but not all, the self-budding capability of the M protein has been attributed 
to the presence of a viral late domain(s) (13, 157, 183).  In order to facilitate virus particle 
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budding, viral late domains are thought to usurp the host cell machinery responsible for cell 
vesicle formation/budding, namely the vacuolar protein sorting (VPS) pathway and 
associated ESCRT (endosomal sorting complex required for transport) complexes (42).  
However, the importance of viral late domains and the VPS pathway in the budding process 
of paramyxoviruses has yet to be fully defined (27).  Regarding the role of the host cell VPS 
pathway in paramyxovirus budding, several key questions remain, including: given that the 
NDV M protein has a classical late domain (Pantua and Morrison, unpublished), which VPS 
molecule(s) interacts with the putative late domain of the NDV M protein?  Do VPS 
components localize to the NDV assembly site?  Does mutation or deletion of the putative 
late domain(s) within the M protein affect release of authentic NDV or NDV virus-like 
particles?  
 The recent finding that purified NDV M protein efficiently budded into synthetic 
liposomes (162) seems to argue against an extensive role for the host cell VPS pathway in 
particle budding driven by NDV M protein.         
 
The M protein in NDV particle budding – cholesterol and DRM association  
Intriguingly, the efficiency of particle budding driven by purified NDV M protein was 
significantly enhanced when cholesterol was present in the liposome (162).  This result is 
consistent with the idea that the cholesterol-enriched membrane raft domains of host cells 
also serve as sites of NDV particle budding.  Indeed, the association of M proteins with DRM 
cell fractions has been shown for several paramyxoviruses (3, 59, 187).  However, for 
reasons explained in Chapter V, the transient association of the NDV M protein with DRM 
cell domains suggests a model in which this viral protein only needs to be briefly situated 
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near, but not interacting with, the membrane domain containing the other virion components 
for particle budding. 
 Regarding the role of paramyxovirus M proteins in virus budding, several key 
questions remain.  For instance, is there a threshold of M protein accumulation necessary for 
the formation and budding of a particle?  Through extensive M – M protein interactions, 
paramyxovirus M proteins form dense arrays underlying the plasma membrane of infected 
cells (61, 7, 58) and such large M protein-containing complexes were found in released NDV 
particles (Chapter V).  The formation of such M protein complexes may help induce the 
membrane curvature needed to promote the vesicularization and budding of a particle.  
Indeed, recent computer simulation models have shown that viral matrix-like proteins placed 
in a membrane environment similar to that of membrane lipid raft domains (in terms of size 
and lipid composition) resulted in spontaneous membrane vesicularization and protein 
release (145).   Additionally, the large size of M protein multimers in cells may increase the 
likelihood that membrane curvature and particle budding occurs below a patch of membrane 
in which the other virion components are assembled.  In the absence of any detectable 
interactions between the M protein and the viral glycoproteins in the NDV system, such a 
mechanism may be important for effectively incorporating the viral glycoproteins (and RNP 
structures tethered to the HN protein) during particle budding. 
 
The M protein in NDV particle budding – interactions with NP and the cytoskeleton 
The paramyxovirus M protein also forms complexes with NP (82) and has been shown to 
interact extensively with cellular actin (47).  In fact, several paramyxovirus M proteins 
modify actin and induce the exposure of novel antigenic sites within the actin protein (5, 6, 
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39).  Association of both NP and M protein with the actin-enriched DRM-H cell fractions of 
NDV-infected cells potentially suggests an important role for the cortical cytoskeleton in the 
virus release process.   
 As mentioned in Chapter II, the cortical cytoskeleton is a meshwork of actin 
underlying the plasma membrane and is often linked to the plasma membrane by interactions 
with lipid raft-associated proteins (168).  As membrane raft domains serve as sites of 
dynamic signaling events (167), rearrangements of proximal components of the cortical 
cytoskeleton often occur (54, 64).   
 It is possible that sites of dynamic actin rearrangements near the cell surface are 
needed in order to facilitate the release of large RNP structures through the cortical 
cytoskeleton and up through the viral protein-enriched membrane assembly site.  During 
entry, many viruses must interact with the cortical cytoskeleton in order to release and/or 
transport their RNP/core structures.  It has been suggested that an intact cortical cytoskeleton 
may be inhibitory to the initial release of RNP structures into the cytosol following 
membrane fusion of particular enveloped viruses at the cell surface (173).  Conceivably, the 
opposite event, i.e. the movement of the RNP structure away from the cytosol, up through the 
cortical cytoskeleton and into the virion as it begins to bud from the surface plasma 
membrane, would also be impeded by an intact membrane cytoskeleton.  Indeed, the release 
of NDV particles from cells is accelerated in the presence of drugs affecting cellular actin 
(117).  
 Thus, association of the NDV NP and M protein with the actin-enriched DRM-H cell 
fraction is consistent with the potential involvement of the cortical cytoskeleton in virus 
assembly and release from membrane raft domains.  The ability of the M protein to interact 
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with actin could indicate an important role for this protein in promoting dynamic remodeling 
of the cortical cytoskeleton which may be conducive for the incorporation of the RNP 
structure into budding virions.   
 
C. Relevance and implications of membrane lipid raft domains in virus assembly 
In addition to contributing to our basic knowledge of the molecular mechanisms in which 
membrane lipid raft domains function during the assembly and release processes of 
paramyxovirus particles, the results presented in this thesis work have several practical 
implications.     
 Enveloped RNA viruses, including the families Filoviridae (Ebola and Marburg 
viruses), Rhabdoviridae (rabies virus), Orthomyxoviridae (influenza virus), Paramyxoviridae 
(NDV, respiratory syncytial virus [RSV], human parainfluenza viruses [hPIV], measles virus, 
Hendra and Nipah viruses) and Retroviridae (human T cell leukemia [HTLV] and HIV-1), 
consist of numerous clinically relevant human and animal pathogens.  Individual members of 
each family have been shown, in part, to utilize membrane lipid raft domains during the 
assembly and release processes of progeny virions [reviewed in (126)]. 
Therefore, in a manner similar to that for NDV, it is quite possible that other 
enveloped RNA viruses are dependent on the integrity of these specific host cell membrane 
domains for proper virus assembly.  Indeed, depletion of cellular cholesterol resulted in the 
impaired release of HIV-1 particles (127) and the release of relatively non-infectious 
influenza virus (10).  These results underscore the importance of membrane raft domains in 
the assembly of HIV-1 and influenza particles and also suggest that these domains may serve 
as commonly employed cellular sites for the assembly of other enveloped RNA viruses.   
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Thus, the development of novel anti-viral therapeutics targeting the cholesterol- and 
membrane raft domain-dependent assembly and release processes of enveloped RNA viruses 
is one potential application of understanding the mechanisms of virus assembly promoted by 
membrane lipid raft domains.  In fact, an anti-viral therapeutic discovery-based commercial 
venture established on this line of thought already exists.    
 Moreover, elucidation of the mechanisms by which membrane lipid raft domains 
support the ordered assembly and release of enveloped RNA viruses may potentially 
contribute to the design and construction of vaccines for a variety of pathogens.   
 As many enveloped RNA viruses have been shown to utilize membrane lipid raft 
domains during assembly and release, several experimental observations suggest that these 
particular viruses would be ideal platforms for vaccine production.  The ability to 
pseudotype, i.e. to associate the viral core components of one virus with the membrane 
proteins of another virus, has been shown, in part, to be a result of two different enveloped 
RNA viruses sharing membrane raft domains as common sites of virus assembly in a co-
infected cell (132).  Furthermore, the exclusive presence of host cell raft-associated 
molecules in released virions suggests that passive incorporation of a membrane raft-targeted 
antigen could be tolerated.   
 The use of a particular virus (e.g. paramyxoviruses infecting a different host species) 
or VLP system (e.g. paramyxovirus M protein-, influenza M1 protein-, or HIV-1 Gag 
protein-based), which assemble and release at membrane lipid raft domains, would allow for 
passive incorporation of foreign proteins or antigens into vaccine particles.  It is conceivable 
that localizing or targeting an antigen of interest to the virus assembly site at membrane lipid 
raft domains would result in the incorporation of that antigen into the released virus particle.  
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Indeed, as proof of this principle, studies have shown incorporation of foreign proteins into 
virus or virus-like particles using several different particle systems, many of which have 
previously been shown to assemble and release from membrane lipid raft domains [reviewed 
in (126)].     
 In order to elicit an adequate immune response, the induction of cytokine molecules is 
often necessary.  As an alternative to the use of immunostimulatory adjuvants (e.g. 
lipopolysaccharide, CpG DNA) during vaccination, the co-administration or expression of 
soluble cytokines with antigens has been shown to be successful as vaccine formulations, 
including those targeting enveloped RNA viruses (51, 63, 78, 88, 123).  Due to systemic 
adverse reactions upon soluble cytokine administration or expression, it has been shown that 
the tethering of these potent immunostimulatory molecules to membranes, which also display 
the antigen of interest, limits the systemic effects of the cytokines (26, 34, 174, 194).   
 Therefore, in conjunction with the assembly and incorporation of foreign antigens, 
the packaging of immunostimulatory molecules into budding particles would enhance the 
immunogenicity and maximize the protective capability of a vaccine.  Indeed, efficient 
incorporation of cytokines (e.g. IL-2, IL-7, IL-15, GM-CSF) has been achieved by targeting 
these molecules with the addition of GPI anchors to membrane lipid raft domains during 
virus particle assembly (76, 170).  In mice, the resulting cytokine-containing vaccine 
particles induced increased levels of neutralizing antibody titers and CD4 and CD8 T cell 
responses against viral antigens in comparison to the same vaccine particles not possessing or 
presenting cytokines (170).         
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